FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Souza, TML
   Vieira, YR
   Delatorre, E
   Barbosa-Lima, G
   Luiz, RLF
   Vizzoni, A
   Jain, K
   Miranda, MM
   Bhuva, N
   Gogarten, JF
   Ng, J
   Thakkar, R
   Calheiros, AS
   Monteiro, APT
   Bozza, PT
   Bozza, FA
   Tschoeke, DA
   Leomil, L
   de Mendonca, MCL
   Rodrigues, CDD
   Torres, MC
   de Filippis, AMB
   Nogueira, RMR
   Thompson, FL
   Lemos, C
   Durovni, B
   Cerbino-Neto, J
   Morel, CM
   Lipkin, WI
   Mishra, N
AF Souza, Thiago Moreno L.
   Vieira, Yasmine Rangel
   Delatorre, Edson
   Barbosa-Lima, Giselle
   Faria Luiz, Raul Leal
   Vizzoni, Alexandre
   Jain, Komal
   Miranda, Milene Mesquita
   Bhuva, Nishit
   Gogarten, Jan F.
   Ng, James
   Thakkar, Riddhi
   Calheiros, Andrea Surrage
   Teixeira Monteiro, Ana Paula
   Bozza, Patricia T.
   Bozza, Fernando A.
   Tschoeke, Diogo A.
   Leomil, Luciana
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Torres, Maria C.
   Bispo de Filippis, Ana Maria
   Ribeiro Nogueira, Rita Maria
   Thompson, Fabiano L.
   Lemos, Cristina
   Durovni, Betina
   Cerbino-Neto, Jose
   Morel, Carlos M.
   Lipkin, W. Ian
   Mishra, Nischay
TI Emergence of the East-Central-South-African genotype of Chikungunya
   virus in Brazil and the city of Rio de Janeiro may have occurred years
   before surveillance detection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS; PHYLOGENETIC ANALYSES; POPULATION-DYNAMICS; MODEL;
   TRANSMISSION; INFERENCE; ACCURACY
AB Brazil, which is hyperendemic for dengue virus DENV), has had recent Zika ZIKV) and CHIKV) Chikungunya virus outbreaks. Since March 2016, CHIKV is the arbovirus infection most frequently diagnosed in Rio de Janeiro. In the analysis of 1835 syndromic patients, screened by real time RT-PCR, 56.4% of the cases were attributed to CHIKV, 29.6% to ZIKV, and 14.1% to DENV-4. Sequence analyses of CHIKV from sixteen samples revealed that the East-Central-South-African ECSA) genotype of CHIKV has been circulating in Brazil since 2013 [95% bayesian credible interval BCI): 03/2012-10/2013], almost a year before it was detected by arbovirus surveillance program. Brazilian cases are related to Central African Republic sequences from 1980's. To the best of our knowledge, given the available sequence published here and elsewhere, the ECSA genotype was likely introduced to Rio de Janeiro early on 2014 02/2014; BCI: 07/2013-08/2014) through a single event, after primary circulation in the Bahia state at the Northestern Brazil in the previous year. The observation that the ECSA genotype of CHIKV was circulating undetected underscores the need for improvements in molecular methods for viral surveillance.
C1 [Souza, Thiago Moreno L.; Vieira, Yasmine Rangel; Barbosa-Lima, Giselle; Faria Luiz, Raul Leal; Vizzoni, Alexandre; Bozza, Fernando A.; Cerbino-Neto, Jose] Fundacao Oswaldo Cruz Fiocruz, INI, Rio De Janeiro, RJ, Brazil.
   [Jain, Komal; Bhuva, Nishit; Gogarten, Jan F.; Ng, James; Thakkar, Riddhi; Lipkin, W. Ian; Mishra, Nischay] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
   [Delatorre, Edson] Fiocruz MS, IOC, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene Mesquita] Fiocruz MS, IOC, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
   [Souza, Thiago Moreno L.; Calheiros, Andrea Surrage; Teixeira Monteiro, Ana Paula; Bozza, Patricia T.] Fiocruz MS, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Bozza, Fernando A.] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio De Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Torres, Maria C.; Bispo de Filippis, Ana Maria; Ribeiro Nogueira, Rita Maria] Fiocruz MS, IOC, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, RJ, Brazil.
   [Lemos, Cristina; Durovni, Betina] Secretaria Municipal Saude, Rio De Janeiro, RJ, Brazil.
   [Souza, Thiago Moreno L.; Morel, Carlos M.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, INCT IDPN, Rio De Janeiro, RJ, Brazil.
   [Gogarten, Jan F.] Robert Koch Inst, Epidemiol Highly Pathogen Microorganisms, Berlin, Germany.
   [Gogarten, Jan F.] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany.
RP Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
EM wil2001@cumc.columbia.edu
RI Leomil, Luciana/O-4860-2019; Monteiro, Ana Paula T/L-9540-2013; Bozza,
   Fernando A/A-2618-2013; Tschoeke, Diogo A/F-9913-2019; Neto, Jose
   Cerbino/P-3713-2018; Morel, Carlos/Q-9657-2019; Vizzoni,
   Alexandre/W-8718-2019; Delatorre, Edson/J-8330-2015; Lipkin, W.
   Ian/ABE-6216-2020
OI Bozza, Fernando A/0000-0003-4878-0256; Tschoeke, Diogo
   A/0000-0001-8134-4259; Neto, Jose Cerbino/0000-0001-9254-917X; Morel,
   Carlos/0000-0003-2752-0009; Vizzoni, Alexandre/0000-0003-0004-5084;
   Delatorre, Edson/0000-0002-5746-0820; Lipkin, W.
   Ian/0000-0002-8768-9386; Souza, Thiago/0000-0003-2212-3899; Thompson,
   Fabiano/0000-0002-7562-1683; Bozza, Patricia/0000-0001-8349-9529
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brasil (CAPES)CAPES; National Council for Scientific and
   Technological Development (CNPq), Ministry of Science, Technology,
   Information and Communications [465313/2014-0]; Ministry of
   Education/CAPESCAPES [465313/2014-0]; Research Foundation of the State
   of Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [465313/2014-0]; Oswaldo
   Cruz Foundation/FIOCRUZ; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U19 AI109761]; DAADDeutscher Akademischer Austausch Dienst
   (DAAD); German Federal Ministry of Education and Research (BMBF)Federal
   Ministry of Education & Research (BMBF); People Programme (Marie Curie
   Actions) of the European Union's Seventh Framework Programme
   (FP7/2007-2013) under REAEuropean Union (EU) [605728]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI109761, U19AI109761, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761, U19AI109761, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761, U19AI109761, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761, U19AI109761, U19AI109761, U19AI109761] Funding Source: NIH
   RePORTER
FX We appreciate the contribution from Rio de Janeiro's city surveillance
   SMS-RJ. This study was financed in part by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance
   Code 001. YRV and ED are funded by fellowships from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES). Funding
   was also provided by National Council for Scientific and Technological
   Development (CNPq), Ministry of Science, Technology, Information and
   Communications (No. 465313/2014-0); Ministry of Education/CAPES (No.
   465313/2014-0); Research Foundation of the State of Rio de
   Janeiro/FAPERJ (No. 465313/2014-0) and Oswaldo Cruz Foundation/FIOCRUZ.
   The study was also supported by the National Institutes of Health (U19
   AI109761) to N.M., W.I.L., K.J., R.T., J.N., N.B. at the Center for
   Infection and Immunity at Columbia University, New York; and J.F.G. is a
   fellow working at CII who was supported by the DAAD with funds from the
   German Federal Ministry of Education and Research (BMBF) and the People
   Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme (FP7/2007-2013) under REA grant agreement no 605728
   (P.R.I.M.E. - Postdoctoral Researchers International Mobility
   Experience). Funders had no role in the experiment design or
   interpretation.
CR [Anonymous], 1969, B EP SECR VIG SAUD
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkr1202]
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282X20160138, 10.1590/0004-282x20160138]
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rathore Mobeen H, 2017, Adv Pediatr, V64, P27, DOI 10.1016/j.yapd.2017.04.002
   Sacramento C. Q., 2016, BIORXIV, DOI [10.1101/061671, DOI 10.1101/061671]
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   US Food and Drug Administration, 2017, CII ARBOVIROPLEX RRT
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   World Health Organization, 2004, LAB BIOS MAN 3 ED
NR 33
TC 14
Z9 14
U1 0
U2 2
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 26
PY 2019
VL 9
AR 2760
DI 10.1038/s41598-019-39406-9
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM7ZT
UT WOS:000459698900021
PM 30809003
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Vasconcellos, AG
   Fonseca, BDFE
   Morel, CM
AF Vasconcellos, Alexandre Guimaraes
   Fonseca e Fonseca, Bruna de Paula
   Morel, Carlos Medicis
TI Revisiting the concept of Innovative Developing Countries (IDCs) for its
   relevance to health innovation and neglected tropical diseases and for
   the prevention and control of epidemics
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; ZIKA VIRUS; SCIENTIFIC COLLABORATION; NETWORKS; BRAZIL;
   INFECTION; TRANSMISSION
AB Introduction
   Countries have traditionally been split into two major groups: developed or industrialized (<"the North) and developing or underdeveloped ("the South"). Several authors and organizations have challenged this classification to recognize countries that have reached an intermediate stage of social and economic development. As proposed by Morel and collaborators in 2005, the concept of Innovative Developing Countries (IDCs) defines a group of nations with impactful scientific programs. Here, IDCs are reexamined by a variety of metrics to highlight their role in health innovation through research and development (R&D) programs on neglected tropical diseases (NTDs) that also positively impact epidemic preparedness.
   Results
   To address the global changes due to expanding globalization we updated the original indicator of the number of USPTO patents deposited by individual countries per GDP and per capita to the number of international patents applications, related to applicant residence and deposited under the Patent Cooperation Treaty (PCT) per GNI (or GDP) and per capita. A comparison of the originally described ranking of top innovative countries to those in the present study revealed new members that updated the list of IDCs and showed a prominent role now played by China.
   Analyzing scientific publications in international journals since the introduction of the IDC concept in 2005 we found that IDCs do prioritize Neglected Tropical Diseases (NTDs) as an area of research.
   Finally we investigated the role of IDCs in two major public health emergencies between 2012 and 2016, the outbreaks of Ebola in West Africa and Zika in South America. An analysis of the co-authorship country networks demonstrated an important role for IDC infrastructure and personnel in the prevention and control of these epidemics.
   Discussion and conclusions
   Different techniques can be used to evaluate and measure innovative performance of countries. Country rankings published by traditional indexes, such as the Bloomberg Innovation Index (BII) and the Global Innovation Index (GII), only include high income economies among the top 20 performers. This is in sharp contrast to our approach, which identified 8-9 IDCs among the first 25 with China occupying the top position. Through an analysis of the pros and cons of the different methodologies, the IDC concept challenges more conventional approaches to address and estimate the innovative capacity of countries.
C1 [Vasconcellos, Alexandre Guimaraes] Natl Inst Ind Property INPI, Postgrad & Res Div, Rio De Janeiro, RJ, Brazil.
   [Fonseca e Fonseca, Bruna de Paula; Morel, Carlos Medicis] Oswaldo Cruz Fdn Fiocruz, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
RP Vasconcellos, AG (corresponding author), Natl Inst Ind Property INPI, Postgrad & Res Div, Rio De Janeiro, RJ, Brazil.; Morel, CM (corresponding author), Oswaldo Cruz Fdn Fiocruz, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
EM alexguim@inpi.gov.br; morel@cdts.fiocruz.br
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Fonseca, Bruna de Paula/0000-0002-8795-2578
FU Oswaldo Cruz Foundation (Fiocruz); National Council for Scientific and
   Technological Development (CNPq), Ministry of Science and
   TechnologyNational Council for Scientific and Technological Development
   (CNPq) [573642/2008-7, 465313/2014-0]; National Council for Scientific
   and Technological Development (CNPq), Ministry of Science and Technology
   (Productivity II Fellowship)National Council for Scientific and
   Technological Development (CNPq); Ministry of Education/CAPESCAPES
   [465313/2014-0]; Research Foundation of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [465313/2014-0]; CNPq postdoctoral fellowship
   at WIPO [202109/2015-1]
FX Funding was provided by the Oswaldo Cruz Foundation (Fiocruz); National
   Council for Scientific and Technological Development (CNPq), Ministry of
   Science and Technology (no. 573642/2008-7, 465313/2014-0 and
   Productivity II Fellowship to CMM); Ministry of Education/CAPES (no.
   465313/2014-0); Research Foundation of the State of Rio de Janeiro
   (FAPERJ) (no. 465313/2014-0) and CNPq postdoctoral fellowship at WIPO to
   AGV (202109/2015-1). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group, 2001, FAT IMB CRIS RES DEV
   [Anonymous], 2017, ECONOMIST
   Attaran A., 2016, HARVARD PUBLIC HLTH
   Baldwin R, 2016, GREAT CONVERGENCE IN
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Batallas DA, 2006, IEEE T ENG MANAGE, V53, P570, DOI 10.1109/TEM.2006.883706
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Benoit Battistelli, 2017, EPO BLOG
   Bornmann L, 2015, J ASSOC INF SCI TECH, V66, P1507, DOI 10.1002/asi.23333
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burhan M, 2016, TECHNOLOGICAL FORECA
   Butler D., 2016, NATURE NEWS, V540, P507
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan M., 2014, WHO DIRECTOR GEN BRI
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cornell University INSEAD & WIPO, 2017, GLOB INN IND 2017 IN
   Costa G, 2016, RIO 2016 FIC R 400 M
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Diniz D., 2016, ZIKA SERTAO NORDESTI
   European Centre for Disease Prevention and Control, 2017, ZIK EP 2014 ONW
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0151-y
   FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gay B, 2005, RES POLICY, V34, P1457, DOI 10.1016/j.respol.2005.07.001
   Global Innovation Index, 2016, WINN GLOB INN
   Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581
   Hotez PJ, 2008, FORGOTTEN PEOPLE FOR
   Jamrisko M, 2017, THESE ARE WORLDS MOS
   Keating C., 2017, K WARREN GREAT NEGLE
   LONG JC, 2013, BMC HEALTH SERV RES, V13, P36569
   Ltd IC, 2017, BLOOMB INN IND REP
   Mahoney R., 2005, INNOVATION STRATEGY, V1, P33
   Mahoney RT, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-33
   Mahoney RT, 2006, INNOVATION STRATEGY, V2, P1
   MAHONEY RT, 2006, GLOBAL FORUM UPDATE, V3, P149
   Mashelkar R. A., 2005, INNOVATION STRATEGY, V1, P16
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morel C, 2005, INNOVATION STRATEGY, V1, P1
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Nilsson A., 2013, THESIS
   OECD, 2005, OSL MAN GUID COLL IN
   Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scott JP, 2000, SOCIAL NETWORK ANALY, DOI [10.2307/3033543, DOI 10.2307/3033543]
   Tavernise S., 2016, NO ZIKA CASES REPORT
   Uniting to Combat Neglected Tropical Diseases, 2012, LOND DECL
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Vollmer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057624
   Warren K. S., 1986, ORPHAN DIS ORPHAN DR, P169
   WHO, 2016, WHO PUBL HLTH ADV RE
   WHO (World Health Organization), 2012, WHOHTMNTD20121
   WHO. World Health Organization, 2001, MACROECONOMICS HLTH
   Wike R, 2017, MORE NAME US CHINA W
   WIPO, 2017, INT PAT CLASS FREQ A
   WIPO, 2017, INT PAT CLASS IPC
   WIPO, 2016, WIPO FACTS FIG TOT A
   World Bank Group, 2016, WORLD DEV IND 2016
   World Health Organization, 2013, NEGLECTED TROPICAL D
   World Health Organization, 2005, WHOCDSCPECEE200554
   World Health Organization, 2014, STAT 1 M IHRE EM COM
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 72
TC 4
Z9 4
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006469
DI 10.1371/journal.pntd.0006469
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700003
PM 30001318
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Carroll, D
   Watson, B
   Togami, E
   Daszak, P
   Mazet, JAK
   Chrisman, CJ
   Rubin, EM
   Wolfe, N
   Morel, CM
   Gao, GF
   Burci, GL
   Fukuda, K
   Auewarakul, P
   Tomori, O
AF Carroll, Dennis
   Watson, Brooke
   Togami, Eri
   Daszak, Peter
   Mazet, Jonna A. K.
   Chrisman, Cara J.
   Rubin, Edward M.
   Wolfe, Nathan
   Morel, Carlos M.
   Gao, George F.
   Burci, Gian Luca
   Fukuda, Keiji
   Auewarakul, Prasert
   Tomori, Oyewale
TI Building a global atlas of zoonotic viruses
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Editorial Material
ID PATHOGENS; GENOMICS; DISEASES; PROJECT; HOST
C1 [Carroll, Dennis; Chrisman, Cara J.] US Agcy Int Dev, Pandem Influenza & Other Emerging Threats Unit, Bur Global Hlth, Washington, DC 20523 USA.
   [Watson, Brooke; Daszak, Peter] EcoHlth Alliance, New York, NY USA.
   [Togami, Eri; Mazet, Jonna A. K.] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA.
   [Rubin, Edward M.; Wolfe, Nathan] Metabiota, San Francisco, CA USA.
   [Morel, Carlos M.] Fundacao Oswaldo Cruz, Ctr Technol Dev Hlth, Rio De Janeiro, Brazil.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.
   [Burci, Gian Luca] Grad Inst Int & Dev Studies, Int Law Dept, Geneva, Switzerland.
   [Fukuda, Keiji] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.
   [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok, Thailand.
   [Tomori, Oyewale] Univ Lagos, Nigerian Acad Sci, Lagos, Nigeria.
RP Togami, E (corresponding author), Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA.
EM etogami@ucdavis.edu
RI TOMORI, OYEWALE/X-3021-2019; Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009; Fukuda, Keiji/0000-0002-9598-9565
CR Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8
   [Anonymous], 2013, FLU OUTBR REM PAND T
   Bird BH, 2018, ANNU REV ANIM BIOSCI, V6, P121, DOI 10.1146/annurev-animal-030117-014628
   Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Chua KB, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.34
   Fan VY, 2015, 22137 NBER
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Institute of Medicine Forum on Microbial Threat, 2004, LEARN SARS PREP NEXT
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920
   Loh EH, 2015, VECTOR-BORNE ZOONOT, V15, P432, DOI 10.1089/vbz.2013.1563
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   PREDICT Consortium, 2014, RED PAND RISK PROM G
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Wilson BJ, 2015, RISK MANAG HEALTHC P, V8, P9, DOI 10.2147/RMHP.S58728
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   World Bank, 2016, WORLD BANK GROUP EB
   WORLD HEALTH ORGANIZATION (WHO), 2005, CONTR NEGL ZOON DIS
NR 23
TC 10
Z9 10
U1 2
U2 9
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD APR
PY 2018
VL 96
IS 4
BP 292
EP 294
DI 10.2471/BLT.17.205005
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GE4VF
UT WOS:000431214900016
PM 29695886
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Carroll, D
   Daszak, P
   Wolfe, ND
   Gao, GF
   Morel, CM
   Morzaria, S
   Pablos-Mendez, A
   Tomori, O
   Mazet, JAK
AF Carroll, Dennis
   Daszak, Peter
   Wolfe, Nathan D.
   Gao, George F.
   Morel, Carlos M.
   Morzaria, Subhash
   Pablos-Mendez, Ariel
   Tomori, Oyewale
   Mazet, Jonna A. K.
TI The Global Virome Project
SO SCIENCE
LA English
DT Editorial Material
ID INFECTIOUS-DISEASES; HUMAN VIRUSES; HOST
EM daszak@ecohealthalliance.org
RI TOMORI, OYEWALE/X-3021-2019; Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
FU USAID EPT PREDICTUnited States Agency for International Development
   (USAID); Rockefeller Foundation
FX P.D., N.D.W., and J.A.K.M. are funded by USAID EPT PREDICT. We
   acknowledge S.J. Anthony, C.J. Chrisman, Y. Feferholtz, T. Goldstein, C.
   K. Johnson, D. Nabarro, K. J. Olival, N. Ross, E. Rubin, R. Waldman, B.
   Watson, C. Zambrana-Torrelio, attendees of the Rockefeller
   Foundation-funded Bellagio Center Global Virome Project Workshop August
   2016 (www.globalviromeproject.org/about/), members of the GVP Core Group
   and Steering Committee, and co-leads of the GVP Working Groups for their
   help refining the concept and this manuscript.
CR Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Geoghegan JL, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170189
   Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113
   Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   King AMQ, 2012, VIRUS TAXONOMY CLASS
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Pike J, 2014, P NATL ACAD SCI USA, V111, P18519, DOI 10.1073/pnas.1412661112
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
NR 14
TC 92
Z9 97
U1 6
U2 53
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD FEB 23
PY 2018
VL 359
IS 6378
BP 872
EP 874
DI 10.1126/science.aap7463
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX0QX
UT WOS:000425752600028
PM 29472471
DA 2020-12-17
ER

PT J
AU Thota, S
   Morel, CM
AF Thota, Sreekanth
   Morel, Carlos M.
TI Drug Discovery for Paediatric Chagas Disease
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Chagas disease; congenital; infants; symptoms; treatment; Trypanosoma
   cruzi
ID TRYPANOSOMA-CRUZI; ETIOLOGIC TREATMENT; MANAGEMENT; FUTURE
AB Chagas disease is caused by the parasite Trypanosoma cruzi and is regularly found among particular people living in Central and South America. Paediatric Chagas disease occurs in 1-10% of infants of infected mothers. The major important point considered in the treatment of congenital Chagas disease focuses on killing the parasite in acute infection and managing signs and symptoms in later stages. Nowadays, two drugs benznidazole and nifurtimox are currently available in the market for the treatment of paediatric Chagas disease.
C1 [Thota, Sreekanth; Morel, Carlos M.] Minist Saude, Fdn Oswaldo Cruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Av Brazil 4036 Predio Expansao,8 Andar Sala 814, BR-21040361 Rio De Janeiro, RJ, Brazil.
RP Thota, S (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth, Natl Inst Sci & Technol Innovat Neglected Dis, Av Brazil 4036,Predio Expansao 8 Andar Sala 814, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM sthota@cdts.fiocruz.br
RI thota, sreekanth/H-7984-2013; THOTA, SREEKANTH/AAH-6589-2019; Morel,
   Carlos/Q-9657-2019
OI thota, sreekanth/0000-0002-7501-3987; THOTA,
   SREEKANTH/0000-0002-7501-3987; Morel, Carlos/0000-0003-2752-0009
FU National Council for Scientific and Technological Development (CNPq),
   Ministry of Science and TechnologyNational Council for Scientific and
   Technological Development (CNPq) [573642/2008-7]; Institute Nacional de
   Ciencia e Tecnologia de Inovacao em Doencas de Populacoes Negligenciadas
   (INCT-IDPN); National Council for Scientific and Technological
   Development (CNPq), Ministry of Science and Technology (IA Productivity
   Fellowship)National Council for Scientific and Technological Development
   (CNPq)
FX National Council for Scientific and Technological Development (CNPq),
   Ministry of Science and Technology (no. 573642/2008-7 and IA
   Productivity Fellowship to CMM); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Ministry of Education (no.
   573642/2008-7) and Oswaldo Cruz Foundation (Fiocruz). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. The authors also acknowledge support
   from the Institute Nacional de Ciencia e Tecnologia de Inovacao em
   Doencas de Populacoes Negligenciadas (INCT-IDPN).
CR Berenstein A., 2006, 34 C ARG PED CIUD CO
   Bern C, 2008, REV SOC BRAS MED TRO, V41, P315
   Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11
   Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204
   Burton OM, 2012, BREASTFEED MED, V7, P334, DOI 10.1089/bfm.2012.0096
   Cancado J. R., 2002, REV INST MED TROP SP, V44, P20
   Carlier Y., PLOS NEGL TROP DIS, V5, pe1250
   Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250
   Clayton J, 2010, NATURE, V465, pS4, DOI 10.1038/nature09220
   Coura J R, 1996, Bol Chil Parasitol, V51, P69
   Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009
   Coura J.R., 1978, P 10 INT C CHEM, V1, P161
   COURA JR, 1991, MEM I OSWALDO CRUZ, V86, P395, DOI 10.1590/S0074-02761991000400003
   Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001
   Dandapani S, 2014, ACS MED CHEM LETT, V5, P149, DOI 10.1021/ml400403u
   deAndrade ALSS, 1996, LANCET, V348, P1407
   Ferreira H. O., 1988, J PEDIAT, V64, P126
   Garcia-Bournissen Facundo, 2009, Paediatr Drugs, V11, P33
   Gartner LM, 2005, PEDIATRICS, V115, P496, DOI [10.1542/peds.2011-3552, 10.1542/peds.2004-2491]
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Ilies MA, 2014, J MED CHEM, V57, P296, DOI 10.1021/jm4019405
   Kraus JM, 2010, J MED CHEM, V53, P3887, DOI 10.1021/jm9013136
   MORENO SNJ, 1982, ARCH BIOCHEM BIOPHYS, V218, P585, DOI 10.1016/0003-9861(82)90383-6
   Patterson S, 2014, TRENDS PARASITOL, V30, P289, DOI 10.1016/j.pt.2014.04.003
   Ponce C, 2005, J CLIN MICROBIOL, V43, P5065, DOI 10.1128/JCM.43.10.5065-5068.2005
   Raether W, 2003, PARASITOL RES, V90, pS19, DOI 10.1007/s00436-002-0754-9
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Rodrigues GC, 2014, J MED CHEM, V57, P298, DOI 10.1021/jm400902y
   Russomando G, 1998, AM J TROP MED HYG, V59, P487, DOI 10.4269/ajtmh.1998.59.487
   Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338
   Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093
   Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011
   Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5
   Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001
   WHO, 2012, WHO TECH REP SER, V975, P1
   WHO, 2010, WHOHTMNTD20101
NR 36
TC 0
Z9 0
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2018
VL 18
IS 9
BP 776
EP 780
DI 10.2174/1389557516666161226155204
PG 5
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GF1QB
UT WOS:000431708500003
PM 26202205
DA 2020-12-17
ER

PT J
AU Katz, N
   Araujo, N
   Coelho, PMZ
   Morel, CM
   Linde-Arias, AR
   Yamada, T
   Horimatsu, Y
   Suzuki, K
   Sunazuka, T
   Omura, S
AF Katz, Naftale
   Araujo, Neusa
   Zech Coelho, Paulo Marcos
   Morel, Carlos Medicis
   Linde-Arias, Ana Rosa
   Yamada, Takeshi
   Horimatsu, Yuki
   Suzuki, Koh
   Sunazuka, Toshiaki
   Omura, Satoshi
TI Ivermectin efficacy against Biomphalaria, intermediate host snail
   vectors of Schistosomiasis
SO JOURNAL OF ANTIBIOTICS
LA English
DT Article
ID MOLLUSCICIDAL PROPERTIES
AB The impact of ivermectin on adult snails of the genus Biomphalaria (B. glabrata, B. tenagophila and B. straminea), B. glabrata infected with Schistosoma mansoni, snail egg-masses cercariae and miracidia, as well as on guppy fish ( Poecilia reticulata) was examined and evaluated. Biomphalaria snails, egg-masses, parasite stages and guppies were all exposed to different concentrations of ivermectin for 24 h, followed by regular observations of mortality. The calculated lethal doses of ivermectin were around an LD50 of 0.03 mu g ml(-1), and an LD90 of 0.3 mu g ml(-1) for the three species of snails. Specimens of B. glabrata actually shedding parasite cercariae all died when exposed to ivermectin at a concentration of a mere 0.01 mu g ml(-1). Ivermectin B-1a, the major (80%) component of commercially available ivermectin, proved to be inactive, and it was the minor (20%) component, ivermectin B-1b, which caused snail death. Snail egg-masses were not affected, even at the highest concentration of 100 mu g ml(-1). With respect to S. mansoni parasite stages, 0.2 mu g ml(-1) ivermectin killed 50% of cercariae and miracidia within five minutes, rising to 90% after 30 min. Mortality of guppy fish within 24 h of exposure to ivermectin at concentrations of 0.5 mu g ml(-1) and 0.01 mu g ml(-1), were 100% and 30%, respectively. The concentration of 0.01 mu g ml(-1) that killed Schistosoma mansoni-infected snails only caused 30% mortality in guppy fish. Ivermectin can be considered a promising molluscicide, especially as it is more potent against infected snails than uninfected ones, although it has no impact on egg-masses. Ivermectin and its derivatives could be explored in the search for a new agent to help control schistosomiasis transmission.
C1 [Katz, Naftale; Araujo, Neusa; Zech Coelho, Paulo Marcos] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
   [Morel, Carlos Medicis; Linde-Arias, Ana Rosa] Fundacao Oswaldo Cruz, FIOCRUZ, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
   [Yamada, Takeshi; Sunazuka, Toshiaki; Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan.
   [Yamada, Takeshi; Horimatsu, Yuki; Suzuki, Koh; Sunazuka, Toshiaki] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo, Japan.
RP Katz, N (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.; Sunazuka, T; Omura, S (corresponding author), Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan.
EM nkatz@cpqrr.fiocruz.br; sunazukatoshiaki@yahoo.co.jp;
   omuras@insti.kitasato-u.ac.jp
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
FU Department of Science and Technology (DECIT), Ministry of Health
   (FIOTEC) [439, 820]; National Council for Scientific and Technological
   Development (CNPq), Ministry of Science and Technology [573642/2008-7];
   National Council for Scientific and Technological Development (CNPq),
   Ministry of Science and Technology (IA Productivity Fellowship);
   Ministry of Education/CAPESCAPES [573642/2008-7]; Research Foundation of
   the State of Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [573642/2008-7]; Oswaldo Cruz Foundation (Fiocruz); Grants-in-Aid for
   Scientific ResearchMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15K18836]
   Funding Source: KAKEN
FX We would like to express our thanks to Sueleny Silva Teixeira Ferreira,
   of the Mollusc Room Lobato Paraense, Research Center Rene
   Rachou/FIOCRUZ, for technical support during the experiments, Dr John
   Kusel for help with the preparation of this manuscript and to Dr Andy
   Crump to check the grammar and to clarify the logic of the manuscript.
   This work was funded by the Department of Science and Technology
   (DECIT), Ministry of Health (FIOTEC nos 439 and 820); National Council
   for Scientific and Technological Development (CNPq), Ministry of Science
   and Technology (nos 573642/2008-7 and IA Productivity Fellowship to
   CMM); Ministry of Education/CAPES (nos 573642/2008-7); Research
   Foundation of the State of Rio de Janeiro (FAPERJ) (nos 573642/2008-7
   and Oswaldo Cruz Foundation (Fiocruz). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361
   CAMPBELL W C, 1985, Parasitology Today, V1, P10, DOI 10.1016/0169-4758(85)90100-0
   CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014
   Clark TE, 1997, J ETHNOPHARMACOL, V56, P1, DOI 10.1016/S0378-8741(96)01495-X
   Crump A, 2011, P JPN ACAD B-PHYS, V87, P13, DOI 10.2183/pjab.87.13
   CUPP EW, 1986, SCIENCE, V231, P740, DOI 10.1126/science.3753801
   GONNERT R., 1962, Comparative investigations of some mollusci-cides. Ciba Foundation Symposium on Bilhar-ziasis, Cairo, March 18-22, 1962., P326
   Greene B. M., 1989, Ivermectin and abamectin., P311
   HARRISON A. D., 1966, S AFRICAN J SCI, V62, P238
   Katz N, 2000, Rev Soc Bras Med Trop, V33, P303, DOI 10.1590/S0037-86822000000300009
   Lemma A, 1974, Ethiop Med J, V12, P109
   LEMMA A, 1972, J PARASITOL, V58, P104, DOI 10.2307/3278251
   MASSOUD J, 1973, Bulletin de la Societe de Pathologie Exotique, V66, P544
   MATHA V, 1988, J INVERTEBR PATHOL, V52, P354, DOI 10.1016/0022-2011(88)90146-2
   OKAFOR F C, 1990, Angewandte Parasitologie, V31, P65
   Oliveira EC, 2000, ECOTOX ENVIRON SAFE, V46, P342, DOI 10.1006/eesa.2000.1924
   Oliver L., 1960, EMPLOYMENT SNAIL EGG
   Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023
   Omura S, 2004, NAT REV MICROBIOL, V2, P984, DOI 10.1038/nrmicro1048
   PEREIRA JP, 1978, REV BRAS PESQUI MED, V11, P345
   RITCHIE LS, 1963, B WORLD HEALTH ORGAN, V29, P281
   Rouquayrol M. Z., 1973, Revista da Sociedade Brasileira de Medicina Tropical, V7, P11, DOI 10.1590/S0037-86821973000100003
   ROZENDAAL J.A., 1997, VECTOR CONTROL METHO, P337
   Souza Cecilia Pereira De, 1995, Memorias do Instituto Oswaldo Cruz Rio de Janeiro, V90, P5
   WHO, 1965, B WORLD HEALTH ORGAN, V33
   Zaha O., 2002, MACROLIDE ANTIBIOTIC, P403
NR 26
TC 4
Z9 5
U1 0
U2 4
PU JAPAN ANTIBIOTICS RESEARCH ASSOC
PI TOKYO
PA 2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN
SN 0021-8820
J9 J ANTIBIOT
JI J. Antibiot.
PD MAY
PY 2017
VL 70
IS 5
BP 680
EP 684
DI 10.1038/ja.2017.31
PG 5
WC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Immunology; Microbiology;
   Pharmacology & Pharmacy
GA ET4FP
UT WOS:000400235000031
PM 28293033
OA Bronze
DA 2020-12-17
ER

PT J
AU Rodrigues, ML
   Morel, CM
AF Rodrigues, Marcio L.
   Morel, Carlos M.
TI The Brazilian Dilemma: Increased Scientific Production and High
   Publication Costs during a Global Health Crisis and Major Economic
   Downturn
SO MBIO
LA English
DT Editorial Material
ID ZIKA VIRUS; PAGE CHARGES; OUTBREAK
C1 [Rodrigues, Marcio L.; Morel, Carlos M.] Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, Brazil.
   [Rodrigues, Marcio L.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
RP Rodrigues, ML; Morel, CM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, Brazil.; Rodrigues, ML (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
EM marciolrodrig@gmail.com; morel@cdts.fiocruz.br
RI Rodrigues, Marcio/J-3727-2013; Morel, Carlos/Q-9657-2019; Morel, Carlos
   M/B-4079-2009
OI Rodrigues, Marcio/0000-0002-6081-3439; Morel,
   Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
FU Wellcome TrustWellcome Trust [WT104741MA] Funding Source: Medline
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CNPq, 2016, ED UN CHAM MCTI CNPQ
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   GRUNDFEST H, 1969, SCIENCE, V164, P905, DOI 10.1126/science.164.3882.905-c
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kligfield P, 2005, J ELECTROCARDIOL, V38, P296, DOI 10.1016/j.jelectrocard.2005.05.004
   Nature Medicine, 2011, NAT MED, V11, P1169
   Petherick A, 2011, NAT MED, V17, P1173, DOI 10.1038/nm1011-1173
   World Factbook, 2009, COUNTR COMP GROSS DO
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 5
Z9 5
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2016
VL 7
IS 3
AR e00907-16
DI 10.1128/mBio.00907-16
PG 2
WC Microbiology
SC Microbiology
GA DW1YP
UT WOS:000383440300075
PM 27353760
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Yamey, G
   Morel, C
AF Yamey, Gavin
   Morel, Carlos
TI Investing in Health Innovation: A Cornerstone to Achieving Global Health
   Convergence
SO PLOS BIOLOGY
LA English
DT Editorial Material
ID GENERATION
C1 [Yamey, Gavin] Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   [Morel, Carlos] Fundacao Oswaldo Cruz, Ctr Technol Dev Hlth, Natl Inst Sci & Technol Innovat Neglected Dis, Rio De Janeiro, Brazil.
RP Yamey, G (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
EM gavin.yamey@duke.edu
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR Engmann Cyril M, 2016, PLoS Med, V13, pe1001969, DOI 10.1371/journal.pmed.1001969
   Fenner F, 1988, SMALLPOX ITS ERADICA
   FOEGE WH, 1971, AM J EPIDEMIOL, V94, P311, DOI 10.1093/oxfordjournals.aje.a121325
   Gray GE, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002372
   Hecht R, 2012, RETHINKHIV: SMARTER WAYS TO INVEST IN ENDING HIV IN SUB-SAHARAN AFRICA, P299
   Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380
   Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0003895
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4
   Jamison Dean T., 2004, 21 DIS CONTR PRIOR P
   Karim SSA, 2012, SCIENCE, V337, P133, DOI 10.1126/science.1226535
   Kruk ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002360
   Kruk ME, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009527
   Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965
   Moran M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002363
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Mundel T, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002376
   Policy Cures, 2015, MEAS GLOB HLTH R D P
   Rottingen JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001219
   Summer LH, 2015, ASTONISHING RETURNS
   Thompson KM, 2006, RISK ANAL, V26, P1423, DOI 10.1111/j.1539-6924.2006.00831.x
NR 21
TC 6
Z9 6
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAR
PY 2016
VL 14
IS 3
AR e1002389
DI 10.1371/journal.pbio.1002389
PG 5
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA DH8JB
UT WOS:000373038200007
PM 26934485
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Buss, PM
   Chamas, C
   Faid, M
   Morel, C
AF Buss, Paulo Marchiori
   Chamas, Claudia
   Faid, Miriam
   Morel, Carlos
TI Development, health, and international policy: the research and
   innovation dimension
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Review
DE Research; Sustainable Development; Innovation
AB This text main objective is to discuss development and health from the perspective of the influence of global health governance, using as the tracer the dimension of research, development, and innovation policies in health, which relate to both important inputs for the health system, like drugs and medicines, vaccines, diagnostic reagents, and equipment, and innovative concepts and practices for the improvement of health systems and public health. The authors examine the two main macro-processes that influence development and health: the post-2015 Development Agenda and the process under way in the World Health Organization concerning research and development, intellectual property, and access to health inputs. The article concludes, first, that much remains to be done for the Agenda to truly represent a coherent and viable international political pact, and that the two macro-processes related to innovation in health need to be streamlined. But this requires democratization of participation by the main stakeholders - patients and the general population of the poorest countries - since this is the only way to overcome a "zero sum" result in the clash in the current debates among member State representatives.
C1 [Buss, Paulo Marchiori] Fundacao Oswaldo Cruz, Ctr Relacoes Int Saude, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Chamas, Claudia; Faid, Miriam; Morel, Carlos] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, RJ, Brazil.
RP Buss, PM (corresponding author), Fundacao Oswaldo Cruz, Ctr Relacoes Int Saude, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM buss@fiocruz.br
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
FU Brazilian National Institute of Science and Technology for Innovation in
   Neglected Diseases (INCT-IDN) (CNPq-SCTIE/MS-FAPERJ)
FX The authors wish to thank the Brazilian National Institute of Science
   and Technology for Innovation in Neglected Diseases (INCT-IDN)
   (CNPq-SCTIE/MS-FAPERJ) for the financial support.
CR Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X
   Buss PM, 2007, J PUBLIC HEALTH POL, V28, P2, DOI 10.1057/palgrave.jphp.3200119
   Buss PM, 2014, CAD SAUDE PUBLICA, V30, P2555, DOI 10.1590/0102-311XAT011214
   Canfin P, 2013, LANCET, V381, P1885, DOI 10.1016/S0140-6736(13)60952-6
   Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ
   Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ
   Department of Economic and Social Affairs United Nations, 2007, UN DEV AG DEV ALL
   Gadelha CAG, 2012, POLITICAS SISTEMA SA, P209
   Global Forum for Health Research, 1999, 10 90 REP HLTH RES 1
   Gadelha CAG, 2012, REV SAUDE PUBL, V46, P13, DOI [10.1590/S0034-89102012005000062, 10.1590/s0034-89102012005000062]
   Grupo de los 77, NUEV ORD MUND VIV BI
   Jacklein W., 2014, DIPLOMATIQUE BRASIL, P13
   Medecins Sans Frontieres, 2001, FAT IMB CRIS RES DEV
   Ministerio das Relacoes Exteriores, 2014, NEG AG DES POS 2015
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Organizacao Mundial da Saude, DECL POL RIO DET SOC
   Ottersen OP, ORIGENS POLITICAS IN
   Piketty T., 2014, CAPITAL SECULO 21
   Stiglitz J, EC STAGNATION DESIGN
   Sustainable Development Solutions Network, 2015, IND MON FRAM SUST DE
   Task Team, HLTH POST 2015 AG
   Terry RF, 2014, SCIENCE, V345, P1302, DOI 10.1126/science.1258737
   Thematic Group on Health for All of the Sustainable Development Solutions Network, 2014, HLTH FRAM SUST DEV
   UN, 2014, ROAD DIGN 2030 END P
   United Nations, OP WORK GROUP SUST D
   United Nations, 2013, NEW GLOB PARTN ER PO
   Wallach LM, 2014, MONDE DIPLOMATIQUE B, P12
   WHO, 2001, MACR HLTH INV HLTH E
   World Health Assembly, A68 34 ADD 1 FOLLOW
   World Health Organisation, 2011, GLOB STRAT PLAN ACT
   World Health Organization, MOSC DECL PREAMBL
   World Health Organization, WHO REF
   World Health Organization, INT WORK GROUP PUBL
   World Health Organization, 2006, PUBL HLTH INN INT PR
   World Health Organization, 2010, REP WHO EXP WORK GRO
   World Health Organization (WHO), 2012, RES DEV MEET HLTH NE
   World Trade Organization, WTO DECL TRIPS AGR P
   World Trade Organization, 1995, AGR TRAD ASP INT PRO
NR 38
TC 3
Z9 3
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2016
VL 32
SU 2
AR e00046815
DI 10.1590/0103-311X00046815
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EC9MK
UT WOS:000388468500006
PM 27828674
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Kritski, A
   Barreira, D
   Junqueira-Kipnis, AP
   Moraes, MO
   Campos, MM
   Degrave, WM
   Miranda, SS
   Krieger, MA
   Chimara, E
   Morel, C
   Dalcolmo, MP
   Maciel, ELN
   Evangelista, MDN
   Villa, TS
   Sanchez, M
   Costa, FD
   Queiroz, I
   Oliveira, MM
   Souza, R
   Silva, JRLE
   Ruffino-Netto, A
AF Kritski, Afranio
   Barreira, Draurio
   Junqueira-Kipnis, Ana Paula
   Moraes, Milton Ozorio
   Campos, Maria Martha
   Degrave, Wim Mauritz
   Miranda, Silvana Spindola
   Krieger, Marco Aurelio
   Chimara, Erica
   Morel, Carlos
   Dalcolmo, Margareth Pretti
   Noia Maciel, Ethel Leonor
   Nantua Evangelista, Maria do Socorro
   Villa, Teresa Scatena
   Sanchez, Mauro
   Costa, Fernanda Dockhorn
   Queiroz, Inacio
   Oliveira, Martha Maria
   Souza Junior, Ruy
   Lapa e Silva, Jose Roberto
   Ruffino-Netto, Antonio
TI Brazilian Response to Global End TB Strategy: The National Tuberculosis
   Research Agenda
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
C1 [Kritski, Afranio; Junqueira-Kipnis, Ana Paula; Campos, Maria Martha; Miranda, Silvana Spindola; Krieger, Marco Aurelio; Chimara, Erica; Dalcolmo, Margareth Pretti; Noia Maciel, Ethel Leonor; Villa, Teresa Scatena; Sanchez, Mauro; Oliveira, Martha Maria; Lapa e Silva, Jose Roberto; Ruffino-Netto, Antonio] Rede Brasileira Pesquisa TB Rede TB, Rio De Janeiro, RJ, Brazil.
   [Kritski, Afranio; Lapa e Silva, Jose Roberto] Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
   [Barreira, Draurio; Nantua Evangelista, Maria do Socorro; Costa, Fernanda Dockhorn; Souza Junior, Ruy] Minist Saude, Secretaria Vigilancia Saude, Programa Nacl Controle TB, Brasilia, DF, Brazil.
   [Junqueira-Kipnis, Ana Paula] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunopatol Doencas Infecciosas, Goiania, Go, Brazil.
   [Moraes, Milton Ozorio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Campos, Maria Martha] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol & Farmacol, Porto Alegre, RS, Brazil.
   [Degrave, Wim Mauritz] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, RJ, Brazil.
   [Miranda, Silvana Spindola] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil.
   [Krieger, Marco Aurelio] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Genom Func, Curitiba, Parana, Brazil.
   [Chimara, Erica] Adolfo Lutz Inst, Lab Micobacterias, Sao Paulo, SP, Brazil.
   [Morel, Carlos; Oliveira, Martha Maria] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, RJ, Brazil.
   [Dalcolmo, Margareth Pretti] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Spain.
   [Nantua Evangelista, Maria do Socorro] Univ Brasilia, Fac Ciencias Saude, Dept Enfermagem, Brasilia, DF, Brazil.
   [Villa, Teresa Scatena] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, Sao Paulo, Brazil.
   [Sanchez, Mauro] Univ Brasilia, Fac Ciencias Saude, Dept Saude Publ, Brasilia, DF, Brazil.
   [Queiroz, Inacio] Grp Pela Vidda, Rio De Janeiro, Brazil.
   [Ruffino-Netto, Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RP Kritski, A (corresponding author), Rede Brasileira Pesquisa TB Rede TB, Rio De Janeiro, RJ, Brazil.; Kritski, A (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
EM kritskia@gmail.com
RI Campos, Maria Martha M/J-8829-2015; Krieger, Marco/AAE-8611-2020;
   Chimara, Erica/U-4381-2019; Morel, Carlos/Q-9657-2019; Sanchez,
   Mauro/AAU-2404-2020; Morel, Carlos M/B-4079-2009; Moraes, Milton
   Ozorio/G-9753-2011; Kritski, Afranio/I-6760-2016; Junqueira-Kipnis, Ana
   Paula/I-5534-2012; Lapa e Silva, Jose R./AAS-4793-2020; Maciel, Ethel
   Leonor LN/G-1027-2012; Villa, Tereza Cristina Scatena/K-7891-2013
OI Campos, Maria Martha M/0000-0002-1153-3633; Morel,
   Carlos/0000-0003-2752-0009; Sanchez, Mauro/0000-0002-0472-1804; Morel,
   Carlos M/0000-0003-2752-0009; Moraes, Milton Ozorio/0000-0003-2653-0037;
   Lapa e Silva, Jose R./0000-0003-3116-0253; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Villa, Tereza Cristina
   Scatena/0000-0001-8927-2624; Campos, Maria/0000-0001-7738-9892; kritski,
   afranio/0000-0002-5900-6007
FU CNPq/INCTNational Council for Scientific and Technological Development
   (CNPq) [573548/2008-0]; ICOHRTA AIDS/TB [5 U2R TW006883-10]
FX This work was funded by CNPq/INCT - Process: 573548/2008-0 and by the
   ICOHRTA AIDS/TB grant # 5 U2R TW006883-10.
CR BRICS Health Ministers, 2014, COMM 4 M
   Dirlikov E, 2015, ANN INTERN MED, V163, P52, DOI 10.7326/M14-2210
   Kritski Afranio, 2010, Rev Port Pneumol, V16SA, pS67, DOI 10.1016/S0873-2159(15)30095-7
   Kritski AL, 2007, REV SAUDE PUBL, V41
   Lienhardt C, 2014, NATURE, V507, P401, DOI 10.1038/507401a
   MS-Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   World Health Organization, 2015, GLOB TUB REP 2015
   World Health Organization (WHO), 2015, GLOB PLAN STOP ENG T
NR 11
TC 11
Z9 11
U1 0
U2 6
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 135
EP 145
DI 10.1590/0037-8682-0330-2015
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300023
PM 27163579
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Thota, S
   Morel, CM
AF Thota, S.
   Morel, C. M.
TI New strategies for research and development
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Thota, S.; Morel, C. M.] Fiocruz MS, Oswaldo Cruz Fdn, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, BR-21045900 Rio De Janeiro, Brazil.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.324
BP 425
EP 425
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802303
DA 2020-12-17
ER

PT J
AU Thota, S
   Morel, CM
AF Thota, Sreekanth
   Morel, Carlos M.
TI Recent Advances in Synthetic Chemistry of Diabetic Research
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Diabetes mellitus; Glucose homeostasis; H-3 receptor antagonists;
   Heterocyclic compounds
ID INSULIN
AB Diseases started even before the existence of human beings. Therefore, when the civilization began, the biggest threats for human were diseases. Man has made several sincere attempts for the search of new drugs in order to cure and control different diseases. Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that accounts for about 85-95% of all diagnosed cases of diabetes. It is characterized by abnormalities in glucose homeostasis in many organs, and is associated with considerable morbidity and mortality. Extensive research has been carried out using rational drug design to identify and optimize new leads for molecular targets of T2DM, which include Heterocyclic compounds, metal complexes, H-3 receptor antagonists, glucagon receptor antagonists and human incretin-degrading enzyme dipeptidyl peptidase IV inhibitors.
C1 [Thota, Sreekanth; Morel, Carlos M.] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, BR-21040361 Rio De Janeiro, RJ, Brazil.
RP Thota, S (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth, Natl Inst Sci & Technol Innovat Neglected Dis, Ave Brazil 4036, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM sthota@cdts.fiocruz.br
RI thota, sreekanth/H-7984-2013; Morel, Carlos/Q-9657-2019; THOTA,
   SREEKANTH/AAH-6589-2019
OI thota, sreekanth/0000-0002-7501-3987; Morel, Carlos/0000-0003-2752-0009;
   THOTA, SREEKANTH/0000-0002-7501-3987
CR Adeghate E., 2001, ARCH PHYSL BIOCH, V109, P96
   Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x
   Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004
   El-Megharbel SM, 2015, SPECTROCHIM ACTA A, V135, P850, DOI 10.1016/j.saa.2014.07.074
   Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956
   Hegarty BD, 2009, ACTA PHYSIOL, V196, P129, DOI 10.1111/j.1748-1716.2009.01968.x
   Jan V V, 2008, J INORG BIOCHEM, V102, P595
   Kaczanowska K, 2010, ACS MED CHEM LETT, V1, P530, DOI 10.1021/ml100200c
   Kharbanda C, 2014, BIOORG MED CHEM LETT, V24, P5298, DOI 10.1016/j.bmcl.2014.09.044
   Kuzuya T, 2000, BRIT J NUTR, V84, pS177
   LeRoith Derek, 2007, Clin Cornerstone, V8 Suppl 7, pS19, DOI 10.1016/S1098-3597(07)80018-4
   Li Z., 2015, CHINESE CHEM LETT, V26, P6137
   Passadouro M, 2010, J INORG BIOCHEM, V104, P987, DOI 10.1016/j.jinorgbio.2010.05.004
   Patil VS, 2013, EUR J MED CHEM, V59, P304, DOI 10.1016/j.ejmech.2012.11.020
   Rao AU, 2012, ACS MED CHEM LETT, V3, P198, DOI 10.1021/ml200250t
   SCHEEN AJ, 1993, ACTA CLIN BELG, V48, P259, DOI 10.1080/17843286.1993.11718317
   Shingalapur RV, 2010, EUR J MED CHEM, V45, P1753, DOI 10.1016/j.ejmech.2010.01.007
   Shu CT, 2014, ACS MED CHEM LETT, V5, P921, DOI 10.1021/ml5001905
   Singh N, 2011, BIOORG MED CHEM LETT, V21, P4404, DOI 10.1016/j.bmcl.2011.06.040
   Song KS, 2011, ACS MED CHEM LETT, V2, P182, DOI 10.1021/ml100256c
   Stefek M., 2010, TRANSWORLD RES NETWO, P341
   Syed N., 2014, BIOORG MED CHEM LETT, V24, P3034
   Trevino George, 2007, MedGenMed, V9, P25
   World Health Organization, 2013, DIAB
   Wu YL, 2013, J MED CHEM, V56, P5094, DOI 10.1021/jm400459m
   Yanardag R, 2009, EUR J MED CHEM, V44, P818, DOI 10.1016/j.ejmech.2008.04.023
   Yelovitch S, 2012, J MED CHEM, V55, P7623, DOI 10.1021/jm3006355
   Yusheng X., 2012, J MED CHEM, V55, P6137
   Zhu X, 2014, MOL PHARMACEUT, V11, P317, DOI 10.1021/mp400493b
NR 29
TC 2
Z9 2
U1 0
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2015
VL 15
IS 14
BP 1159
EP 1163
DI 10.2174/1389557515666150722112942
PG 5
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA CT0WX
UT WOS:000362519700004
PM 26202188
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, Carlos Medicis
TI Debate on the paper by Guimaraes
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
C1 Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil.
RP Morel, CM (corresponding author), Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil.
EM morel@cdts.fiocruz.br
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR Bush V., 1945, TECHNICAL REPORT
   Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ
   Gibbons M., 1994, NEW PRODUCTION KNOWL
   Gadelha CAG, 2012, REV SAUDE PUBL, V46, P21, DOI 10.1590/S0034-89102012005000065
   Stokes Donald E., 1997, PASTEURS QUADRANT BA
NR 5
TC 0
Z9 0
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD AUG
PY 2014
VL 30
IS 8
BP 1598
EP 1598
DI 10.1590/0102-311XCO010814
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AP5ON
UT WOS:000342128600004
PM 25210896
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Silva, AB
   Morel, CM
   de Moraes, IHS
AF Silva, Angelica Baptista
   Morel, Carlos Medicis
   Sozzi de Moraes, Ilara Haemmerli
TI Proposal for a telehealth concept in the translational research model
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Translational Medical Research; Research in Health Services Health
   Research Policy; Milk Banks; Breast Feeding; Review
ID CLINICAL-RESEARCH; HEALTH-CARE; SCIENCE; INNOVATION; EPIDEMIOLOGY;
   ASSOCIATION; CHALLENGES; EPICENTER; QUALITY
AB OBJECTIVE: To review the conceptual relationship between telehealth and translational research.
   METHODS: Bibliographical search on telehealth was conducted in the Scopus, Cochrane BVS, LILACS and MEDLINE databases to find experiences of telehealth in conjunction with discussion of translational research in health. The search retrieved eight studies based on analysis of models of the five stages of translational research and the multiple strands of public health policy in the context of telehealth in Brazil. The models were applied to telehealth activities concerning the Network of Human Milk Banks, in the Telemedicine University Network.
   RESULTS: The translational research cycle of human milk collected, stored and distributed presents several integrated telehealth initiatives, such as video conferencing, and software and portals for synthesizing knowledge, composing elements of an information ecosystem, mediated by information and communication technologies in the health system.
   CONCLUSIONS: Telehealth should be composed of a set of activities in a computer mediated network promoting the translation of knowledge between research and health services.
C1 [Silva, Angelica Baptista] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Lab Telessaude, Rio De Janeiro, RJ, Brazil.
   [Morel, Carlos Medicis] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, RJ, Brazil.
   [Sozzi de Moraes, Ilara Haemmerli] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Sociais, Rio De Janeiro, RJ, Brazil.
RP Silva, AB (corresponding author), IFF, Lab Telessaude, Av Rui Barbosa,716 Predio Anexo 5 Andar Flamengo, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM angelica.silva@iff.fiocruz.br
RI Silva, Angelica Baptista/AAX-8301-2020; Morel, Carlos/Q-9657-2019;
   Morel, Carlos M/B-4079-2009
OI Silva, Angelica Baptista/0000-0003-0292-5106; Morel,
   Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR Alkmim MB, 2012, IMPROVING PATIENT AC
   Almeida Filho N., 2012, EPIDEMIOLOGIA SAUDE, P291
   Almeida JAG, 2001, BREASTFEEDING NATURE
   Almeida JAG, 2006, REV CUBANA SALUD PUB, V32
   Bashshur R, 2011, TELEMED E-HEALTH, V17, P484, DOI 10.1089/tmj.2011.0103
   Bergel SD, 1999, REV BIOETICA, V7, P165
   Blanton RE, 2011, EPIDEMIOLOGIA SAUDE, P342
   Canepa MA, 2011, MODELO COOPERACION H
   Capella A. C. N., 2007, POLITICAS PUBLICAS B, P87
   Carroll M, 2010, TELEMED J E-HEALTH, V16, P107, DOI 10.1089/tmj.2009.0157
   CASTELLS M., 2003, GALAXIA INTERNET REF
   Cook EDM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006929.pub2
   Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Doarn CR, 2010, TELEMED J E-HEALTH, V16, P89, DOI 10.1089/tmj.2009.0151
   Donabedian A., 2003, INTRO QUALITY ASSURA
   Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e20
   Gardner CA, 2007, HEALTH AFFAIR, V26, P1052, DOI 10.1377/hlthaff.26.4.1052
   Giugliani Elsa Regina Justo, 2002, J. Pediatr. (Rio J.), V78, P183, DOI 10.1590/S0021-75572002000300001
   Glasgow RE, 2012, AM J PREV MED, V42, P646, DOI 10.1016/j.amepre.2012.02.016
   Hall Jacqueline A, 2012, Stud Health Technol Inform, V179, P38
   Hall R Whit, 2010, Ethn Dis, V20, pS1
   Hawthorne K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub2
   Hiatt RA, 2010, AM J EPIDEMIOL, V172, P525, DOI 10.1093/aje/kwq212
   Kailas A, 2009, WIRELESS PERS COMMUN, V51, P673, DOI 10.1007/s11277-009-9763-7
   Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P148, DOI 10.1038/clpt.2010.287
   Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293
   Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211
   Khoury MJ, 2010, AM J EPIDEMIOL, V172, P528, DOI 10.1093/aje/kwq214
   Kingdon JW, 2002, LONGMAN CLASSICS POL
   LATOUR B., 2000, CIENCIA ACAO COMO SE
   Latour B., 1994, JAMAIS FOMOS MODERNO, P34
   Maia Paulo Ricardo da Silva, 2004, Cad. Saúde Pública, V20, P1700, DOI 10.1590/S0102-311X2004000600029
   Manderson L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000332
   Masi C, 2012, J CLIN HYPERTENS, V14, P45, DOI 10.1111/j.1751-7176.2011.00559.x
   Morel Carlos M., 2006, Cad. Saúde Pública, V22, P1522, DOI 10.1590/S0102-311X2006000800001
   Novak Franz R., 2002, J. Pediatr. (Rio J.), V78, P193, DOI 10.1590/S0021-75572002000300005
   Oda L, 2000, Hist Cienc Saude Manguinhos, V7, P515, DOI 10.1590/S0104-59702000000300022
   Offit K, 2011, HUM GENET, V130, P3, DOI 10.1007/s00439-011-1028-3
   Patki S, 2010, HUM CELL, V23, P35, DOI 10.1111/j.1749-0774.2010.00083.x
   Patterson SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008165.pub2
   Schmeida M, 2007, J HEALTH CARE POOR U, V18, P637, DOI 10.1353/hpu.2007.0068
   Schmittdiel JA, 2010, ANN FAM MED, V8, P256, DOI 10.1370/afm.1117
   Silva Angélica Baptista, 2012, Physis, V22, P1211, DOI 10.1590/S0103-73312012000300019
   Silva AB, 2009, J TELEMED TELECARE, V15, P373, DOI 10.1258/jtt.2009.090204
   Souza PPR, 2010, REV I A LUTZ, V69, P7
   Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278
   Topol EJ, 2011, CTS-CLIN TRANSL SCI, V4, P8, DOI 10.1111/j.1752-8062.2010.00256.x
   Viacava F, 2012, CIENC SAUDE COLETIVA, V17, P921, DOI 10.1590/S1413-81232012000400014
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26
   World Health Organizaton International Telecommunication Union, 2012, NAT EHEALTH STRAT TO
NR 52
TC 3
Z9 4
U1 0
U2 20
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 2014
VL 48
IS 2
BP 347
EP 356
DI 10.1590/S0034-8910.2014048004923
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AI7TQ
UT WOS:000337102300018
PM 24897057
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Hotez, PJ
   Diemert, D
   Bacon, KM
   Beaumier, C
   Bethony, JM
   Bottazzi, ME
   Brooker, S
   Couto, AR
   Freire, MD
   Homma, A
   Lee, BY
   Loukas, A
   Loblack, M
   Morel, CM
   Oliveira, RC
   Russell, PK
AF Hotez, Peter J.
   Diemert, David
   Bacon, Kristina M.
   Beaumier, Coreen
   Bethony, Jeffrey M.
   Bottazzi, Maria Elena
   Brooker, Simon
   Couto, Artur Roberto
   Freire, Marcos da Silva
   Homma, Akira
   Lee, Bruce Y.
   Loukas, Alex
   Loblack, Marva
   Morel, Carlos Medicis
   Oliveira, Rodrigo Correa
   Russell, Philip K.
TI The Human Hookworm Vaccine
SO VACCINE
LA English
DT Review
DE Hookworm; Helminth; Na-GST-1; Na-APR-1; Anemia
ID NEUTRALIZING ANTIBODIES; INFECTION; MEBENDAZOLE; EFFICACY; ANEMIA;
   HEMOGLOBINASE; ALBENDAZOLE; POPULATIONS; CANDIDATE; BILLION
AB Hookworm infection is one of the world's most common neglected tropical diseases and a leading cause of iron deficiency anemia in low- and middle-income countries. A Human Hookworm Vaccine is currently being developed by the Sabin Vaccine Institute and is in phase 1 clinical testing. The candidate vaccine is comprised of two recombinant antigens known as Na-GST-1 and Na-APR-1, each of which is an important parasite enzyme required for hookworms to successfully utilize host blood as a source of energy. The recombinant proteins are formulated on Alhydrogel (R) and are being tested in combination with a synthetic Toll-like receptor 4 agonist. The aim of the vaccine is to induce anti-enzyme antibodies that will reduce both host blood loss and the number of hookworms attached to the gut. Transfer of the manufacturing technology to the Oswaldo Cruz Foundation (FIOCRUZ)/Bio-Manguinhos (a Brazilian public sector developing country vaccine manufacturer) is planned, with a clinical development plan that could lead to registration of the vaccine in Brazil. The vaccine would also need to be introduced in the poorest regions of Africa and Asia, where hookworm infection is highly endemic. Ultimately, the vaccine could become an essential tool for achieving hookworm control and elimination, a key target in the 2012 London Declaration on Neglected Tropical Diseases. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hotez, Peter J.; Diemert, David; Beaumier, Coreen; Bethony, Jeffrey M.; Bottazzi, Maria Elena; Loblack, Marva; Russell, Philip K.] Sabin Vaccine Inst Prod Dev Partnership, Houston, TX USA.
   [Hotez, Peter J.; Diemert, David; Beaumier, Coreen; Bethony, Jeffrey M.; Bottazzi, Maria Elena; Loblack, Marva; Russell, Philip K.] Sabin Vaccine Inst Prod Dev Partnership, Washington, DC USA.
   [Hotez, Peter J.; Beaumier, Coreen; Bottazzi, Maria Elena] Sabin Vaccine Inst, Houston, TX USA.
   [Hotez, Peter J.; Beaumier, Coreen; Bottazzi, Maria Elena] Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Diemert, David; Bethony, Jeffrey M.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
   [Bacon, Kristina M.; Lee, Bruce Y.] Univ Pittsburgh, Sch Med, Publ Hlth Computat & Operat Res PHICOR, Pittsburgh, PA USA.
   [Brooker, Simon] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Couto, Artur Roberto; Freire, Marcos da Silva; Homma, Akira; Morel, Carlos Medicis] Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.
   [Loukas, Alex] James Cook Univ, Queensland Trop Hlth Alliance, Cairns, Australia.
   [Oliveira, Rodrigo Correa] Fiocruz MS, Oswaldo Cruz Fdn, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil.
RP Hotez, PJ (corresponding author), Sabin Vaccine Inst Prod Dev Partnership, Houston, TX USA.
EM hotez@bcm.edu
RI Loukas, Alex/B-7355-2014; Diemert, David/AAQ-3353-2020; Morel, Carlos
   M/B-4079-2009; Morel, Carlos/Q-9657-2019; Idn, Inct/J-8385-2013
OI Loukas, Alex/0000-0002-0896-8441; Morel, Carlos M/0000-0003-2752-0009;
   Morel, Carlos/0000-0003-2752-0009; Diemert, David/0000-0002-2789-0512;
   Couto Rendeiro, Ana Rita/0000-0002-3600-2812; Hotez,
   Peter/0000-0001-8770-1042; Bottazzi, Maria Elena/0000-0002-8429-0476
FU Bill & Melinda Gates FoundationBill & Melinda Gates Foundation; Dutch
   Ministry of Foreign Affairs; Brazilian Ministry of Health
FX We acknowledge the financial support of the Bill & Melinda Gates
   Foundation, the Dutch Ministry of Foreign Affairs, and the Brazilian
   Ministry of Health.
CR Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343
   ALBONICO M, 1995, T ROY SOC TROP MED H, V89, P538, DOI 10.1016/0035-9203(95)90101-9
   Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73
   Blount D, 2009, AM J TROP MED HYG, V81, P911, DOI 10.4269/ajtmh.2009.09-0237
   Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1
   Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291
   Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88
   Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99
   Diemert DJ, 2012, J ALLERGY CLIN IMMUN, V130, P169, DOI 10.1016/j.jaci.2012.04.027
   Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x
   Gaze S, 2012, PLOS PATHOG, V8
   Geiger SM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001280
   Goud GN, 2012, PROTEIN EXPRES PURIF, V83, P145, DOI 10.1016/j.pep.2012.03.013
   Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16
   Hotez P, 2011, VACCINE, V29, pD104, DOI 10.1016/j.vaccine.2011.06.024
   Hotez P, 2011, HEALTH AFFAIR, V30, P1080, DOI 10.1377/hlthaff.2011.0317
   Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102
   Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492
   Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937
   Lee BY, 2011, VACCINE, V29, P1201, DOI 10.1016/j.vaccine.2010.12.004
   Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2
   McSorley HJ, 2010, PARASITE IMMUNOL, V32, P549, DOI 10.1111/j.1365-3024.2010.01224.x
   McSorley HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024092
   Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Pearson MS, 2010, J INFECT DIS, V201, P1561, DOI 10.1086/651953
   Pearson MS, 2009, FASEB J, V23, P3007, DOI 10.1096/fj.09-131433
   Plieskatt J, 2012, HUM VACCINE IMMUNOTH, P8
   Riveau G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001704
   Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x
   Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417
   STOLL NR, 1947, J PARASITOL, V33, P1
   Tendler M, 2008, ACTA TROP, V108, P263, DOI 10.1016/j.actatropica.2008.09.002
   THEINHLAING, 1991, T ROY SOC TROP MED H, V85, P519, DOI 10.1016/0035-9203(91)90241-P
   World Health Organization, 2002, WHO TECHN REP SER, V912
NR 37
TC 63
Z9 63
U1 0
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 18
PY 2013
VL 31
SU 2
BP B227
EP B232
DI 10.1016/j.vaccine.2012.11.034
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 137TV
UT WOS:000318462000028
PM 23598487
OA Green Published, Other Gold, Green Accepted
DA 2020-12-17
ER

PT J
AU Vasconcellos, AG
   Morel, CM
AF Vasconcellos, Alexandre Guimaraes
   Morel, Carlos Medicis
TI Enabling Policy Planning and Innovation Management through Patent
   Information and Co-Authorship Network Analyses: A Study of Tuberculosis
   in Brazil
SO PLOS ONE
LA English
DT Article
AB Introduction: New tools and approaches are necessary to facilitate public policy planning and foster the management of innovation in countries' public health systems. To this end, an understanding of the integrated way in which the various actors who produce scientific knowledge and inventions in technological areas of interest operate, where they are located and how they relate to one another is of great relevance. Tuberculosis has been chosen as a model for the present study as it is a current challenge for Brazilian research and innovation.
   Methodology: Publications about tuberculosis written by Brazilian authors were accessed from international databases, analyzed, processed with text searching tools and networks of coauthors were constructed and visualized. Patent applications about tuberculosis in Brazil were retrieved from the Brazilian National Institute of Industrial Property (INPI) and the European Patent Office databases, through the use of International Patent Classification and keywords and then categorized and analyzed.
   Results/Conclusions: Brazilian authorship of articles about tuberculosis jumped from 1% in 1995 to 5% in 2010. Article production and patent filings of national origin have been concentrated in public universities and research institutions while the participation of private industry in the filing of Brazilian patents has remained limited. The goals of national patenting efforts have still not been reached, as up to the present none of the applications filed have been granted a patent. The analysis of all this data about TB publishing and patents clearly demonstrates the importance of maintaining the continuity of Brazil's production development policies as well as government support for infrastructure projects to be employed in transforming the potential of research. This policy, which already exists for the promotion of new products and processes that, in addition to bringing diverse economic benefits to the country, will also contribute to effective dealing with public health problems affecting Brazil and the World.
C1 [Morel, Carlos Medicis] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.
   [Vasconcellos, Alexandre Guimaraes] Natl Inst Ind Property INPI, Rio De Janeiro, RJ, Brazil.
RP Morel, CM (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.
EM morel@cdts.fiocruz.br
RI Idn, Inct/J-8385-2013; Morel, Carlos/Q-9657-2019; Morel, Carlos
   M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
FU Department of Science and Technology (DECIT), Ministry of Health
   (FIOTEC)Department of Science & Technology (India)Department of Science
   & Technology (DOST), Philippines [439, 820]; National Council for
   Scientific and Technological Development (CNPq), Ministry of Science and
   TechnologyNational Council for Scientific and Technological Development
   (CNPq) [573642/2008-7]; Ministry of Education/CAPESCAPES
   [573642/2008-7]; Research Foundation of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [573642/2008-7]; Oswaldo Cruz Foundation
   (Fiocruz)
FX Funding was provided by the Department of Science and Technology
   (DECIT), Ministry of Health (FIOTEC no. 439 and 820); National Council
   for Scientific and Technological Development (CNPq), Ministry of Science
   and Technology (no. 573642/2008-7 and IA Productivity Fellowship to
   CMM); Ministry of Education/CAPES (no. 573642/2008-7); Research
   Foundation of the State of Rio de Janeiro (FAPERJ) (no. 573642/2008-7,
   post-doctoral fellowship to AGV and "Cientista do Nosso Estado" to CMM)
   and Oswaldo Cruz Foundation (Fiocruz). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454
   Allarakhia M, 2012, EXPERT OPINION DRUG, P1
   Analytic Technologies, 1999, UC 5 0 VERS 1 00 COM
   Bhardwaj A, 2011, TUBERCULOSIS, V91, P479, DOI 10.1016/j.tube.2011.06.004
   Bound K, 2008, BRAZIL NATURAL KNOWL
   Brito RC, 2010, INT J TUBERC LUNG D, V14, P24
   de Brito Bahruth E, 2004, THESIS FEDERAL U RIO
   Diacon AH, 2012, LANCET
   DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1
   Esteves B, 2011, NAT MED, V17, P1174, DOI 10.1038/nm1011-1174b
   Frickmann Fabiana dos Santos e Souza, 2011, Journal of Technology Management & Innovation, V6, P136, DOI 10.4067/S0718-27242011000400011
   Gadelha CAG, 2008, MEDICAMENTOS BRASIL
   Gadelha Carlos Augusto Grabois, 2003, Ciênc. saúde coletiva, V8, P521, DOI 10.1590/S1413-81232003000200015
   Gadelha CAG, 2006, REV SAUDE PUBL, V40, P11, DOI [10.1590/S0034-89102006000400003, 10.1590/s0034-89102006000400003]
   Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340
   Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348
   Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9
   Ministerio da Saude, 2011, SIT TUB BRAS
   Ministerio do Desenvolvimento, TECHNICAL REPORT
   Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443
   Morel CM, 2007, NATURE, V449, P180, DOI 10.1038/449180a
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851
   Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.69.066133]
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   OECD, 2005, OSL MAN GUID COLL IN
   Scott J., 2000, SOCIAL NETWORK ANAL
   Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889
   Vasconcellos AG, 2009, 60 C NAC BOT LIVR EL, P1072
   World Health Organization, 2010, TUB
   World Health Organization, 2011, GLOB TUB CONTR 2011
   World Intellectual Property Organization, FREQ ASK QUEST INT P
NR 33
TC 27
Z9 28
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2012
VL 7
IS 10
AR e45569
DI 10.1371/journal.pone.0045569
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015NU
UT WOS:000309454000009
PM 23056208
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Crump, A
   Morel, CM
   Omura, S
AF Crump, Andy
   Morel, Carlos M.
   Omura, Satoshi
TI The onchocerciasis chronicle: from the beginning to the end?
SO TRENDS IN PARASITOLOGY
LA English
DT Review
DE onchocerciasis; disease control; vector control; ivermectin; disease
   elimination
ID POTENT ANTHELMINTIC AGENTS; SIMULIUM-DAMNOSUM; IVERMECTIN; VOLVULUS;
   AVERMECTINS; FAMILY; EFFICACY; AFRICA; ELIMINATION; DIETHYLCARBAMAZINE
AB The year 2012 marks the 25th anniversary of the donation of ivermectin to fight onchocerciasis and the projected date for elimination of transmission of the disease in the Americas. This review looks at the history of onchocerciasis, from its discovery through to 2025, by which time it is projected that the disease will have been eliminated as a public health problem, except in a handful of sub-Saharan countries, where it should be well on the way towards elimination.
C1 [Crump, Andy; Omura, Satoshi] Kitasato Inst, Minato Ku, Tokyo 1088641, Japan.
   [Crump, Andy; Omura, Satoshi] Kitasato Univ, Minato Ku, Tokyo 1088641, Japan.
   [Morel, Carlos M.] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.
RP Omura, S (corresponding author), Kitasato Inst, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.
EM acys@mac.com; omuras@insti.kitasato-u.ac.jp
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Idn,
   Inct/J-8385-2013
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009; 
CR Abdi YA, 1995, HDB DRUGS TROPICAL P
   Adeleke M. A., 2010, Journal of Public Health and Epidemiology, V2, P109
   AWADZI K, 1985, ANN TROP MED PARASIT, V79, P63, DOI 10.1080/00034983.1985.11811889
   AWADZI K, 1980, ANN TROP MED PARASIT, V74, P189, DOI 10.1080/00034983.1980.11687330
   AZIZ MA, 1982, LANCET, V2, P171
   AZIZ MA, 1982, LANCET, V2, P1456
   BLACKLOCK D. B., 1926, ANN TROP MED & PARASITOL, V20, P203
   BLACKLOCK D. B., 1926, ANN TROP MED & PARASITOL, V20, P1
   Blacklock DB, 1927, BRIT MED J, V1927, P129
   BLAIR LS, 1978, J HELMINTHOL, V52, P305, DOI 10.1017/S0022149X00005538
   BROWN AWA, 1962, B WORLD HEALTH ORGAN, V27, P511
   Brumpt E., 1919, Bulletin de la Societe de Pathologie Exotique Paris, V12
   BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361
   CAMPBELL WC, 1991, ANNU REV MICROBIOL, V45, P445, DOI 10.1146/annurev.mi.45.100191.002305
   CAMPBELL WC, 1978, J HELMINTHOL, V52, P308, DOI 10.1017/S0022149X0000554X
   CARTER GT, 1988, J ANTIBIOT, V41, P519, DOI 10.7164/antibiotics.41.519
   Crump A., 2003, APP TECH, V30, P13
   Crump A, 2011, P JPN ACAD B-PHYS, V87, P13, DOI 10.2183/pjab.87.13
   CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0
   Currie DC, 2008, HYDROBIOLOGIA, V595, P469, DOI 10.1007/s10750-007-9114-1
   Dampf Alfonso, 1942, BOL OFIC SANITARIA PANAMER, V21, P753
   Davidson Andrew, 1893, HYGIENE DIS WARM CLI
   Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497
   Donnelly J, 2012, LANCET, V379, P299, DOI 10.1016/S0140-6736(12)60126-3
   DUKE B. O. L., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P37, DOI 10.1016/0035-9203(57)90004-4
   DUKE B. O. L., 1962, Transactions of the Royal Society of Tropical Medicine and Hygiene, V56, P271
   DUKE BOL, 1968, B WORLD HEALTH ORGAN, V39, P157
   DUKE BOL, 1968, B WORLD HEALTH ORGAN, V39, P137
   DUKE BOL, 1968, B WORLD HEALTH ORGAN, V39, P169
   EGERTON JR, 1979, ANTIMICROB AGENTS CH, V15, P372, DOI 10.1128/AAC.15.3.372
   Fulleborn F., 1924, Proc Intern Conf Health Problems Trop America Boston, P241
   Gaillard J., 2005, UNESCO SCI REPORT 20, P177
   GARMS R, 1979, TROPENMED PARASITOL, V30, P345
   GARNHAM PCC, 1947, B ENTOMOL RES, V37, P619, DOI 10.1017/S000748530003011X
   Grove D.I., 1990, HIST HUMAN HELMINTHO
   Habbema J.D.F., 2007, HLTH IMPACT ASSESSME
   Haddad D, 2008, ANN TROP MED PARASIT, V102, P35, DOI 10.1179/136485908X337472
   HEWITT RI, 1947, J LAB CLIN MED, V32, P1293
   HISSETTE J., 1932, ANN SOC BEIGE MED TROP, V12, P433
   Hissette J, 1931, ANN SOC BELG MED TR, VXI, P45
   Hodgkin C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000074
   Hoerauf A., 2007, Wolbachia: a bug's life in another bug, P31, DOI 10.1159/000104231
   Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1
   HOFFMANN CARLOS C., 1930, ARCH SCHIFFS U TROPEN HYG, V34, P461
   Keiser PB, 2002, J INFECT DIS, V185, P805, DOI 10.1086/339344
   Kershaw W.E., 1954, BRIT MED J, Vi, P724
   Kipp W, 1996, AM J TROP MED HYG, V54, P80, DOI 10.4269/ajtmh.1996.54.80
   Kluxen G., 2011, J HISSETTES RES EXPE
   Labadie-Lagrave F., 1899, ARCH PARASITOL, V2, P451
   Lammie Patrick J, 2007, PLoS Negl Trop Dis, V1, pe71, DOI 10.1371/journal.pntd.0000071
   LEBERRE R, 1979, PHILOS T R SOC B, V287, P277
   Liese B., 1991, 159 WORLD BANK
   Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003
   Manson P, 1902, BRIT MED J, V1902, P1894, DOI 10.1136/bmj.2.2190.1894
   Mazzotti I., 1948, REV I SALUBRIDAD ENF, V9, P235
   Mectizan Donation Programme, 2012, ANN HIGHL 2011 CEL 2
   MILLER TW, 1979, ANTIMICROB AGENTS CH, V15, P368, DOI 10.1128/AAC.15.3.368
   Molyneux DH, 2003, TRENDS PARASITOL, V19, P516, DOI 10.1016/j.pt.2003.09.004
   Montpellier J., 1920, Bulletin de la Societe de Pathologie Exotique Paris, V13
   NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893
   O'Neil J., 1875, LANCET, V1, P265
   Ochoterena I., 1930, Anales del Instituto de Biologia Mexico, V1, P307
   Ochoterena I., 1928, ANALES I BIOL U NACL, V1, P59
   Omura S, 2004, NAT REV MICROBIOL, V2, P984, DOI 10.1038/nrmicro1048
   Omura S., 2002, MACROLIDE ANTIBIOTIC, P571
   OUZILLEAU F., 1913, Bulletin de la Societe de Pathologie Exotique, V7, P80
   Ouzilleau F., 1923, PRESSE MED, V31, P617
   Prout WT, 1901, BRIT MED J, V1901, P209, DOI 10.1136/bmj.1.2091.209
   Railliet A., 1910, B SOC PATHOL EXOT, V3, P91
   Ridley N.H.L., 1945, BR J OPHTHALMOL S, V29, P1
   ROBERTS JMD, 1967, B WORLD HEALTH ORGAN, V37, P195
   Robles R., 1919, Bulletin de la Societe de Pathologie Exotique Paris, V12
   Robles R, 1917, JUVENTUD MED, V17, P97
   Rock DW, 2002, MACROCYCLIC LACTONES
   Ruiz Reyes F., 1952, REV MED MEX, V32, P49
   Silva R., 1932, Southern Medical Journal, V25, P113, DOI 10.1097/00007611-193202000-00001
   Strong R. P., 1938, American Journal of Tropical Medicine Baltimore 1 Suppl, V18, P1
   STRONG R. P., 1937, TRANS ROY SOC TROP MED AND HYG, V30, P487, DOI 10.1016/S0035-9203(37)90002-6
   Taylor MJ, 2003, ANN NY ACAD SCI, V990, P444, DOI 10.1111/j.1749-6632.2003.tb07409.x
   Torroella J.L., 1930, ANALES I BIOL U NACL, V1, P201
   UBACHUKWU PO, 2004, NIG J PARASITOL, V25, P93
   UNESCO, 2004, STRUGGL SLAV
   Usip LPE, 2006, MEM I OSWALDO CRUZ, V101, P201, DOI 10.1590/S0074-02762006000200012
   VAN HOOF L., 1947, Annales de la Societe Belge de Medecine Tropicale, V27, P173
   WHO, 2010, 1 WHO REP NEGL TROP
   WHO, 2011, WKLY EPIDEMIOL REC, V48, P541
   World Health Organization, 2012, ACC WORK OV GLOB IMP
   World Health Organization, 2012, 17 SESS JOINT ACT FO
   World Health Organization, 2012, INT PREV CHEM NEGL T
   World Health Organization, 1985, 10 YEARS ONCH CONTR
   World Health Organization/African Programme for Onchocerciasis Control, 2011, 15 YEARS WORK COMM E
   World Health Organization/African Programme for Onchocerciasis Control, 2011, FUT APOC
   World Health Organization/African Programme for Onchocerciasis Control, 2011, WHO AFR PROGR ONCH C
   ZIMMERMAN PA, 1994, MOL BIOL EVOL, V11, P384
NR 94
TC 42
Z9 42
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JUL
PY 2012
VL 28
IS 7
BP 280
EP 288
DI 10.1016/j.pt.2012.04.005
PG 9
WC Parasitology
SC Parasitology
GA 972BT
UT WOS:000306252200004
PM 22633470
DA 2020-12-17
ER

PT S
AU Carvalho, FP
   Morel, CM
   Desiderio, M
AF Carvalho, Fernando Porto
   Morel, Carlos Medicis
   Desiderio, Monica
BE Durrani, T
   Tjakraatmadja, JH
   Dhewanto, W
TI Health Universal Access and Innovation: the Triple Helix Approach in
   Action
SO 10TH TRIPLE HELIX CONFERENCE 2012
SE Procedia Social and Behavioral Sciences
LA English
DT Proceedings Paper
CT 10th Triple Helix Conference
CY AUG 08-10, 2012
CL Bandung, INDONESIA
DE Public Private Partnership; Innovative Developing Country; Health
   Innovation; Neglected Diseases, Triple Helix in health innovation
AB This paper presents how innovation in health/health services in IDCs - Innovative Developing Countries (developing countries with relevant investments in education, health research infrastructure, and manufacturing capacity in the last decades) can benefit from the Triple Helix approach. Diseases affect populations of developed and developing countries unequally in terms of disease burden distribution worldwide and in the R&D investment in health. Global diseases are object of intense R&D, whilst diseases related to poverty (or neglected diseases) do not receive the same attention from pharmaceutical industry. This market failure scenario highlights the role of the IDCs in the struggle against neglected diseases, since they are closer to the reality of such diseases and have an increasingly capacity to cope with health issues globally. In this sense, the case here presented is an example of the potential offered by Triple Helix approach to address the neglected diseases issue. Despite technology transfer agreements being a widespread practice of Brazilian Ministry of Health, when it comes to neglected diseases, its effectiveness is limited, due to the market failure already mentioned. Nevertheless, in an IDC environment the Ministry of Health can make use of its purchasing power both to introduce a new product in the Unified Health System, ensuring the nationalization of production, and to stimulate private investment in R&D for neglected diseases. The mechanism used in this case: the association of technology transfer to collaborative development of a new product, presents itself as a feasible option to foster innovation in neglected diseases, combining the efforts of a private company, a public R&D institution and an innovation policy with a strong presence of the Ministry of Health and respective use of State's purchasing power. We argue that the feasibility of such an action depends on the presence of two key elements: Brazil's condition as an IDC and the articulation of these three key actors as proposed by the Triple Helix Approach. (c) 2012 The Authors. Published by Elsevier B.V. Selection and/or peer-review under responsibility of Institut Teknologi Bandung
C1 [Carvalho, Fernando Porto] Fiocruz MS, Biomanguinhos, BR-21040360 Rio De Janeiro, Brazil.
   [Morel, Carlos Medicis] CDTS, BR-4365360 Rio De Janeiro, Brazil.
   [Desiderio, Monica] CDTS, BR-21040360 Rio De Janeiro, Brazil.
   [Desiderio, Monica] PPED IE UFRJ, Rio De Janeiro, Brazil.
RP Carvalho, FP (corresponding author), Fiocruz MS, Biomanguinhos, BR-21040360 Rio De Janeiro, Brazil.
EM fporto@bio.fiocruz.br
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009; Porto de Carvalho,
   Fernando/0000-0001-9193-3049
CR Bio-Manguinhos, 2009, BIONOTICIAS
   Bound K, 2008, BRAZIL THE NATURAL K
   FIOCRUZ, 2011, INNOVATION PORTFOLIO
   Gadelha Carlos, 2003, Hist. cienc. saude-Manguinhos, V10, P697, DOI 10.1590/S0104-59702003000500012
   Guimaraes R. F. N., 2004, CIENCIA SAUDE COLETI, V9
   Homma A, 2011, CIENC SAUDE COLETIVA, V16, P445, DOI 10.1590/S1413-81232011000200008
   IFPMA International Federation of Pharmaceutical Manufacturers & Associations, 2011, INTERNATIONAL FEDERA
   Ministerio da Saude, 2009, BRASIL PRODUZIRA VAC
   Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302
   Morel C, 2005, INNOVATION STRATEGY, V1, P1
   Serruya S. J., 2008, FOSTERING INNOVATION, V5
NR 11
TC 1
Z9 1
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0428
J9 PROCD SOC BEHV
PY 2012
VL 52
BP 236
EP 245
DI 10.1016/j.sbspro.2012.09.460
PG 10
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA BDN58
UT WOS:000314048100026
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, Carlos Medicis
TI Chagas disease: Transcriptomic recovery in animal models after
   transplantation of bone marrow cells
SO CELL CYCLE
LA English
DT News Item
C1 Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.
RP Morel, CM (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.
EM morel@cdts.fiocruz.br
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Idn,
   Inct/J-8385-2013
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009; 
CR Soares MBP, 2009, MEM I OSWALDO CRUZ, V104, P325, DOI 10.1590/S0074-02762009000900043
   Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021
   Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093
   Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003
   Soares MBP, 2011, CELL CYCLE, V10, P1448, DOI 10.4161/cc.10.9.15487
NR 5
TC 0
Z9 0
U1 0
U2 1
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1538-4101
J9 CELL CYCLE
JI Cell Cycle
PD JUN 15
PY 2011
VL 10
IS 12
BP 1892
EP 1892
DI 10.4161/cc.10.12.15688
PG 1
WC Cell Biology
SC Cell Biology
GA 777UT
UT WOS:000291651300007
PM 21577049
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Morel, CM
   Serruya, SJ
   Penna, GO
   Guimaraes, R
AF Morel, Carlos Medicis
   Serruya, Suzanne Jacob
   Penna, Gerson Oliveira
   Guimaraes, Reinaldo
TI Co-authorship Network Analysis: A Powerful Tool for Strategic Planning
   of Research, Development and Capacity Building Programs on Neglected
   Diseases
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID COAUTHORSHIP NETWORKS; INSTITUTIONAL COLLABORATION; ERADICATION;
   PATTERNS; MALARIA
AB Background: New approaches and tools were needed to support the strategic planning, implementation and management of a Program launched by the Brazilian Government to fund research, development and capacity building on neglected tropical diseases with strong focus on the North, Northeast and Center-West regions of the country where these diseases are prevalent.
   Methodology/Principal Findings: Based on demographic, epidemiological and burden of disease data, seven diseases were selected by the Ministry of Health as targets of the initiative. Publications on these diseases by Brazilian researchers were retrieved from international databases, analyzed and processed with text-mining tools in order to standardize author- and institution's names and addresses. Co-authorship networks based on these publications were assembled, visualized and analyzed with social network analysis software packages. Network visualization and analysis generated new information, allowing better design and strategic planning of the Program, enabling decision makers to characterize network components by area of work, identify institutions as well as authors playing major roles as central hubs or located at critical network cut-points and readily detect authors or institutions participating in large international scientific collaborating networks.
   Conclusions/Significance: Traditional criteria used to monitor and evaluate research proposals or R&D Programs, such as researchers' productivity and impact factor of scientific publications, are of limited value when addressing research areas of low productivity or involving institutions from endemic regions where human resources are limited. Network analysis was found to generate new and valuable information relevant to the strategic planning, implementation and monitoring of the Program. It afforded a more proactive role of the funding agencies in relation to public health and equity goals, to scientific capacity building objectives and a more consistent engagement of institutions and authors from endemic regions based on innovative criteria and parameters anchored on objective scientific data.
C1 [Morel, Carlos Medicis] Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.
   [Serruya, Suzanne Jacob] Minist Hlth, Secretary Sci Technol & Strateg Goods SCTIE, Dept Sci & Technol DECIT, Brasilia, DF, Brazil.
   [Penna, Gerson Oliveira] Minist Hlth, Secretary Hlth Surveillance SVS, Brasilia, DF, Brazil.
RP Morel, CM (corresponding author), Oswaldo Cruz Fdn Fiocruz, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Rio De Janeiro, Brazil.
EM morel@cdts.fiocruz.br
RI Idn, Inct/J-8385-2013; Morel, Carlos M/B-4079-2009; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Penna, Gerson/0000-0001-8967-536X
FU Department of Science and Technology (DECIT)Department of Science &
   Technology (India); Ministry of HealthMinistry of Health - Turkey [439,
   820]; National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Ministry of Science and Technology [573642/2008-7]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Ministry
   of Education [573642/2008-7]; Research Foundation of the State of Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [573642/2008-7]; Oswaldo Cruz
   Foundation (Fiocruz)
FX Department of Science and Technology (DECIT), Ministry of Health (FIOTEC
   no. 439 and 820); National Council for Scientific and Technological
   Development (CNPq), Ministry of Science and Technology (no.
   573642/2008-7 and IA Productivity Fellowship to CMM); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministry of
   Education (no. 573642/2008-7); Research Foundation of the State of Rio
   de Janeiro (FAPERJ) (no. 573642/2008-7 and "Cientista do Nosso Estado''
   to CMM) and Oswaldo Cruz Foundation (Fiocruz). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aleixandre-Benavent R, 2008, Farm Hosp, V32, P226
   Analytic Technologies, 1999, UC 5 0 VERS 1 00 COM
   [Anonymous], 2008, B WORLD HEALTH ORGAN, V86, P248
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006
   da Silva PA, 2006, CLIN MICROBIOL INFEC, V12, P293, DOI 10.1111/j.1469-0691.2005.01355.x
   deNooy W., 2005, EXPLORATORY SOCIAL N
   Gibbons M., 1994, NEW PRODUCTION KNOWL
   Gonzalez-Alcaide G, 2008, FERTIL STERIL, V90, P941, DOI 10.1016/j.fertnstert.2007.07.1378
   Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996
   GUIMARAES R, 2005, HLTH TECHNOLOGY INNO, P47
   GUIMARAES R, 2005, GLOBAL FORUM UPDATE, V2, P96
   Guimarães Reinaldo, 2006, Cad. Saúde Pública, V22, P1775, DOI 10.1590/S0102-311X2006000900002
   Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340
   Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P971, DOI 10.1136/jech.2003.014530
   HENDERSON DA, 1998, B WORLD HEALTH ORGAN, V76, P7
   Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102
   Hunter PR, 2009, LANCET, V373, P630, DOI 10.1016/S0140-6736(09)60397-4
   Hwang WC, 2008, CLIN PHARMACOL THER, V84, P563, DOI 10.1038/clpt.2008.129
   Ioannidis JPA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002778
   Mahoney RT, 2006, INNOVATION STRATEGY, V2, P1
   MAHONEY RT, 2006, GLOBAL FORUM UPDATE, V3, P149
   *MED SANS FRONT AC, 2001, FAT IMB CRIS RES DEV, P1
   Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11
   Molyneux DH, 2004, TRENDS PARASITOL, V20, P347, DOI 10.1016/j.pt.2004.06.004
   Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302
   Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Pasqualoto KFM, 2006, INT J QUANTUM CHEM, V106, P2689, DOI 10.1002/qua.21055
   Said YH, 2008, COMPUT STAT DATA AN, V52, P2177, DOI 10.1016/j.csda.2007.07.021
   Scott J., 2000, SOCIAL NETWORK ANAL
   SERRUYA S, 2007, GFHR 11 BEIJ OCT NOV
   SERRUYA SJ, 2008, GLOBAL FORUM UPDATE, V5, P24
   Valderrama-Zurian JC, 2007, REV ESP CARDIOL, V60, P117, DOI 10.1016/S1885-5857(07)60124-8
   WHO, 2001, MAN ECH HUM AN PUBL, P1, DOI DOI 10.1016/B978-0-7506-0898-5.50011-0
   Yousefi-Nooraie Reza, 2008, Health Res Policy Syst, V6, P9, DOI 10.1186/1478-4505-6-9
NR 38
TC 74
Z9 75
U1 0
U2 47
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2009
VL 3
IS 8
AR e501
DI 10.1371/journal.pntd.0000501
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 486TL
UT WOS:000269220900008
PM 19688044
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, Carlos M.
TI The road to recovery
SO NATURE
LA English
DT Editorial Material
ID DEVELOPING-COUNTRIES; EXPERIENCE; BRAZIL
C1 Fiocruz MS, Ctr Technol Dev Hlth, BR-21045900 Rio De Janeiro, Brazil.
   Fiocruz MS, Med & Drugs Technol Inst, BR-21045900 Rio De Janeiro, Brazil.
RP Morel, CM (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth, BR-21045900 Rio De Janeiro, Brazil.
RI Morel, Carlos M/B-4079-2009; Casas, Carmen Phang Romero/J-3465-2017;
   Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Casas, Carmen Phang
   Romero/0000-0002-2759-0544; Morel, Carlos/0000-0003-2752-0009
CR Almeida Celia, 2002, Cad. Saúde Pública, V18, P905, DOI 10.1590/S0102-311X2002000400002
   Basu P, 2005, NAT BIOTECHNOL, V23, P13, DOI 10.1038/nbt0105-13
   Bernardes AT, 2003, RES POLICY, V32, P865, DOI 10.1016/S0048-7333(02)00089-6
   Borgatti S. P., 1999, UCINET 6 0 VERSION 1
   Buss PM, 2005, VACINAS SOROS IMUNIZ
   Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8
   GADELHA C, 2003, SAUDE MANGUINHOS, V10, P697
   Gama A. A. S., 2003, QUIM NOVA, V26, P618
   Gadelha CAG, 2006, REV SAUDE PUBL, V40, P11, DOI [10.1590/S0034-89102006000400003, 10.1590/s0034-89102006000400003]
   Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001
   Mahoney RT, 2007, VACCINE, V25, P4003, DOI 10.1016/j.vaccine.2007.02.047
   Morel C, 2005, INNOVATION STRATEGY, V1, P1
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Olive JM, 1997, J INFECT DIS, V175, pS189, DOI 10.1093/infdis/175.Supplement_1.S189
   Temporão José Gomes, 2003, Hist. cienc. saude-Manguinhos, V10, P601, DOI 10.1590/S0104-59702003000500008
   Viotti EB, 2002, TECHNOL FORECAST SOC, V69, P653, DOI 10.1016/S0040-1625(01)00167-6
NR 16
TC 15
Z9 15
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD SEP 13
PY 2007
VL 449
IS 7159
BP 180
EP 182
DI 10.1038/449180a
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 209NF
UT WOS:000249394500040
PM 17851516
DA 2020-12-17
ER

PT J
AU Morel, CM
   Acharya, T
   Broun, D
   Dang, AJ
   Elias, C
   Ganguly, NK
   Gardner, CA
   Gupta, RK
   Haycock, J
   Heher, AD
   Hotez, PJ
   Kettler, HE
   Keusch, GT
   Krattiger, AF
   Kreutz, FT
   Lall, S
   Lee, K
   Mahoney, R
   Martinez-Palomo, A
   Mashelkar, RA
   Matlin, SA
   Mzimba, M
   Oehler, J
   Ridley, RG
   Pramilla, S
   Singer, P
   Yun, MY
AF Morel, CM
   Acharya, T
   Broun, D
   Dang, AJ
   Elias, C
   Ganguly, NK
   Gardner, CA
   Gupta, RK
   Haycock, J
   Heher, AD
   Hotez, PJ
   Kettler, HE
   Keusch, GT
   Krattiger, AF
   Kreutz, FT
   Lall, S
   Lee, K
   Mahoney, R
   Martinez-Palomo, A
   Mashelkar, RA
   Matlin, SA
   Mzimba, M
   Oehler, J
   Ridley, RG
   Pramilla, S
   Singer, P
   Yun, MY
TI Health innovation networks to help developing countries address
   neglected diseases
SO SCIENCE
LA English
DT Editorial Material
AB Gross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation.
C1 Fiocruz MS, Ctr Technol Dev Hlth, BR-21040900 Rio De Janeiro, Brazil.
   Joint United Nations Programme HIV AIDS, New Delhi 110003, India.
   Org Pharmaceut Producers India, Peninsula Chambers, Bombay 400013, Maharashtra, India.
   Program Appropriate Technol Hlth, Seattle, WA 98107 USA.
   Indian Council Med Res, New Delhi 110029, India.
   Rockefeller Fdn, New York, NY 10018 USA.
   CSIR, Intellectual Property Management Div, New Delhi 110067, India.
   Mission United Kingdon United Nations, New York, NY 10017 USA.
   Univ Cape Town, Res & Innovat House, ZA-7701 Cape Town, South Africa.
   George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20037 USA.
   Bill & Melinda Gates Fdn, Seattle, WA 98102 USA.
   Boston Univ, Boston, MA 02118 USA.
   Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.
   Univ Fed Rio Grande do Sul, FK Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Oxford, Oxford OX1 3LA, England.
   Seoul Natl Univ, Dept Econ, Seoul 151742, South Korea.
   Minist Hlth, Mexico City 01900, DF, Mexico.
   CSIR, New Delhi 110001, India.
   Global Forum Hlth Res, CH-1211 Geneva, Switzerland.
   S African Embassy, Dept Sci & Technol, B-1040 Brussels, Belgium.
   Concept Fdn, Klongluang 12120, Pathumthani, Thailand.
   WHO, Trop Dis Res Program, CH-1211 Geneva, Switzerland.
   Global Forum Hlth Res, Colombo 2, Sri Lanka.
   Univ Toronto, Toronto, ON M5G 1L4, Canada.
   Korea Inst Int Econ Policy, Seoul 137747, South Korea.
RP Morel, CM (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth, Ave Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
EM morel@fiocruz.br
RI Morel, Carlos M/B-4079-2009; Lee, Keun/AAU-8046-2020; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Lee, Keun/0000-0002-0403-6348;
   Morel, Carlos/0000-0003-2752-0009; Hotez, Peter/0000-0001-8770-1042;
   /0000-0001-5724-2965
CR BALE HE, 2000, WG43 WHO CMH
   Dahlman C. J., 1995, SOCIAL CAPABILITY LO, P82, DOI [10.1007/978-1-349-13512-7, DOI 10.1007/978-1-349-13512-7]
   Edquist C, 2001, SYSTEMS INNOVATION D
   GRACE C, 2004, EFFECT CHANGING INTE
   Hotez PJ, 2005, PLOS MED, V2, P187, DOI 10.1371/journal.pmed.0020067
   *HOUS COMM, 2004, US SCI UK INT DEV PO
   Juma C, 2001, INT J TECHNOL MANAGE, V22, P629, DOI 10.1504/IJTM.2001.002982
   Kettler HE, 2001, B WORLD HEALTH ORGAN, V79, P742
   King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a
   LEVI GC, 2002, J ACQ IMMUN DEF SYND, V16, P2373
   MASHELKAR RA, UNPUB
   *MEX STAT HLTH RES, STRENGTH HLTH SYST
   *MIN HLTH BRAZ, SCAL INT RESP AIDS B
   Morel C, 2005, INNOVATION STRATEGY, V1, P1
   *ORG PHARM PROD IN, 2003, OUTS OPP IND PHARM I, P24
   Pereira JCR, 2004, REV SAUDE PUBL, V38, P1, DOI [10.1590/S0034-89102004000100001, 10.1590/s0034-89102004000100001]
   Prahalad C.K., 2004, FORTUNE BOTTOM PYRAM
   SAHA R, 2004, IP STRATEGY TODAY, V9, P23
   THORSTEINSDOTTI.H, COMMUNICATION
   *UN MILL PROJ UN D, 2004, INT REP TASK FORC 10
   WHO Commission on Macroeconomics and Health & World Health Organization, 2001, MACR HLTH INV HLTH E
   WIDDUS R, COMBATING DIS ASS PO
   *WORLD BANK, 2005, WORLD DEV REP, pCH3
   2004, NAT BIOTECHNOL S, V22
   2002, FINANCIAL TIMES 0614
   2004, MONITORING FINANCIAL, V2, P14
NR 26
TC 115
Z9 118
U1 1
U2 37
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 15
PY 2005
VL 309
IS 5733
BP 401
EP 404
DI 10.1126/science.1115538
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 946LY
UT WOS:000230574900033
PM 16020723
OA Green Published
DA 2020-12-17
ER

PT J
AU Hotez, PJ
   Remme, JHF
   Buss, P
   Alleyne, G
   Morel, C
   Breman, JG
AF Hotez, PJ
   Remme, JHF
   Buss, P
   Alleyne, G
   Morel, C
   Breman, JG
TI Combating tropical infectious diseases: Report of the disease control
   priorities in developing countries project
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
ID LYMPHATIC FILARIASIS; COST-EFFECTIVENESS; GLOBAL BURDEN;
   SCHISTOSOMIASIS; LEISHMANIASIS; TUBERCULOSIS; ELIMINATION; AMERICA;
   IMPACT
AB Infectious diseases are responsible for >25% of the global disease toll. The new Disease Control Priorities in Developing Countries Project (DCPP) aims to decrease the burden of these diseases by producing science-based analyses from demographic, epidemiologic, disease intervention, and economic evidence for the purpose of defining disease priorities and implementing control measures. The DCPP recently reviewed selected tropical infectious diseases, examined successful control experiences, and defined unsettled patient treatment, prevention, and research issues. Disease elimination programs against American trypanosomiasis ( Chagas disease), onchocerciasis, lymphatic filariasis, leprosy, trachoma, and measles are succeeding. Dengue, leishmaniasis, African trypanosomiasis, malaria, diarrheal diseases, helminthic infections, and tuberculosis have reemerged because of inadequate interventions and control strategies and the breakdown of health delivery systems. Application of technologies must be cost-effective and intensified research is essential if these and other scourges are to be controlled or eliminated in the 21st century.
C1 NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   George Washington Univ, Washington, DC USA.
   Pan Amer Hlth Org, Washington, DC USA.
   WHO, CH-1211 Geneva, Switzerland.
   Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Breman, JG (corresponding author), NIH, Fogarty Int Ctr, Bldg 16,Rm 214,16 Ctr Dr,MSC 6705, Bethesda, MD 20892 USA.
EM jbreman@nih.gov
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Hotez, Peter/0000-0001-8770-1042
CR Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8
   Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309
   Breman JG, 2001, AM J TROP MED HYG, V64, P1
   Broder S, 2002, EMBO REP, V3, P806, DOI 10.1093/embo-reports/kvf187
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009
   Davies CR, 2003, BRIT MED J, V326, P377, DOI 10.1136/bmj.326.7385.377
   DESAVIGNY D, IN PRESS AM J TROP M
   Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002
   Dye C, 2002, B WORLD HEALTH ORGAN, V80, P437
   Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85
   Garrett Laurie, 2000, BETRAYAL TRUST COLLA
   *GLOB FOR HLTH RES, 2002, 10 90 REP HLTH RES 2, P1
   Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8
   GOODMAN RA, 1998, B WHO S, V76, P116
   Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X
   Guerrant RL, 2002, ARCH MED RES, V33, P351, DOI 10.1016/S0188-4409(02)00379-X
   Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003
   Hanson K, 2003, J INT DEV, V15, P1, DOI DOI 10.1002/JID.963
   Hopkins DR, 2002, AM J TROP MED HYG, V67, P266
   Hotez PJ, 2003, INT J PARASITOL, V33, P1245, DOI 10.1016/S0020-7519(03)00158-9
   Hotez PJ, 2002, COMP PARASITOL, V69, P140, DOI 10.1654/1525-2647(2002)069[0140:RTGBOH]2.0.CO;2
   *INDEPTH, 2002, POP HLTH SURV INDEPT, V1, P1
   Jacobson RR, 1999, LANCET, V353, P655, DOI 10.1016/S0140-6736(98)06322-3
   Jamison DT, 1993, DIS CONTROL PRIORITI, V1993
   Keusch GT, 2003, J NUTR, V133, p336S
   Keusch GT, 2003, NATURE, V422, P561, DOI 10.1038/422561a
   Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197
   Kuper H, 2003, LANCET INFECT DIS, V3, P372, DOI 10.1016/S1473-3099(03)00659-5
   Miller M A, 2000, Int J Infect Dis, V4, P14, DOI 10.1016/S1201-9712(00)90060-2
   Murray CA, 1996, GLOBAL BURDEN DIS CO
   Remme JHF, 2002, TRENDS PARASITOL, V18, P421, DOI 10.1016/S1471-4922(02)02387-5
   Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2
   Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0
   Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9
   Schmunis GA, 2001, AM J TROP MED HYG, V65, P924, DOI 10.4269/ajtmh.2001.65.924
   Stich A, 2003, TRENDS PARASITOL, V19, P195, DOI 10.1016/S1471-4922(03)00055-2
   *WHO, 2002, WORLD HLTH REP, P192
   WHO, 2001, MACR HLTH INV HLTH E
   Wiseman V, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.161
   *WORLD BANK, 2003, 2003 WORLD DEV IND, P3
   Zagaria N, 2002, ANN TROP MED PARASIT, V96, pS3, DOI [10.1179/00034980215002347, 10.1179/0034980215002347]
NR 43
TC 108
Z9 112
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 15
PY 2004
VL 38
IS 6
BP 871
EP 878
DI 10.1086/382077
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 800QI
UT WOS:000220042400023
PM 14999633
DA 2020-12-17
ER

PT J
AU Toure, YT
   Oduola, AMJ
   Morel, CM
AF Toure, YT
   Oduola, AMJ
   Morel, CM
TI The Anopheles gambiae genome: next steps for malaria vector control
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID POPULATION-STRUCTURE; MOLECULAR-IDENTIFICATION; GENETIC DIFFERENTIATION;
   INCIPIENT SPECIATION; CULICIDAE; DIPTERA; MOSQUITOS; SEQUENCE; COMPLEX;
   MARKERS
AB Malaria remains a major public health problem that is made worse by poor implementation of control measures, and by the spread of drug- and insecticide-resistant parasites and vectors, respectively. Availability of the Anopheles gambiae genome sequence will accelerate identification and exploitation of new target genes in this insect vector. This provides unique opportunities to improve on existing vector control tools and to generate new tools within a global partnership. However, significant capacity needs to be built for investigators in disease-endemic countries to exploit the genome data. When integrated with existing strategies, the new tools will form an effective package for selective vector control in an effort to prevent mortality and morbidity due to malaria.
C1 WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland.
RP Toure, YT (corresponding author), WHO, Special Programme Res & Training Trop Dis, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM tdr@vho.int
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3
   Annan Z, 2003, MOL ECOL NOTES, V3, P56, DOI 10.1046/j.1471-8286.2003.00347.x
   Beebe NW, 2002, INT J PARASITOL, V32, P563, DOI 10.1016/S0020-7519(01)00359-9
   Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2
   Chareonviriyaphap Theeraphap, 2000, Science Asia, V26, P123, DOI 10.2306/scienceasia1513-1874.2000.26.123
   Chen B, 2002, MED VET ENTOMOL, V16, P253, DOI 10.1046/j.1365-2915.2002.00373.x
   COLLINS FH, 1996, SCI MED, V3, P52
   COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343
   Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769
   Coluzzi M., 2002, Parassitologia (Rome), V44, P131
   Conn JE, 1999, J AM MOSQUITO CONTR, V15, P468
   Costantini C., 1999, Parassitologia (Rome), V41, P595
   della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170
   Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70
   Estrada-Franco Jose G., 1992, Boletin de la Oficina Sanitaria Panamericana, V113, P297
   ESTRADAFRANCO JG, 1993, AM J TROP MED HYG, V49, P746, DOI 10.4269/ajtmh.1993.49.746
   Fairley TL, 2002, J MED ENTOMOL, V39, P861, DOI 10.1603/0022-2585-39.6.861
   Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x
   FloresMendoza C, 1996, MEM I OSWALDO CRUZ, V91, P265, DOI 10.1590/S0074-02761996000300001
   Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Gentile G, 2002, GENETICS, V161, P1561
   Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052
   Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Kager PA, 2002, TROP MED INT HEALTH, V7, P1042, DOI 10.1046/j.1365-3156.2002.00981.x
   Kamau L, 1998, AM J TROP MED HYG, V58, P64, DOI 10.4269/ajtmh.1998.58.64
   Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804
   Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647
   Lochouarn L, 1998, T ROY SOC TROP MED H, V92, P607, DOI 10.1016/S0035-9203(98)90782-9
   MACER D, 2003, SPECIAL TOPICS SOCIA
   Manguin S, 1999, AM J TROP MED HYG, V60, P364, DOI 10.4269/ajtmh.1999.60.364
   Manguin S, 2002, MED VET ENTOMOL, V16, P46, DOI 10.1046/j.0269-283x.2002.00344.x
   Mongin E, 2004, TRENDS PARASITOL, V20, P49, DOI 10.1016/j.pt.2003.11.003
   Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200
   Morel CM, 2002, SCIENCE, V298, P79, DOI 10.1126/science.1078047
   Nirmala X, 2003, TRENDS PARASITOL, V19, P384, DOI 10.1016/S1471-4922(03)00188-0
   NKONDJIO A, 2002, INFECT GENET EVOL, V45, P1
   Norris DE, 2002, INT J PARASITOL, V32, P1607, DOI 10.1016/S0020-7519(02)00189-3
   Rai K.S., 1974, P119
   Rai Karamjit S., 1996, P564
   Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a
   Rongnoparut P, 1996, AM J TROP MED HYG, V55, P589, DOI 10.4269/ajtmh.1996.55.589
   Scarpassa VM, 1999, AM J TROP MED HYG, V60, P1010, DOI 10.4269/ajtmh.1999.60.1010
   Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117
   SHAKAROV IV, 2002, SCIENCE, V298, P182
   Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633
   Subbarao SK, 1997, INDIAN J MED RES, V106, P164
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Torres EP, 2000, J MED ENTOMOL, V37, P933, DOI 10.1603/0022-2585-37.6.933
   Toure Y. T., 1998, Parassitologia (Rome), V40, P477
   Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x
   Van Bortel W, 2002, MED VET ENTOMOL, V16, P329, DOI 10.1046/j.1365-2915.2002.00376.x
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Walton C, 2001, MOL ECOL, V10, P569, DOI 10.1046/j.1365-294x.2001.01201.x
   ZIMMERMAN RH, 1992, MEM I OSWALDO CRUZ, V87, P371, DOI 10.1590/S0074-02761992000700064
   1995, WHO TECH REP SERIES, V857
   2003, EC ASPECTS APPL GENE, P1
   1991, PROSPECTS MALARIA CO
NR 64
TC 17
Z9 17
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD MAR
PY 2004
VL 20
IS 3
BP 142
EP 149
DI 10.1016/j.pt.2004.01.008
PG 8
WC Parasitology
SC Parasitology
GA 802ST
UT WOS:000220183900011
PM 15036036
DA 2020-12-17
ER

PT J
AU Engers, H
   Morel, CM
AF Engers, H
   Morel, CM
TI Disease watch - Focus - Leprosy
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Editorial Material
ID TOLL-LIKE RECEPTOR-2; MYCOBACTERIUM-LEPRAE
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Buhrer-Sekula S, 2003, J CLIN MICROBIOL, V41, P1991, DOI 10.1128/JCM.41.5.1991-1995.2003
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Honore N, 2001, LEPROSY REV, V72, P441
   Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864
   Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096
   Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2
   Oliveira RB, 2003, INFECT IMMUN, V71, P1427, DOI 10.1128/IAI.71.3.1427-1433.2003
   Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631
   Santos AR, 2002, J INFECT DIS, V186, P1687, DOI 10.1086/345366
   Shin YC, 2000, J CLIN MICROBIOL, V38, P4535, DOI 10.1128/JCM.38.12.4535-4538.2000
   VISSA VD, 2002, FUNC GENOM, V2, P85
NR 13
TC 12
Z9 12
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD NOV
PY 2003
VL 1
IS 2
BP 94
EP 95
DI 10.1038/nrmicro764
PG 2
WC Microbiology
SC Microbiology
GA 805YV
UT WOS:000220402500010
PM 15035038
DA 2020-12-17
ER

PT J
AU Morel, CM
   Lazdins, J
AF Morel, CM
   Lazdins, J
TI Chagas disease
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Editorial Material
ID TRYPANOSOMA-CRUZI; IMMUNOLOGICAL-TOLERANCE; INFECTION; AUTOIMMUNITY;
   EPIDEMIOLOGY; MYOCARDITIS; DIAGNOSIS; ANTIGENS
C1 TDR WHO, CH-1211 Geneva, Switzerland.
RP Morel, CM (corresponding author), TDR WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.
EM morelc@who.int; lazdinsj@who.int
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR Castro AM, 2002, PARASITOL RES, V88, P894, DOI 10.1007/s00436-002-0679-3
   Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001
   da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
   Devera R, 2003, MEM I OSWALDO CRUZ, V98, P1, DOI 10.1590/S0074-02762003000100001
   Di Noia JM, 2002, J EXP MED, V195, P401, DOI 10.1084/jem.20011433
   Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002
   Gao WD, 2003, FRONT BIOSCI-LANDMRK, V8, pE218, DOI 10.2741/1004
   Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438
   Girones N, 2003, TRENDS PARASITOL, V19, P19, DOI 10.1016/S1471-4922(02)00006-5
   Kierszenbaum F, 2003, FEMS IMMUNOL MED MIC, V37, P1, DOI 10.1016/S0928-8244(03)00097-X
   Miles MA, 2003, BMJ-BRIT MED J, V326, P1444, DOI 10.1136/bmj.326.7404.1444
   Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001
   Monteiro FA, 2001, TRENDS PARASITOL, V17, P344, DOI 10.1016/S1471-4922(01)01921-3
   Pontes-de-Carvalho L, 2002, J AUTOIMMUN, V18, P131, DOI 10.1006/jaut.2001.0574
   Reina-San-Martin B, 2000, PARASITOL TODAY, V16, P62, DOI 10.1016/S0169-4758(99)01591-4
   Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3
   VILASBOAS F, IN PRESS ARQUIVOS BR
   Villar J. C., 2002, COCHRANE DB SYST REV
   Williams-Blangero S, 2003, FRONT BIOSCI-LANDMRK, V8, pE337, DOI 10.2741/1058
NR 19
TC 76
Z9 78
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD OCT
PY 2003
VL 1
IS 1
BP 14
EP 15
DI 10.1038/nrmicro735
PG 2
WC Microbiology
SC Microbiology
GA 803TT
UT WOS:000220254100010
PM 15040175
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, CM
TI Neglected diseases: under-funded research and inadequate health
   interventions - Can we change this reality?
SO EMBO REPORTS
LA English
DT Article; Proceedings Paper
CT Meeting on Infectious Diseases and Bioweapons
CY NOV, 2002
CL HELDELBERG, GERMANY
ID INDIAN VISCERAL LEISHMANIASIS; PUBLIC-HEALTH; INFECTIOUS-DISEASE;
   CONTROLLED TRIAL; CHAGAS-DISEASE; MALARIA; BIOTERRORISM; GENOMICS;
   MORTALITY; MILTEFOSINE
C1 WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland.
RP Morel, CM (corresponding author), WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR *ADV COMM HLTH RES, 2002, GEN WORLD HLTH
   ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E
   Binka FN, 1996, TROP MED INT HEALTH, V1, P147
   Broder S, 2002, EMBO REP, V3, P806, DOI 10.1093/embo-reports/kvf187
   Cassels A, 2002, CAN MED ASSOC J, V167, P1281
   Curtis CF, 2000, SCIENCE, V290, P1508, DOI 10.1126/science.290.5496.1508
   Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229
   deAndrade ALSS, 1996, LANCET, V348, P1407
   Feldmann H, 2002, MED MICROBIOL IMMUN, V191, P63, DOI 10.1007/s00430-002-0122-5
   Fenner F, 1988, SMALLPOX ITS ERADICA
   *GLOB FOR HLTH RES, 2002, 1090 GLOB FOR HLTH R
   Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17
   Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340
   Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279
   Henderson DA, 2000, INT J CLIN PRACT, P32
   Hoffman SL, 2000, SCIENCE, V290, P1509, DOI 10.1126/science.290.5496.1509
   James AA, 2001, SCIENCE, V291, P435, DOI 10.1126/science.291.5503.435C
   Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403
   Kafatos FC, 2002, J MOL BIOL, V319, P861, DOI 10.1016/S0022-2836(02)00427-8
   Kealey T, 1996, EC LAWS SCI RES
   *MED FRONT ACC ESS, 2001, FAT IMB CRIS RES DEV
   Molyneux DH, 1998, BRIT MED BULL, V54, P327, DOI 10.1093/oxfordjournals.bmb.a011691
   Morel CM, 1999, MEM I OSWALDO CRUZ, V94, P3, DOI 10.1590/S0074-02761999000700002
   Morel CM, 2002, SCIENCE, V298, P79, DOI 10.1126/science.1078047
   MOREL CM, 2000, ACTION INFECT, V3, P1
   Nevill CG, 1996, TROP MED INT HEALTH, V1, P139
   Nosten F, 2002, DRUGS, V62, P1315, DOI 10.2165/00003495-200262090-00003
   Reich MR, 2000, SCIENCE, V287, P1979, DOI 10.1126/science.287.5460.1979
   Remme JHF, 2002, TRENDS PARASITOL, V18, P421, DOI 10.1016/S1471-4922(02)02387-5
   Sachs J, 2002, NEW SCI, V175, P52
   Sachs J.D., 2001, MACROECONOMICS HLTH
   Sauerborn R, 1999, TROP MED INT HEALTH, V4, P827, DOI 10.1046/j.1365-3156.1999.00497.x
   Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2
   Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633
   Stokes Donald E., 1997, PASTEURS QUADRANT BA
   Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556
   Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7
   *UN, 2002, UN MILL DEV GOALS MD
   *UN DEV PROGR, 2002, HUM DEV REP 2002 DEE
   WATKIN DR, 2000, BURDEN DIS GLOBAL PO
   *WHO, 1996, TDRGEN961 WHO
   Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176
   2002, ECONOMIST, V364, P20
NR 43
TC 36
Z9 39
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1469-221X
J9 EMBO REP
JI EMBO Rep.
PD JUN
PY 2003
VL 4
SI SI
BP S35
EP S38
DI 10.1038/sj.embor.embor851
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 699LJ
UT WOS:000184058100009
PM 12789404
OA Green Published
DA 2020-12-17
ER

PT B
AU Toure, YT
   Oduola, AMJ
   Sommerfeld, J
   Morel, CM
AF Toure, YT
   Oduola, AMJ
   Sommerfeld, J
   Morel, CM
BE Takken, W
   Scott, TW
TI Biosafety and risk assessment in the use of genetically modified
   mosquitoes for disease control
SO ECOLOGICAL ASPECTS FOR APPLICATION OF GENETICALLY MODIFIED MOSQUITOES
SE WAGENINGEN UR FRONTIS SERIES
LA English
DT Proceedings Paper
CT Workshop on Ecological Aspects for Application of Genetically Modified
   Mosquitoes
CY JUN, 2002
CL WAGENINGEN UNIV, WAGENINGEN, NETHERLANDS
SP Frontis
HO WAGENINGEN UNIV
DE genetically modified mosquito; biosafety; risk assessment; disease
   control; malaria; dengue
ID YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; GERMLINE TRANSFORMATION;
   ANOPHELES-GAMBIAE; TRANSMISSION; GENOME
AB The development and implementation of the release of genetically modified mosquitoes (GMM) for interrupting pathogen transmission represent a major challenge, despite the fact that several achievements have been made about Anopheles and Aedes mosquitoes. There are major biotechnology challenges remaining about the improvement of the stability of a gene construct and its expression for a robust and complete interruption of pathogen transmission and the devise of safe means of spreading foreign antipathogen genes through mosquito populations in the wild. The implementation obstacles to overcome include proper risk assessment and management, conduct of studies to ensure safety for humans and the environment, devise of appropriate control strategies based on sound gene-driving systems, address properly ethical, legal and social implications of the release of GMM and public concerns. Although the development of GMM as disease-control tool is technically feasible, for proper implementation no field release must be undertaken until clear scientific proof of safety for humans and the environment and efficacy is provided and ELSI concerns and public acceptance are properly addressed.
C1 WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland.
RP Toure, YT (corresponding author), WHO, Special Programme Res & Training Trop Dis, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   [Anonymous], 1991, M PROSP MAL CONTR GE
   Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198
   Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hoy MA, 2000, INSECT TRANSGENESIS, P335
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   MACER D, 2002, 6 WORLD C BIOETH BRA
   Morel CM, 2002, SCIENCE, V298, P79, DOI 10.1126/science.1078047
   Olson KE, 1996, SCIENCE, V272, P884, DOI 10.1126/science.272.5263.884
   Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117
   WHEELIS M, 1998, MANUAL ASSESSING ECO
NR 16
TC 4
Z9 4
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1584-4
J9 WAG UR FRON
PY 2003
VL 2
BP 217
EP 222
PG 6
WC Biotechnology & Applied Microbiology; Ecology; Entomology; Parasitology
SC Biotechnology & Applied Microbiology; Environmental Sciences & Ecology;
   Entomology; Parasitology
GA BX77Q
UT WOS:000186387000016
DA 2020-12-17
ER

PT J
AU Morel, CM
   Toure, YT
   Dobrokhotov, B
   Oduola, AMJ
AF Morel, CM
   Toure, YT
   Dobrokhotov, B
   Oduola, AMJ
TI The mosquito genome - a breakthrough for public health
SO SCIENCE
LA English
DT Editorial Material
ID MALARIA MOSQUITO
C1 WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland.
RP Morel, CM (corresponding author), WHO, Special Programme Res & Training Trop Dis, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR *ADV COMM HLTH RES, 2002, GEN WORLD HLTH, P1
   Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   Beaty BJ, 2000, P NATL ACAD SCI USA, V97, P10295, DOI 10.1073/pnas.97.19.10295
   Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096
   Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412
   Collins T, 1996, CLIN DIAGN LAB IMMUN, V3, P5, DOI 10.1128/CDLI.3.1.5-9.1996
   Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Lycett GJ, 2002, NATURE, V417, P387, DOI 10.1038/417387a
   Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117
   Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633
   *SPEC PROGR RES TR, 1991, TDRBCVMALENT913 SPEC
   Thomasova D, 2002, P NATL ACAD SCI USA, V99, P8179, DOI 10.1073/pnas.082235599
   Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198
NR 17
TC 25
Z9 27
U1 1
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD OCT 4
PY 2002
VL 298
IS 5591
BP 79
EP 79
DI 10.1126/science.1078047
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 600BJ
UT WOS:000178370500033
PM 12364774
DA 2020-12-17
ER

PT J
AU Remme, JHF
   Blas, E
   Chitsulo, L
   Desjeux, PMP
   Engers, HD
   Kanyok, TR
   Kayondo, JFK
   Kioy, DW
   Kumaraswami, V
   Lazdins, JK
   Nunn, PP
   Oduola, A
   Ridley, RG
   Toure, YT
   Zicker, F
   Morel, CM
AF Remme, JHF
   Blas, E
   Chitsulo, L
   Desjeux, PMP
   Engers, HD
   Kanyok, TR
   Kayondo, JFK
   Kioy, DW
   Kumaraswami, V
   Lazdins, JK
   Nunn, PP
   Oduola, A
   Ridley, RG
   Toure, YT
   Zicker, F
   Morel, CM
TI Strategic emphases for tropical diseases research: a TDR perspective
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID INSTITUTES-OF-HEALTH; DRUG; DISCOVERY; AFRICA; BURDEN; SCALE
AB Setting priorities for health research is a difficult task, especially for the neglected diseases of the poor. A new approach to priority setting for tropical diseases research has been adopted by the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (known as the TDR). Priorities are defined on the basis of a comprehensive analysis of research needs and research opportunities for each of the ten major tropical diseases in the TDR portfolio. The resulting strategic emphases matrix reflects the priorities for tropical diseases research from the perspective of the TDR. Its purpose is not to impose global research priorities, but we believe the results could be useful to other organizations.
C1 UNDP World Bank WHO Special Programme Res & Train, CH-1211 Geneva 27, Switzerland.
RP Morel, CM (corresponding author), UNDP World Bank WHO Special Programme Res & Train, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM morelc@who.it
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009; Zicker,
   Fabio/I-4138-2012; Zicker, Fabio/B-4209-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009;
   Zicker, Fabio/0000-0002-9751-7430
CR *ADV COMM HLTH RES, 2002, GEN WORLD HLTH
   Cao WC, 1997, TROP MED INT HEALTH, V2, P393
   *COMM NIH RES PRIO, 1998, SCI OPP PUBL NEEDS I
   Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ
   Dean PM, 2001, TRENDS BIOTECHNOL, V19, P288, DOI 10.1016/S0167-7799(01)01696-1
   Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171
   Dolle RE, 2001, J COMB CHEM, V3, P477, DOI 10.1021/cc010049g
   Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9
   *GLOB FOR HLTH RES, 2002, 1090 GLOB FOR HLTH R
   GODAL T, 1996, TDRGEN961 WHO
   Goodman CA, 1999, HEALTH POLICY PLANN, V14, P301, DOI 10.1093/heapol/14.4.301
   Goodnow RA, 2001, J CELL BIOCHEM, V84, P13, DOI 10.1002/jcb.10061
   Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406
   GYAPONG JO, IN PRESS ANN TROP ME
   HABBEMA JDF, 1992, PARASITOL TODAY, V8, P99, DOI 10.1016/0169-4758(92)90248-Z
   Hearst N, 2001, HEALTH POLICY PLANN, V16, P1, DOI 10.1093/heapol/16.suppl_2.1
   Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673
   Hursey BS, 2001, TRENDS PARASITOL, V17, P2, DOI 10.1016/S1471-4922(00)01851-1
   Hutubessy RCW, 2001, ACTA TROP, V78, P191, DOI 10.1016/S0001-706X(00)00176-5
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036
   KARBWANG J, 1999, TDRTDPSOP991 CLIN IN
   Kenney Richard T., 2002, Vaccine, V20, P2155, DOI 10.1016/S0264-410X(02)00091-9
   KIOY D, 2001, TDRPRDGLP011C
   Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235
   LEVINE RJ, 2000, BIOMEDICAL RES ETHIC
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Marchant T, 2002, TROP MED INT HEALTH, V7, P149, DOI 10.1046/j.1365-3156.2002.00840.x
   Morel CM, 2000, PARASITOL TODAY, V16, P522, DOI 10.1016/S0169-4758(00)01815-9
   Morison M, 1998, J ADV NURS, V28, P106, DOI 10.1046/j.1365-2648.1998.00768.x
   MOUNT DW, 2001, BIOINFORMATICS SEQUE
   Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981
   Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170
   Reich MR, 2000, SCIENCE, V287, P1979, DOI 10.1126/science.287.5460.1979
   Remme J., 1989, Demography and vector-borne diseases., P367
   Rothman David, 1997, BEGINNINGS COUNT TEC
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Sachs J., 2001, MACR HLTH INV HLTH E
   Sakallah S A, 2000, Biotechnol Annu Rev, V6, P141, DOI 10.1016/S1387-2656(00)06021-X
   *TDR, 2000, TDRGENSP001REV1, P1
   Varmus H, 1999, NEW ENGL J MED, V340, P1914, DOI 10.1056/NEJM199906173402411
   Venkatesh S, 2000, J PHARM SCI-US, V89, P145, DOI 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6
   Vlassoff C, 2000, SOC SCI MED, V50, P1353, DOI 10.1016/S0277-9536(99)00389-5
   WIGZELL H, 1998, TDRJCB21985, P1
   World Bank, 1993, WORLD DEV REP 1993 I
   World Health Organization, 2002, WORLD HLTH REP 2001
NR 47
TC 22
Z9 22
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD OCT
PY 2002
VL 10
IS 10
BP 435
EP 440
AR PII S0966-842X(02)02431-9
DI 10.1016/S0966-842X(02)02431-9
PG 6
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 601WN
UT WOS:000178471900001
PM 12377547
DA 2020-12-17
ER

PT J
AU Remme, JHF
   Blas, E
   Chitsulo, L
   Desjeux, PMP
   Engers, HD
   Kanyok, TP
   Kayondo, JFK
   Kioy, DW
   Kumaraswami, V
   Lazdins, JK
   Nunn, PP
   Oduola, A
   Ridley, RG
   Toure, YT
   Zicker, F
   Morel, CM
AF Remme, JHF
   Blas, E
   Chitsulo, L
   Desjeux, PMP
   Engers, HD
   Kanyok, TP
   Kayondo, JFK
   Kioy, DW
   Kumaraswami, V
   Lazdins, JK
   Nunn, PP
   Oduola, A
   Ridley, RG
   Toure, YT
   Zicker, F
   Morel, CM
TI Strategic emphases for tropical diseases research: a TDR perspective
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID INSTITUTES-OF-HEALTH; DRUG; DISCOVERY; AFRICA; BURDEN; SCALE
AB Setting priorities for health research is a difficult task, especially for the neglected diseases of the poor. A new approach to priority setting for tropical diseases research has been adopted by the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (known as the TDR). Priorities are defined on the basis of a comprehensive analysis of research needs and research opportunities for each of the ten major tropical diseases in the TDR portfolio. The resulting strategic emphases matrix reflects the priorities for tropical diseases research from the perspective of the TDR. Its purpose is not to impose global research priorities, but we believe the results could be useful to other organizations.
C1 UNDP, World Bank, WHO Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland.
RP Remme, JHF (corresponding author), UNDP, World Bank, WHO Special Programme Res & Training Trop Dis, 20 Ave Appia, CH-1211 Geneva, Switzerland.
EM morelc@who.int
RI Zicker, Fabio/I-4138-2012; Morel, Carlos M/B-4079-2009; Morel,
   Carlos/Q-9657-2019; Zicker, Fabio/B-4209-2009
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Zicker, Fabio/0000-0002-9751-7430
CR Cao WC, 1997, TROP MED INT HEALTH, V2, P393
   *COMM NIH RES PRIO, 1998, SCI OPP PUBL NEEDS I
   Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ
   Dean PM, 2001, TRENDS BIOTECHNOL, V19, P288, DOI 10.1016/S0167-7799(01)01696-1
   Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171
   Dolle RE, 2001, J COMB CHEM, V3, P477, DOI 10.1021/cc010049g
   Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9
   *GLOB FOR HLTH RES, 2002, 1090 GLOB FOR HLTH R
   GODAL T, 1996, TDRGEN961 WHO
   Goodman CA, 1999, HEALTH POLICY PLANN, V14, P301, DOI 10.1093/heapol/14.4.301
   Goodnow RA, 2001, J CELL BIOCHEM, V84, P13, DOI 10.1002/jcb.10061
   Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406
   GYAPONG JO, IN PRESS ANN TROP ME
   HABBEMA JDF, 1992, PARASITOL TODAY, V8, P99, DOI 10.1016/0169-4758(92)90248-Z
   Hearst N, 2001, HEALTH POLICY PLANN, V16, P1, DOI 10.1093/heapol/16.suppl_2.1
   Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673
   Hursey BS, 2001, TRENDS PARASITOL, V17, P2, DOI 10.1016/S1471-4922(00)01851-1
   Hutubessy RCW, 2001, ACTA TROP, V78, P191, DOI 10.1016/S0001-706X(00)00176-5
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036
   KARBWANG J, 1998, TDRTDPSOP991
   Kenney Richard T., 2002, Vaccine, V20, P2155, DOI 10.1016/S0264-410X(02)00091-9
   KIOY D, 2001, TDRPRDGLP011C
   Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235
   LEVINE RJ, 2000, BIOMEDICAL RES ETHIC
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Marchant T, 2002, TROP MED INT HEALTH, V7, P149, DOI 10.1046/j.1365-3156.2002.00840.x
   Morel CM, 2000, PARASITOL TODAY, V16, P522, DOI 10.1016/S0169-4758(00)01815-9
   Morison M, 1998, J ADV NURS, V28, P106, DOI 10.1046/j.1365-2648.1998.00768.x
   MOUNT DW, 2001, BIOINFORMATICS SEQUE
   Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981
   Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170
   Reich MR, 2000, SCIENCE, V287, P1979, DOI 10.1126/science.287.5460.1979
   REMME JHF, 1989, DEMOGRAPHY VECTOR BO, P369
   ROTHMAN DJ, 1997, BEGINNINGS COSTS TEC
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Sachs J.D., 2001, MACROECONOMICS HLTH
   Sakallah S A, 2000, Biotechnol Annu Rev, V6, P141, DOI 10.1016/S1387-2656(00)06021-X
   *TDR, 2000, TDRGENSP001REV1128
   Varmus H, 1999, NEW ENGL J MED, V340, P1914, DOI 10.1056/NEJM199906173402411
   Venkatesh S, 2000, J PHARM SCI-US, V89, P145, DOI 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6
   Vlassoff C, 2000, SOC SCI MED, V50, P1353, DOI 10.1016/S0277-9536(99)00389-5
   WHO, 2000, WORLD HLTH REP 2001
   *WHO, 2002, GEN WORLD HLTH
   WIGZELL H, 1998, TDRJCB219851133
   World Bank, 1993, WORLD DEV REP 1993 I
   World Health Organization, 2002, WORLD HLTH REP 2001
NR 48
TC 88
Z9 96
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD OCT
PY 2002
VL 18
IS 10
BP 421
EP 426
AR PII S1471-4922(02)02387-5
DI 10.1016/S1471-4922(02)02387-5
PG 6
WC Parasitology
SC Parasitology
GA 598VF
UT WOS:000178296600001
PM 12377584
DA 2020-12-17
ER

PT J
AU Morel, C
AF Morel, C
TI Special issue: A global network on schistosomiasis information systems
   and control of snail-borne diseases - Foreword
SO ACTA TROPICA
LA English
DT Editorial Material
C1 UNDP World Bank WHO Special Programme Res & Train, CH-1211 Geneva 27, Switzerland.
RP Morel, C (corresponding author), UNDP World Bank WHO Special Programme Res & Train, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
NR 0
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
J9 ACTA TROP
JI Acta Trop.
PD APR 27
PY 2001
VL 79
IS 1
BP 1
EP 2
DI 10.1016/S0001-706X(01)00133-4
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 433PR
UT WOS:000168769400001
PM 11378135
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, CM
TI Present and future control of malaria
SO SCIENCE
LA English
DT Letter
C1 WHO, CH-1211 Geneva 27, Switzerland.
   TDR, Geneva, Switzerland.
RP Morel, CM (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR Brundtland GH, 1998, SCIENCE, V280, P2027
   Morel CM, 2000, PARASITOL TODAY, V16, P522, DOI 10.1016/S0169-4758(00)01815-9
NR 2
TC 3
Z9 3
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD JAN 19
PY 2001
VL 291
IS 5503
BP 435
EP 436
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 393UF
UT WOS:000166487500017
PM 11228137
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, CM
TI Reaching maturity - 25 years of the TDR
SO PARASITOLOGY TODAY
LA English
DT Review
ID CHAGAS-DISEASE; ONCHOCERCIASIS CONTROL; MORTALITY; MALARIA; PREVALENCE;
   PARASITES; PROGRAM; HEALTH; AFRICA
AB In its first 25 years of existence, TDR has become a key player in the development of new tools for the control of tropical diseases and the training of researchers from disease-endemic countries. In order to maintain ifs leading position, cope with new health challenges and profit from new avenues opened by science and technology breakthroughs, a new strategic vision is now being implemented It aims at a closer interaction with health systems and disease control programmes, capacity strengthening based on selected research initiatives and full exploitation of scientific and technological advances in the biomedical, social and information sciences, as discussed here by Carlos Morel.
C1 WHO, TDR, CH-1211 Geneva 27, Switzerland.
RP Morel, CM (corresponding author), WHO, TDR, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR Balter M, 1999, SCIENCE, V285, P508
   BEATTIE P, 1999, STRENGTHENING HLTH R
   Brundtland GH, 1998, SCIENCE, V280, P2027
   BRUNDTLAND GH, 1999, EX BOARD 105 SESS WH
   Buse K, 2000, B WORLD HEALTH ORGAN, V78, P699
   Buse K, 2000, B WORLD HEALTH ORGAN, V78, P549
   Butler D, 2000, NATURE, V403, P692, DOI 10.1038/35001735
   Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096
   *COMM HLTH RES DEV, HLTH RES ESS LINK EQ
   CRAMPTON J, 1990, PARASITOL TODAY, V6, P31, DOI 10.1016/0169-4758(90)90057-B
   Davies C, 2000, PARASITOL TODAY, V16, P219, DOI 10.1016/S0169-4758(00)01670-7
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677
   FUJISAKI T, 1998, TDRERRD985 UNDP WHO
   FUJISAKI T, 1998, TDRERRD983 UNDP WHO
   *GLOB FOR HLTH RES, 2000, 1090 GLOB FOR HLTH R
   GODAL T, 1996, TDRGEN961 WHO
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   Gwatkin DR, 2000, BURDEN DIS AMONG GLO
   Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403
   Johnston DA, 1999, BIOESSAYS, V21, P131, DOI 10.1002/(SICI)1521-1878(199902)21:2<131::AID-BIES7>3.0.CO;2-I
   LENGELER C, 1996, NET GAIN NEW METHOD
   LUCAS A, 2000, WORKSH PUBL PRIV PAR
   Lucas A. O., 1985, World Health, P19
   Lucky R, 2000, SCIENCE, V289, P259, DOI 10.1126/science.289.5477.259
   MILLERON R, 1998, TDRERRD984 UNDP WHO
   MODABBER F, 2000, CURR OPIN ANTIINFECT, V2, P35
   Molyneux DH, 1998, BRIT MED BULL, V54, P327, DOI 10.1093/oxfordjournals.bmb.a011691
   Moncayo A, 1999, MEM I OSWALDO CRUZ, V94, P401, DOI 10.1590/S0074-02761999000700079
   Morel CM, 1999, MEM I OSWALDO CRUZ, V94, P3, DOI 10.1590/S0074-02761999000700002
   NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893
   *ONCH CONTR PROGR, 1994, 20 YEARS ONCH CONTR
   PLAISIER AP, 1995, J INFECT DIS, V172, P204, DOI 10.1093/infdis/172.1.204
   Reich MR, 2000, NAT MED, V6, P617, DOI 10.1038/76176
   Reich MR, 2000, SCIENCE, V287, P1979, DOI 10.1126/science.287.5460.1979
   REMME JHF, 1995, PARASITOL TODAY, V11, P403, DOI 10.1016/0169-4758(95)80017-4
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692
   Snow RW, 1999, PARASITOL TODAY, V15, P99, DOI 10.1016/S0169-4758(99)01395-2
   Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624
   von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X
   *WHO, 1997, TDRMALVAC97 WHO
   *WHO, 2000, WHOCDS20002
   *WHO, 1996, TDRAFRRP961 WHO
   WHO, 1998, TDRTDFCOMDT982 WHO
   *WHO, 2000, WHOCDSTB2000275
   WIGZELL H, 1998, TDRJCB21985 UNDP WHO, P5
   World Health Assembly, 1997, EL LYMPH FIL PUBL HL
   1991, TDRBCVMALENT913 WHO
   1998, 981 WHODTR
   2000, WEEKLY EPIDEMILL REC, V75, P226
NR 50
TC 65
Z9 66
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0169-4758
J9 PARASITOL TODAY
JI Parasitol. Today
PD DEC
PY 2000
VL 16
IS 12
BP 522
EP +
DI 10.1016/S0169-4758(00)01815-9
PG 5
WC Parasitology
SC Parasitology
GA 380NU
UT WOS:000165708600007
PM 11121849
DA 2020-12-17
ER

PT J
AU Morel, C
AF Morel, C
TI Special issue: Schistosomiasis in the post-transmission phase - Foreword
SO ACTA TROPICA
LA English
DT Editorial Material
C1 UNDP, World Bank, WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland.
RP Morel, C (corresponding author), UNDP, World Bank, WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
J9 ACTA TROP
JI Acta Trop.
PD OCT 23
PY 2000
VL 77
IS 1
BP 1
EP 1
DI 10.1016/S0001-706X(00)00119-4
PG 1
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 354XL
UT WOS:000089356500001
DA 2020-12-17
ER

PT J
AU Fernandes, O
   Mangia, RH
   Lisboa, CV
   Pinho, AP
   Morel, CM
   Zingales, B
   Campbell, DA
   Jansen, AM
AF Fernandes, O
   Mangia, RH
   Lisboa, CV
   Pinho, AP
   Morel, CM
   Zingales, B
   Campbell, DA
   Jansen, AM
TI The complexity of the sylvatic cycle of Trypanosoma cruzi in Rio de
   Janeiro state (Brazil) revealed by the non-transcribed spacer of the
   mini-exon gene
SO PARASITOLOGY
LA English
DT Article
DE Trypanosoma cruzi; mini-exon gene; sylvatic cycle; Didelphis
   marsupialis; Leontophitecus rosalia
ID CHAGAS-DISEASE; IDENTIFICATION; HETEROGENEITY; AREA
AB American trypanosamiasis occurs in nature as a sylvatic cycle, where Trypanosoma cruzi interacts with wild triatomines and mammalian reservoirs, such as marsupials, rodents, armadillos and other animals. Due tu difficulties in trying to isolate T. cruzi stocks from the sylvatic cycle, very few studies hal-e been performed in order to understand the parasite infection in natural environments. Traditionally T. cruzi has been considered to be composed of a highly heterogeneous population of parasites. In contrast, the mini-exon and the 24S alpha rRNA gene loci have shown that T. cruzi stocks can be clustered in 2 major phylogenetic groups: lineage 1 and lineage 2. In this report, 68 recently isolated T. cruzi samples from the sylvatic cycle belonging to different geographical areas in Rio de Janeiro, Brazil, have been typed based on a variable spot in the nun-transcribed spacer of the mini-exon gene. Eight isolates were from triatomines, 26 stocks were from golden-lion tamarins, 31 from opossums, 2 from rodents and 1 from a three-toed sloth. Thirty (44 % - 30/68) isolates were typed as lineage 1, while 36 (53 % - 36/68) isolates were typed as lineage 2. Tno opossums presented mixed infection. Therefore, 3 % (2/68) of the isolates were typed as lineage 1 + lineage 2. Using these geographical regions as models of sylvatic environments, it was observed that 96 % of the Didelphis marsupialis were infected by lineage 2 isolates, while all 26 golden-lion tamarins were infected by lineage 1. The results show preferential association of thr 2 lineages of T. cruzi with different hosts, composing the complexity of the sylvatic cycle.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Trop Med, Fundacao Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Biochem, BR-21045900 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Protozool, BR-21045900 Rio De Janeiro, Brazil.
   Univ Sao Paulo, Inst Quim, Dept Biochem, BR-05508 Sao Paulo, Brazil.
   Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90024 USA.
   Univ Estado Rio De Janeiro, Dept Pathol, Rio De Janeiro, Brazil.
RP Fernandes, O (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Trop Med, Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM octaviof@gene.dbbm.fiocruz.br
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Jansen, Ana Maria/0000-0001-5804-6210
CR BARRETO MP, 1979, JTRYPANOSOMA CRUZI D, P1
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CLARK CG, 1994, MOL BIOCHEM PARASIT, V66, P175, DOI 10.1016/0166-6851(94)90045-0
   Deane M P, 1984, Mem Inst Oswaldo Cruz, V79, P495, DOI 10.1590/S0074-02761984000400016
   DEANE MP, 1984, MEMORIAS I O CRUZ S, V99, P19
   DVORAK JA, 1988, MOL BIOCHEM PARASIT, V31, P19, DOI 10.1016/0166-6851(88)90141-7
   FERNANDES O, 1994, MOL BIOCHEM PARASIT, V66, P261, DOI 10.1016/0166-6851(94)90153-8
   Fernandes O, 1998, AM J TROP MED HYG, V58, P807, DOI 10.4269/ajtmh.1998.58.807
   FERNANDES O, 1993, PARASITOLOGY, V107, P219, DOI 10.1017/S003118200007918X
   HENRIKSSON J, 1993, EXP PARASITOL, V77, P334, DOI 10.1006/expr.1993.1091
   Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4
   MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0
   MILES MA, 1980, T ROY SOC TROP MED H, V74, P221, DOI 10.1016/0035-9203(80)90251-5
   MILES MA, 1977, T ROY SOC TROP MED H, V71, P217, DOI 10.1016/0035-9203(77)90012-8
   MOREL C, 1980, AM J TROP MED HYG, V29, P1070, DOI 10.4269/ajtmh.1980.29.1070
   Nunes LR, 1997, GENE, V188, P157, DOI 10.1016/S0378-1119(96)00726-3
   PARSONS M, 1984, CELL, V38, P309, DOI 10.1016/0092-8674(84)90552-X
   Pinho A. P., 1997, Memorias do Instituto Oswaldo Cruz, V92, P121
   PINHO AP, 1996, MEM I OSWALDO CRUZ S, V91, P220
   PUNG OJ, 1998, IN PRESS J ZOO WILDL
   Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7
   STURM NR, 1995, FEMS MICROBIOL LETT, V130, P177, DOI 10.1111/j.1574-6968.1995.tb07716.x
   TIBAYRENC M, 1993, P NATL ACAD SCI USA, V90, P1335, DOI 10.1073/pnas.90.4.1335
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   ZELEDON R, 1970, J PARASITOL, V56, P38, DOI 10.2307/3277448
   Zingales B, 1998, INT J PARASITOL, V28, P105, DOI 10.1016/S0020-7519(97)00178-1
NR 26
TC 86
Z9 89
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD FEB
PY 1999
VL 118
BP 161
EP 166
DI 10.1017/S0031182098003709
PN 2
PG 6
WC Parasitology
SC Parasitology
GA 167GR
UT WOS:000078624600006
PM 10028530
DA 2020-12-17
ER

PT J
AU Morel, CM
AF Morel, CM
TI Chagas disease, from discovery to control - and beyond: History, myths
   and lessons to take home
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT International Symposium on the Advances in Knowledge of Chagas Disease
   90 Years After its Discovery
CY APR 11-16, 1999
CL RIO JANEIRO, BRAZIL
SP Acad Nacl Med, Conselho Nacl Desenvolvimento Cientifico Technol, Financiadora Estudos Projetos, Fundacao Amparo Pesquisa Rio de Janeiro, Fundacao nacl Saude, Fundacao Oswaldo Cruz, Org Pan Amer Saude, Org Mundial Saude, Roche Prod Quimicos Farmaceuticos, Unibind, ABT & I Technoway
DE Chagas disease; discovery; research and development; control
ID CRUZI GENOME PROJECT; CLONE CL-BRENER; EMERGING INFECTIOUS-DISEASES;
   TRYPANOSOMA-CRUZI; KINETOPLAST-DNA; IDENTIFICATION; BRAZIL; PARASITE;
   LESIONS; CARDIOMYOPATHY
AB There is a sad dissociation between the crucial role that research plays in improving health and the general lack of recognition of its role, importance and priority in public health policies. We tend to forget how much we owe to research once a success story in disease control achieves a happy end. Health authorities and policy makers use to say that they want the real thing - in other words, disease control, now - and not lose time and money with unnecessary and odd expenses - in other terms, health research for tomorrow.
   Therefore, I decided to choose as the subject of my lecture a success story in disease control in South America and to point out to the role research has played along its development. It starts at the very beginning - the discovery of the disease and goes until the most recent chapter - its elimination as a major public health problem in large regions of the Southern Cone countries. Although no one can yet assure a final "happy end" to this story, progress in its control has been very successful, to the point that the World Health Organization calls it a disease whose days are numbered (Division of Control of Tropical Diseases, 1996). It is a long story - 90 years of history - that illustrates the fundamental importance of research in improving health. By analyzing it, studying the actors, the personalities, the facts, the true or false stories - in other words, the myths -, I think we can derive some universal notions and also some lessons to take home, to keep in mind and put into use when time and opportunity comes.
   It is a real story, about Chagas disease - from its discovery in 1909 by the Brazilian scientist Carlos Chagas working at the Oswaldo Cruz Institute in Rio de Janeiro to its successful control in the large regions of the Southern Cone countries in the 90s.
C1 WHO, UNDP World Bank WHO Special Programme Res & Train, CH-1211 Geneva 27, Switzerland.
RP Morel, CM (corresponding author), WHO, UNDP World Bank WHO Special Programme Res & Train, 20 Av Appia, CH-1211 Geneva 27, Switzerland.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR AKHAVAN D, 1997, ANAL CUSTO EFETIVIDA
   [Anonymous], 1997, WORLD HLTH REPORT 19
   ARAGO HENRIQUE de BEAUREPAIRE, 1950, MEM INST OSWALDO CRUZ, V48, P1
   Benchimol Jaime, 1993, COBRAS LAGARTOS OUTR
   BENCHIMOL Jaime L., 1990, MANGUINHOS SONHO VID
   Brandao A, 1997, MEM I OSWALDO CRUZ, V92, P863, DOI 10.1590/S0074-02761997000600024
   Brandariz S, 1996, LANCET, V347, P914
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   BRENER Z, 1977, INTRASPECIFIC VARIAT
   BRENER Z, 1989, MEM I OSW CRUZ S2, V84, P1
   BRITTO C, 1995, PARASITOLOGY, V110, P241, DOI 10.1017/S0031182000080823
   BRITTO C, 1995, EXP PARASITOL, V81
   Brumpt E., 1914, Annaes Paulistas de Medicina e Cirurgia, V3
   CAMARGO ME, 1984, REV I MED TROP, V26, P192, DOI 10.1590/S0036-46651984000400003
   CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A
   Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1
   Chagas Filho Carlos, 1993, MEU PAI
   Coura J.R., 1997, CLIN TERAPEUTICA DOE, P469
   CunhaNeto E, 1996, J CLIN INVEST, V98, P1709, DOI 10.1172/JCI118969
   CUNHANETO E, 1995, P NATL ACAD SCI USA, V92, P3541, DOI 10.1073/pnas.92.8.3541
   DAFONSECA O, 1973, ANONYMOUS O CRUZ MON, V2, P43
   DAVIES AM, 1992, RES STRATEGIES HLTH
   deAndrade ALSS, 1996, LANCET, V348, P1407
   Deane M.P., 1984, Memorias do Instituto Oswaldo Cruz, V79, P513, DOI 10.1590/S0074-02761984000400021
   Degrave W, 1997, MEM I OSWALDO CRUZ, V92, P859, DOI 10.1590/S0074-02761997000600023
   Degrave W, 1997, MEM I OSWALDO CRUZ, V92, P805, DOI 10.1590/S0074-02761997000600015
   deLana M, 1996, PARASITOL RES, V82, P257, DOI 10.1007/s004360050106
   Delaporte F., 1995, Historia Ciencias, Saude - Manguinhos, V1, P39, DOI 10.1590/S0104-59701995000100004
   DiAS E., 1948, Brasil-Medico, V62, P185
   DIAS E, 1918, O I O CRUZ RESUMO HI
   Dias J C, 1986, Rev Soc Bras Med Trop, V19, P129, DOI 10.1590/S0037-86821986000300001
   DIAS JCP, 1987, PARASITOL TODAY, V3, P336, DOI 10.1016/0169-4758(87)90117-7
   DIAS JCP, 1997, MEM I O CRUZ, V92, P13
   Duboule D, 1997, SCIENCE, V278, P555, DOI 10.1126/science.278.5338.555
   Ferrari I, 1997, MEM I OSWALDO CRUZ, V92, P843, DOI 10.1590/S0074-02761997000600021
   Garrett L., 1994, COMING PLAGUE NEWLY
   GODAL T, 1996, INVESTING HLTH RES D
   GUERRA F, 1970, AM J TROP MED HYG, V73, P83
   GUERREIRO C, 1913, BRAZIL MEDICO, V27, P225
   HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S
   Jansen AM, 1997, EXP PARASITOL, V86, P37, DOI 10.1006/expr.1997.4144
   JONES EM, 1993, AM J TROP MED HYG, V48, P348, DOI 10.4269/ajtmh.1993.48.348
   KINGMAN S, 1991, NEW SCI, V16
   KOBERLE F., 1956, Revista Goiana de Medicina, V2, P101
   KOBERLE F, 1955, REV PAUL MED, V47, P89
   Kraus R, 1915, PRENSA MED ARGENT, V1, P2
   KRAUS R, 1919, REV I BACTERIOL BUEN, V2, P224
   LAZZARI JO, 1994, CHAGAS DIS NERVOUS S, P72
   LeDuc JW, 1996, JAMA-J AM MED ASSOC, V275, P318, DOI 10.1001/jama.275.4.318
   LENZI HL, 1984, MEM I OSWALDO CRUZ S, V79, P7
   Levin MJ, 1996, PARASITOL TODAY, V12, P415, DOI 10.1016/0169-4758(96)20051-1
   LEWINSOHN R, 1979, T R SOC TROP MED HYG, V73, P523
   Luquetti AO, 1997, PARASITOL TODAY, V13, P127, DOI 10.1016/S0169-4758(97)01018-1
   Marques M B, 1995, Cad Saude Publica, V11, P361
   MARSHALL E, 1995, SCIENCE, V267, P811, DOI 10.1126/science.7846525
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   Mazza S., 1936, MEPRA, V28, P41
   Mazza S, 1934, MEPRA, V17, P3
   MAZZA Salvador, 1936, Prensa Medica Argentina, V23, P1979
   MELLO RC, 1978, J PARASITOL, V64, P475
   MILES MA, 1977, T ROY SOC TROP MED H, V71, P217, DOI 10.1016/0035-9203(77)90012-8
   MILES MA, 1996, ILLUSTRATED HIST TRO, P192
   MONCAYO A, 1990, MEM I OSWALDO CRUZ, V85, P489, DOI 10.1590/S0074-02761990000400020
   MONCAYO A, 1994, CHAGAS DIS NERVOUS S, P54
   Montamat EE, 1996, AM J TROP MED HYG, V55, P625, DOI 10.4269/ajtmh.1996.55.625
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   NUSSENZWEIG V, 1953, Rev Paul Med, V42, P57
   Oliveira Filho A M, 1988, Rev Argent Microbiol, V20, P39
   Oury B, 1997, J PARASITOL, V83, P52, DOI 10.2307/3284316
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Pellegrino J., 1954, Memorias do Instituto Oswaldo Cruz, V51, P611, DOI 10.1590/S0074-02761953000100019
   Pena SDJ, 1996, TRENDS BIOTECHNOL, V14, P74, DOI 10.1016/0167-7799(96)80926-7
   Perleth M., 1997, HIST ASPECTS AM TRYP
   PETERSON DS, 1986, NATURE, V322, P566, DOI 10.1038/322566a0
   Prata A., 1981, CARLOS CHAGAS COLETA
   RAYMOND SU, 1997, GLOBAL HLTH COLLABOR
   ROMANA C., 1948, An. Inst. Med. Regional, V2, P95
   SALGADO JOAO AMILCAR, 1962, REV INST MED TROP SSB PAULO, V4, P330
   SANTOS FD, 1996, REV AMAZONIA EXPEDIC
   Santos MRM, 1997, MEM I OSWALDO CRUZ, V92, P821, DOI 10.1590/S0074-02761997000600018
   SCHMUNIS G A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P287, DOI 10.1590/S0074-02761987000500011
   Schmunis GA, 1996, LANCET, V348, P1171, DOI 10.1016/S0140-6736(05)65305-6
   SCHMUNIS GA, 1994, CHAGAS DIS NERVOUS S, P3
   Schmunis GA, 1997, CLIN TERAPEUTICA DOE, P11
   Schofield CJ, 1997, PARASITOL TODAY, V13, P141, DOI 10.1016/S0169-4758(97)89811-0
   SCHOFIELD CJ, 1996, P INT WORKSH POP GEN, P11
   SCHOFIELD CJ, 1994, TRIATOMINAE BIOL CON
   Schwartz DA, 1996, ARCH PATHOL LAB MED, V120, P117
   Silveira A. C., 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P11, DOI 10.1590/S0037-86821994000100003
   SILVEIRA AC, 1985, ANN SOC BELG MED TR, V65, P137
   Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7
   STEPAN N, 1976, OSWALDO CRUZ MED RES
   TEIXEIRA ARL, 1975, AM J PATHOL, V80, P163
   THIELEN EV, 1991, SCIENCE HEADING BACK
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   Tilghman SM, 1996, GENOME RES, V6, P773, DOI 10.1101/gr.6.9.773
   Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969
   Vago AR, 1996, LANCET, V348, P891, DOI 10.1016/S0140-6736(05)64761-7
   Vianna Gaspar, 1911, Memorias do Instituto Oswaldo Cruz, V3
   WENDEL S, 1992, CHAGAS DIS AM TRYPAN, P5
   *WHO, 1996, CHAG DIS DIS WHOS DA
   WILSON ME, 1994, DIS EVOLUTION GLOBAL
   Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016
   Zingales B, 1997, ACTA TROP, V68, P159, DOI 10.1016/S0001-706X(97)00088-0
   Zingales B, 1997, PARASITOL TODAY, V13, P16
   1991, ESSENTIAL NATL HLTH
   1994, ADDRESSING EMERGING
   1995, TROPICAL DIS RES PRO
   1990, HLTH RES ESSENTIAL L
   1997, WHO TROPICAL DIS RES, P112
   1996, DIVISION CONTROL TRO
NR 111
TC 32
Z9 37
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 1999
VL 94
SU 1
BP 3
EP 16
DI 10.1590/S0074-02761999000700002
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 245AH
UT WOS:000083083300002
PM 10677688
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Britto, C
   Cardoso, MA
   Marques, P
   Fernandes, O
   Morel, CM
AF Britto, C
   Cardoso, MA
   Marques, P
   Fernandes, O
   Morel, CM
TI Polymerase chain reaction detection: New insights into the diagnosis of
   chronic Chagas disease
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT International Symposium on the Advances in Knowledge of Chagas Disease
   90 Years After its Discovery
CY APR 11-16, 1999
CL RIO JANEIRO, BRAZIL
SP Acad Nacl Med, Conselho Nacl Desenvolvimento Cientifico Technol, Financiadora Estudos Projetos, Fundacao Amparo Pesquisa Rio de Janeiro, Fundacao nacl Saude, Fundacao Oswaldo Cruz, Org Pan Amer Saude, Org Mundial Saude, Roche Prod Quimicos Farmaceuticos, Unibind, ABT & I Technoway
DE Trypanosoma cruzi; kinetoplast DNA; Chagas disease; PCR diagnosis
C1 Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-21045900 Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz, Dept Trop Med, BR-21045900 Rio De Janeiro, Brazil.
   UERJ, Dept Patol, Rio De Janeiro, Brazil.
RP Britto, C (corresponding author), Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009; Britto,
   Constanca/L-7658-2016
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030
NR 0
TC 12
Z9 12
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 1999
VL 94
SU 1
BP 305
EP 306
DI 10.1590/S0074-02761999000700056
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 245AH
UT WOS:000083083300056
PM 10677742
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Molyneux, DH
   Morel, C
AF Molyneux, DH
   Morel, C
TI Onchocerciasis and Chagas' disease control: the evolution of control via
   applied research through changing development scenarios
SO BRITISH MEDICAL BULLETIN
LA English
DT Article
ID TRYPANOSOMA-CRUZI; WEST-AFRICA; CONTROL PROGRAM; COMPLEX;
   IDENTIFICATION; VOLVULUS; BRAZIL; EPIDEMIOLOGY; POPULATIONS; SIMULIIDAE
AB This paper addresses the development of control strategies of two different parasitic diseases and identifies commonalities which have contributed to the success of regional intercountry programmes of onchocerciasis control in Africa, the Onchocerciasis Control Programme (OCP), and the new African Programme for Onchocerciasis Control (APOC)(1-3) and the Chagas' Disease Control Programme in the southern cone of South America(4).
C1 Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   FIOCRUZ, Fundacao Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
RP Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR [Anonymous], 1996, CANC PAIN REL, P1
   BAKER RHA, 1990, PHILOS T R SOC LON B, V728, P731
   BENTON B, 1990, ACT LEIDENS, V59, P405
   BOAKYE DA, 1993, B ENTOMOL RES, V83, P171, DOI 10.1017/S0007485300034659
   Boatin B, 1997, J HELMINTHOL, V71, P91, DOI 10.1017/S0022149X00015741
   BRENER Z, 1977, Pan American Health Organization Scientific Publication, V347, P11
   Brener Z., 1985, REV SOC BRASILEIRA S, V18, P1
   CAMARGO ME, 1984, REV I MED TROP, V26, P192, DOI 10.1590/S0036-46651984000400003
   CHANCE ML, 1996, TRYPANOSOMIASIS LEIS, P163
   DADZIE KY, 1992, TROP MED PARASITOL, V43, P75
   deAndrade ALSS, 1996, LANCET, V348, P1407
   DESOLE G, 1991, B WORLD HEALTH ORGAN, V69, P689
   DiAS E., 1948, Brasil-Medico, V62, P185
   Dias J C, 1988, Rev Argent Microbiol, V20, P81
   Dias J C, 1986, Rev Soc Bras Med Trop, V19, P129, DOI 10.1590/S0037-86821986000300001
   DIAS JCP, 1987, PARASITOL TODAY, V3, P336, DOI 10.1016/0169-4758(87)90117-7
   Docampo R, 1997, PARASITOL TODAY, V13, P129, DOI 10.1016/S0169-4758(97)01021-1
   Dujardin JP, 1996, ACTA TROP, V61, P263, DOI 10.1016/0001-706X(96)00008-3
   FILHO AMO, 1988, REV ARGENT MICROBIOL, V20, P39
   FILHO JC, 1979, REVBRAS MALARIOL DOE, V31, P85
   GARMS R, 1979, TROPENMED PARASITOL, V30, P345
   GARMS R, 1978, TROPENMED PARASITOL, V29, P483
   GIBSON WC, 1985, BRIT MED BULL, V41, P115, DOI 10.1093/oxfordjournals.bmb.a072037
   GUILLEN G, 1997, MEM I O CRUZ, V91, P1
   HABBEMA JDF, 1992, PARASITOL TODAY, V8, P99, DOI 10.1016/0169-4758(92)90248-Z
   HOUGARD JM, 1993, ANN TROP MED PARASIT, V87, P435, DOI 10.1080/00034983.1993.11812793
   KINGMAN S, 1991, NEW SCI, P16
   KURTAK D, 1987, MED VET ENTOMOL, V1, P137, DOI 10.1111/j.1365-2915.1987.tb00334.x
   Luquetti AO, 1997, PARASITOL TODAY, V13, P127, DOI 10.1016/S0169-4758(97)01018-1
   MARSDEN PD, 1984, REV INFECT DIS, V6, P855
   MCCALL PJ, 1992, T ROY SOC TROP MED H, V86, P63, DOI 10.1016/0035-9203(92)90443-G
   MEREDITH SEO, 1981, TROPENMED PARASITOL, V32, P123
   MILES MA, 1977, T ROY SOC TROP MED H, V71, P217, DOI 10.1016/0035-9203(77)90012-8
   MILES MA, 1983, T ROY SOC TROP MED H, V77, P5, DOI 10.1016/0035-9203(83)90004-4
   MILES MA, 1981, LANCET, V2, P1338
   MOLYNEUX DH, 1995, PARASITOL TODAY, V11, P399, DOI 10.1016/0169-4758(95)80016-6
   MONCAYO A, 1990, MEM I OSWALDO CRUZ, V85, P489, DOI 10.1590/S0074-02761990000400020
   Montamat EE, 1996, AM J TROP MED HYG, V55, P625, DOI 10.4269/ajtmh.1996.55.625
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   NUSSENZWEIG V, 1953, Rev Paul Med, V42, P57
   *ONCH CONTR PROGR, 1997, M EXP ADV COMM JUN
   REMME JHF, 1995, PARASITOL TODAY, V11, P403, DOI 10.1016/0169-4758(95)80017-4
   SAMBA EM, 1994, PUBLIC HLTH ACTION
   Schmunis GA, 1996, LANCET, V348, P1171, DOI 10.1016/S0140-6736(05)65305-6
   SCHOFIELD CJ, 1991, MEM I OSWALDO CRUZ, V86, P285, DOI 10.1590/S0074-02761991000300002
   Schofield CJ, 1997, PARASITOL TODAY, V13, P141, DOI 10.1016/S0169-4758(97)89811-0
   Silveira A. C., 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P11, DOI 10.1590/S0037-86821994000100003
   SILVEIRA AC, 1985, ANN SOC BELG MED TR, V65, P137
   Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7
   STEINDEL M, 1993, MOL BIOCHEM PARASIT, V60, P71, DOI 10.1016/0166-6851(93)90030-2
   TANG J, 1995, INSECT MOL BIOL, V4, P79, DOI 10.1111/j.1365-2583.1995.tb00011.x
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   TREES AJ, 1992, PARASITOL TODAY, V8, P337, DOI 10.1016/0169-4758(92)90068-D
   WENDEL S, 1993, VOX SANG, V64, P1, DOI 10.1111/j.1423-0410.1993.tb02507.x
   *WHO, 1991, WHO TECH REP SER, V811, P1
   WILSON MD, 1993, ANN TROP MED PARASIT, V87, P65, DOI 10.1080/00034983.1993.11812739
   World Health Organization, 1997, TOB HLTH GLOB STAT R, P1
   YAMEOGO L, 1991, VERH INT VREIN LIMNO, V24, P2932
   ZIMMERMAN PA, 1992, J INFECT DIS, V165, P964, DOI 10.1093/infdis/165.5.964
   1995, TROP DIS RES PROGR 1, P1
   1997, TROPICAL DIS RES PRO, P112
NR 61
TC 12
Z9 13
U1 0
U2 0
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND
SN 0007-1420
J9 BRIT MED BULL
JI Br. Med. Bull.
PY 1998
VL 54
IS 2
BP 327
EP 339
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA 105WM
UT WOS:000075098000006
PM 9830200
OA Bronze
DA 2020-12-17
ER

PT J
AU Zingales, B
   Pereira, MES
   Oliveira, RP
   Almeida, KA
   Umezawa, ES
   Souto, RP
   Vargas, N
   Cano, MI
   daSilveira, JF
   Nehme, NS
   Morel, CM
   Brener, Z
   Macedo, A
AF Zingales, B
   Pereira, MES
   Oliveira, RP
   Almeida, KA
   Umezawa, ES
   Souto, RP
   Vargas, N
   Cano, MI
   daSilveira, JF
   Nehme, NS
   Morel, CM
   Brener, Z
   Macedo, A
TI Trypanosoma cruzi genome project: biological characteristics and
   molecular typing of clone CL Brener
SO ACTA TROPICA
LA English
DT Article
DE Trypanosoma cruzi; Genome project; reference organism; molecular typing;
   biological characteristics
ID CHAGAS-DISEASE; STRAINS; DNA; KETOCONAZOLE; POLYMORPHISM; CELLS; CURE
AB Clone CL Brener is the reference organism used in the Trypanosoma cruzi Genome Project. CL Brener was obtained by cloning procedures from bloodstream trypomastigotes isolated from mice infected with the CL strain. The doubling time of CL Brener epimastigotes cultured at 28 degrees C in liver infusion-tryptose (LIT) medium is 58 +/- 13 h. Differentiation to metacyclic forms is induced by incubation of epimastigotes in LIT-20% Grace's medium. Metacyclics give very low parasitemia in mice, contrary to what is observed for blood forms which promote 100% mortality of the animals with inocula of 5 x 10(3) parasites. CL Brener blood forms are highly susceptible to nifurtimox, benznidazole and ketoconazole. Allopurinol is inefficient in the treatment of mice experimental infection. The clone infects mammalian cultured cells and performs the complete intracellular cycle at 33 and 37 degrees C. The molecular typing of CL Brener has been done by isoenzymatic profiles; sequencing of a 24S alpha ribosomal RNA gene domain and by schizodeme, randomly amplified polymorphic DNA and DNA fingerprinting analyses. For each typing approach the patterns obtained do not change after prolonged parasite subcultivation in LIT medium (up to 100 generations). The stability of the molecular karyotype of the clone was also confirmed. (C) 1997 Elsevier Science B.V.
C1 FIOCRUZ MS, CTR PESQUISAS RENE RACHOU, BELO HORIZONTE, MG, BRAZIL.
   UFMG, INST CIENCIAS BIOL, BELO HORIZONTE, MG, BRAZIL.
   UNIV SAO PAULO, INST TROP MED, SAO PAULO, BRAZIL.
   UNIFESP, ESCOLA PAULISTA MED, SAO PAULO, BRAZIL.
   FIOCRUZ MS, INST OSWALDO CRUZ, BR-21045900 RIO DE JANEIRO, BRAZIL.
RP Zingales, B (corresponding author), UNIV SAO PAULO, INST QUIM, CAIXA POSTAL 26077, BR-05599970 SAO PAULO, BRAZIL.
RI Souto, Ricardo/F-7828-2012; Cano, Maria Isabel/M-7691-2019; Morel,
   Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009; Cano, Maria
   Isabel/A-4020-2008; Franco da Silveira, Jose/F-5390-2012; Oliveira,
   Riva/J-8408-2013
OI Souto, Ricardo/0000-0002-6281-5956; Cano, Maria
   Isabel/0000-0001-9798-6627; Morel, Carlos/0000-0003-2752-0009; Morel,
   Carlos M/0000-0003-2752-0009; Oliveira, Riva/0000-0002-4917-7646; de
   Paula Oliveira, Riva/0000-0002-6092-6142
CR Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009
   BOGLIOLO AR, 1986, BRAZ J MED BIOL RES, V19, P673
   BRENER Z, 1993, MEM I OSWALDO CRUZ, V88, P149, DOI 10.1590/S0074-02761993000100023
   BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220
   BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389
   BRENER Z, 1976, J PROTOZOOL, V23, P147, DOI 10.1111/j.1550-7408.1976.tb05258.x
   BRENER Z, 1977, CHAGAS DIS, V347, P11
   CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A
   CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x
   Chiari E., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P23
   DVORAK JA, 1984, J CELL BIOCHEM, V24, P357, DOI 10.1002/jcb.240240406
   FILARDI L S, 1984, Memorias do Instituto Oswaldo Cruz, V79, P221, DOI 10.1590/S0074-02761984000200008
   FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   GONCALVES AM, 1990, MEM I OSWALDO CRUZ, V85, P101, DOI 10.1590/S0074-02761990000100017
   HENRIKSSON J, 1995, MOL BIOCHEM PARASIT, V73, P63, DOI 10.1016/0166-6851(95)00096-J
   JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0
   MACEDO AM, 1992, MOL BIOCHEM PARASIT, V55, P147, DOI 10.1016/0166-6851(92)90135-7
   MCCABE RE, 1987, T ROY SOC TROP MED H, V81, P613, DOI 10.1016/0035-9203(87)90430-5
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   MELO RC, 1978, J PARASITOL, V64, P475, DOI 10.2307/3279787
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   Pena Sergio D. J., 1993, Ciencia e Cultura (Sao Paulo), V45, P236
   Penner G A, 1993, PCR Methods Appl, V2, P341
   RAETHER W, 1984, Z PARASITENKD, V70, P135, DOI 10.1007/BF00929583
   ROMANHA AJ, 1979, COMP BIOCHEM PHYS B, V62, P139, DOI 10.1016/0305-0491(79)90299-2
   SANTOS FR, 1993, HUM GENET, V90, P655
   Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7
   SOUTO RP, 1993, MOL BIOCHEM PARASIT, V62, P45, DOI 10.1016/0166-6851(93)90176-X
   STEINDEL M, 1993, MOL BIOCHEM PARASIT, V60, P71, DOI 10.1016/0166-6851(93)90030-2
   TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x
   Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969
   VANDERPLOEG LHT, 1984, CELL, V36, P459, DOI 10.1016/0092-8674(84)90239-3
   Zingales B, 1997, PARASITOL TODAY, V13, P16
   ZINGALES B, 1985, CURR TOP MICROBIOL, V117, P129
   ZINGALES B, 1982, MOL BIOCHEM PARASIT, V6, P111, DOI 10.1016/0166-6851(82)90069-X
NR 36
TC 66
Z9 68
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 1997
VL 68
IS 2
BP 159
EP 173
DI 10.1016/S0001-706X(97)00088-0
PG 15
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA YC382
UT WOS:A1997YC38200003
PM 9386791
DA 2020-12-17
ER

PT J
AU Degrave, W
   Levin, MJ
   daSilveira, JF
   Morel, CM
AF Degrave, W
   Levin, MJ
   daSilveira, JF
   Morel, CM
TI Parasite Genome Projects and the Trypanosoma cruzi genome initiative
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT Symposium on Genome Projects
CY NOV 13-24, 1995
CL INGEBI, BUENOS AIRES, ARGENTINA
SP WHO, TDR
HO INGEBI
DE Trypanosoma cruzi; clone CL Brener; Parasite Genome Projects
ID COMPLETE NUCLEOTIDE-SEQUENCE; DNA
AB Since the start of the human genome project, a great number of genome projects on other ''model'' organism have been initiated, some of them already completed Several initiatives have also been started on parasite genomes, mainly through support from WHO/TDR, involving North-South and South-South collaborations, and great hopes are vested in that these initiatives will lead to new tools for disease control and prevention, as well as to the establishment of genomic research technology in developing countries. The Trypanosoma cruzi genome project, using the clone CL-Brener as starting point, has made considerable progress through the concerted action of more than 20 laboratories, most of them in the South. A brief overview of the current state of the project is given.
C1 UNIV BUENOS AIRES,FAC CIENCIAS EXACTAS & NAT,CONICET,INGEBI,INST INVEST INGN GENET & BIOL MOL,RA-1428 BUENOS AIRES,DF,ARGENTINA.
   UNIV FED SAO PAULO,UNIFESP,EPM,BR-04023062 SAO PAULO,SP,BRAZIL.
RP Degrave, W (corresponding author), INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOL,AV BRASIL 4365,BR-21045900 RIO JANEIRO,RJ,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Degrave, Wim/B-4162-2009; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0
   Burke DT, 1997, GENOME RES, V7, P189, DOI 10.1101/gr.7.3.189
   DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4
   FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0
   FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0
   Hanke J, 1996, BIOTECHNIQUES, V21, P686
   HENRIKSSON J, 1995, MOL BIOCHEM PARASIT, V73, P63, DOI 10.1016/0166-6851(95)00096-J
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0
   PENN SDJ, 1996, TIBTECH, V14, P74
   SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0
   SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7
   TILGHMAN SM, 1986, GENOME RES, V6, P773
   Zingales B, 1997, PARASITOL TODAY, V13, P16
NR 17
TC 10
Z9 10
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV-DEC
PY 1997
VL 92
IS 6
BP 859
EP 862
DI 10.1590/S0074-02761997000600023
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA YF942
UT WOS:A1997YF94200023
PM 9566219
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Wincker, P
   Telleria, J
   Bosseno, MF
   Cardoso, MA
   Marques, P
   Yaksic, N
   Aznar, C
   Liegeard, P
   Hontebeyrie, M
   Noireau, F
   Morel, CM
   Breniere, SF
AF Wincker, P
   Telleria, J
   Bosseno, MF
   Cardoso, MA
   Marques, P
   Yaksic, N
   Aznar, C
   Liegeard, P
   Hontebeyrie, M
   Noireau, F
   Morel, CM
   Breniere, SF
TI PCR-based diagnosis for Chagas' disease in Bolivian children living in
   an active transmission area: Comparison with conventional serological
   and parasitological diagnosis
SO PARASITOLOGY
LA English
DT Article
DE Trypanosoma cruzi; Chagas' disease; PCR diagnosis; serological diagnosis
ID POLYMERASE CHAIN-REACTION; KINETOPLAST MINICIRCLE DNA;
   TRYPANOSOMA-CRUZI; REACTION AMPLIFICATION; BLOOD-SAMPLES
AB A large field study has been performed in the Cochabamba region of Bolivia with the aim of comparing the polymerase chain reaction (PCR) with other diagnostic methods for Chagas' disease. The amplification of Trypanosoma cruzi-specific kinetoplast DNA sequences in blood samples was compared with classical serological methods, specific IgM detection and direct parasite visualization for 268 school children in a single village where Chagas' disease transmission is active. Of 113 children positive by classical serology or buffy coat examination, 106 were detected by PCR (sensitivity: 93.8 %). We did not observe any significant difference of PCR sensitivity between initial (IgM and/or buffy coat positive) and indeterminate stage (only IgG positive) patients. Among the remaining 155 children unconfirmed as chagasic (who were either only IgM positive, IgG-, IgM-, and huffy coat-negative) only 1 case was PCR positive. This case may be due to DNA contamination, or to a very recent infection not detected otherwise, or to specific immune depression. These results show that PCR is a very sensitive parasitological test for Chagas' disease in active transmission regions. The future follow-up of the possibly infected patients who were only IgM-positive should clarify the interest of PCR and IgM tests in the detection of starting infections.
C1 FUNDACAO OSWALDO CRUZ,INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOL,LAB BIOL MOL & DOENCAS ENDEMICAS,BR-21045900 RIO JANEIRO,BRAZIL.
   UMR ORSTOM,UR41,CNRS GENET MOL PARASITES & VECTEURS 9926,LA PAZ,BOLIVIA.
   UNIV MAYOR DE SAN ANDRES,IBBA,LA PAZ,BOLIVIA.
   INST PASTEUR,DEPT IMMUNOL,F-75724 PARIS 15,FRANCE.
   CTR MED BIOL,F-75724 PARIS 15,FRANCE.
   UR 41 ORSTOM,LA PAZ,BOLIVIA.
RP Wincker, P (corresponding author), FAC MED MONTPELLIER,LAB GENOME PARASITES PARASITOL,163 RUE AUGUSTE BROUSSONET,F-34000 MONTPELLIER,FRANCE.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009; Breniere, Simone
   Frederique/J-9214-2016
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009;
   Breniere, Simone Frederique/0000-0003-4385-3989
CR ALVAREZ M, 1968, Boletin Chileno de Parasitologia, V23, P4
   AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   AVILA HA, 1993, J CLIN MICROBIOL, V31, P2421, DOI 10.1128/JCM.31.9.2421-2426.1993
   AZNAR C, 1995, FEMS IMMUNOL MED MIC, V12, P231, DOI 10.1016/0928-8244(95)00075-7
   BIRTTO C, 1995, EXPT PARASITOLOGY, V81, P462
   BRAUN M, 1985, ACTA PHYSIOL PHARM L, V35, P1
   BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335
   BRENIERE SF, 1984, TROPICAL GEOGRAPHICA, V37, P231
   BRENIERE SF, 1995, AM J TROP MED HYG, V53, P169
   BRITTO C, 1995, PARASITOLOGY, V110, P241, DOI 10.1017/S0031182000080823
   BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030
   Camargo ME, 1992, CHAGAS DIS AM TRYPAN, P165
   Chiari E, 1989, Rev Soc Bras Med Trop, V22, P19, DOI 10.1590/S0037-86821989000100004
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   DECASTRO SL, 1993, ACTA TROP, V53, P83, DOI 10.1016/0001-706X(93)90021-3
   Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X
   LAFUENTE C, 1984, T ROY SOC TROP MED H, V78, P278, DOI 10.1016/0035-9203(84)90299-2
   LAURENT JP, 1994, THESIS U MONTPELLIER
   Moncayo A., 1993, 11 PROGRAMME REPORT, P67
   MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989
   SANCHEZ G, 1990, EXP PARASITOL, V71, P125, DOI 10.1016/0014-4894(90)90015-5
   SCHMUNIS GA, 1980, AM J TROP MED HYG, V29, P170, DOI 10.4269/ajtmh.1980.29.170
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   Taibi A, 1995, PARASITOLOGY, V111, P581, DOI 10.1017/S0031182000077064
   VATTUONE NH, 1978, AM J TROP MED HYG, V27, P473
   WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771
   WINCKER P, 1994, FEMS MICROBIOL LETT, V124, P419, DOI 10.1111/j.1574-6968.1994.tb07318.x
NR 27
TC 43
Z9 46
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211
SN 0031-1820
J9 PARASITOLOGY
JI Parasitology
PD APR
PY 1997
VL 114
BP 367
EP 373
DI 10.1017/S0031182096008554
PN 4
PG 7
WC Parasitology
SC Parasitology
GA WU618
UT WOS:A1997WU61800007
PM 9107023
OA Green Published
DA 2020-12-17
ER

PT J
AU deLana, M
   Chiari, CA
   Chiari, E
   Morel, CM
   Goncalves, AM
   Romanha, AJ
AF deLana, M
   Chiari, CA
   Chiari, E
   Morel, CM
   Goncalves, AM
   Romanha, AJ
TI Characterization of two isolates of Trypanosoma cruzi obtained from the
   patient Berenice, the first human case of Chagas' disease described by
   Carlos Chagas in 1909
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID STRAINS; ISOENZYME; PATTERN; CLONES; MICE
AB Two isolates of Trypanosoma cruzi were obtained from the patient Berenice, the first human case of Chagas' disease (Chagas 1909), when she was 55 and 71 years old, respectively. The isolates were characterized on the basis of their epimastigote-trypomastigote differentiation in liquid media and of the electrophoretic pattern of EcoR1 digestion products of kinetoplast DNA (k-DNA) minicircles (schizodeme) and isoenzyme patterns (zymodeme). Clear differences were found between the isolates, suggesting the occurrence of a heterogeneous population of T. cruzi in the infection of this patient.
C1 UNIV FED OURO PRETO, ESCOLA FARM, DEPT ANAL CLIN, BR-35400 CENTRO, MG, BRAZIL.
   UNIV FED MINAS GERAIS, INST CIENCIAS BIOL, DEPT PARASITOL, BR-31270 BELO HORIZONTE, MG, BRAZIL.
   FIOCRUZ MS, IOC, DEPT BIOQUIM & BIOL MOLEC, RIO DE JANEIRO, BRAZIL.
   FIOCRUZ MS, CTR PESQUISAS RENE RACHOU, LAB PARASITOL CELULAR & MOL, BELO HORIZONTE, MG, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Lana, Marta/0000-0002-1565-4707
CR ALVES AMB, 1993, EXP PARASITOL, V77, P246, DOI 10.1006/expr.1993.1081
   Brener Z., 1974, Revista Inst Med trop Sao Paulo, V16, P39
   BRENER Z, 1965, ANN TROP MED PARASIT, V59, P19, DOI 10.1080/00034983.1965.11686277
   BRENIERE SF, 1989, AM J TROP MED HYG, V41, P521, DOI 10.4269/ajtmh.1989.41.521
   BRENIERE SF, 1985, CR ACAD SCI III-VIE, V300, P555
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CARNEIRO M, 1990, ACTA TROP, V47, P35, DOI 10.1016/0001-706X(90)90005-K
   Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   Chiari E., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P23
   De Araujo S M, 1988, Mem Inst Oswaldo Cruz, V83, P175, DOI 10.1590/S0074-02761988000200005
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   Garnham P.C.C., 1980, Memorias do Instituto Oswaldo Cruz, V75, P181
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   KILGOUR V, 1973, NATURE-NEW BIOL, V244, P69
   LANA M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P247, DOI 10.1590/S0074-02761986000300001
   LANA M, 1981, THESIS UFMG BELO HOR
   LUQUETTI AO, 1986, T ROY SOC TROP MED H, V80, P462, DOI 10.1016/0035-9203(86)90347-0
   MELO RC, 1978, J PARASITOL, V64, P475, DOI 10.2307/3279787
   MILES MA, 1981, LANCET, V1, P1338
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   ROCHA LOS, 1992, GRAFICA FUNDACAO CUL, P356
   ROMANHA AJ, 1982, THESIS UFMG BELO HOR
   SALGADO JOAO AMILCAR, 1962, REV INST MED TROP SSB PAULO, V4, P330
   SCHLEMPER BR, 1982, THESIS UFMG BELO HOR
NR 24
TC 11
Z9 13
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAR
PY 1996
VL 82
IS 3
BP 257
EP 260
DI 10.1007/s004360050106
PG 4
WC Parasitology
SC Parasitology
GA TZ333
UT WOS:A1996TZ33300013
PM 8801560
OA Green Published
DA 2020-12-17
ER

PT J
AU Britto, C
   Cardoso, MA
   Ravel, C
   Santoro, A
   Pereira, JB
   Coura, JR
   Morel, CM
   Wincker, P
AF Britto, C
   Cardoso, MA
   Ravel, C
   Santoro, A
   Pereira, JB
   Coura, JR
   Morel, CM
   Wincker, P
TI Trypanosoma cruzi: Parasite detection and strain discrimination in
   chronic chagasic patients from northeastern Brazil using PCR
   amplification of kinetoplast DNA and nonradioactive hybridization
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE Trypanosoma cruzi; PCR diagnosis; schizodeme; kDNA hybridizations;
   Chagas' disease; molecular epidemiology
ID CHAIN-REACTION AMPLIFICATION; MINICIRCLE DNA; DISEASE; DIAGNOSIS;
   ORGANIZATION; SEQUENCES; ANTIGENS; CLONES; AGENT
AB Blood samples from 172 individuals from northeastern Brazil were subjected to PCR amplification of Trypanosoma cruzi-specific kDNA sequences. This method enabled us to detect parasite DNA in 21 of 47 patients that were serologically positive, In addition, 1 patient that gave doubtful results with chagasic serology was confirmed as positive by PCR. We applied the same PCR detection method to the feces of wild triatomines captured in the same region, obtaining three positive results that were confirmed by microscopic examination. The 25 amplified products obtained in this study were then reamplified with primers that gave a final amplicon containing sequences from the most variable region of kDNA minicircles. These were used as probes in hybridization experiments aimed at defining the degree of relatedness between the strains infecting humans and insects based on kDNA homologies. We found that the amplification products from the three triatomines were related and showed no crosshybridization with those obtained from human infections. Eight amplified products from human infections showed no cross-hybridization and did not hybridize with products from other patients. This indicates that the strains of T. cruzi circulating in the region present a high level of genetic heterogeneity. Finally, a number of amplified products hybridized with amplicons that did not hybridize with each other, indicating that infections with a parasite population presenting a mixed kDNA content (either due to different strains of T. cruzi or to a hybrid parasite) are a more frequent event than previously thought. (C) 1995 Academic Press, Inc.
C1 FIOCRUZ MS,INST OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,LAB MOLEC BIOL & ENDEM DIS,BR-21045900 RIO JANEIRO,BRAZIL.
   FAC MED MONTPELLIER,PARASITOL LAB,F-34000 MONTPELLIER,FRANCE.
   FIOCRUZ MS,INST OSWALDO CRUZ,DEPT TROP MED,BR-21045900 RIO JANEIRO,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009; Ravel,
   Christophe/A-7369-2008; Britto, Constanca/L-7658-2016
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030; ravel,
   christophe/0000-0002-7590-582X
CR ARAUJO FG, 1986, INFECT IMMUN, V53, P179, DOI 10.1128/IAI.53.1.179-185.1986
   AVILA H, 1990, MOL BIOCHEM PARASIT, V42, P175, DOI 10.1016/0166-6851(90)90160-N
   AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   AVILA HA, 1993, J CLIN MICROBIOL, V31, P2421, DOI 10.1128/JCM.31.9.2421-2426.1993
   BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335
   BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030
   Camargo ME, 1992, CHAGAS DIS AM TRYPAN, P165
   Chiari E, 1989, Rev Soc Bras Med Trop, V22, P19, DOI 10.1590/S0037-86821989000100004
   Coura J. R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P107, DOI 10.1590/S0074-02761984000500020
   COURA J R, 1984, Memorias do Instituto Oswaldo Cruz, V79, P101, DOI 10.1590/S0074-02761984000100012
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   DIAS JCP, 1992, CHAGAS DIS AM TRYPAN, P49
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   KRIEGER MA, 1992, AM J TROP MED HYG, V46, P427, DOI 10.4269/ajtmh.1992.46.427
   MACINA RA, 1987, MOL BIOCHEM PARASIT, V25, P45, DOI 10.1016/0166-6851(87)90017-X
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   MOREL C M, 1986, Parasitology Today, V2, P97, DOI 10.1016/0169-4758(86)90038-4
   Pereira J B, 1987, Rev Soc Bras Med Trop, V20, P101, DOI 10.1590/S0037-86821987000200007
   Pereira J B, 1992, Rev Soc Bras Med Trop, V25, P101, DOI 10.1590/S0037-86821992000200003
   SHOU Q, 1992, NUCLEIC ACIDS RES, V20, P171
   SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x
   Veas F., 1990, Acta Tropica, V48, P79
   WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771
NR 26
TC 49
Z9 55
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0014-4894
J9 EXP PARASITOL
JI Exp. Parasitol.
PD DEC
PY 1995
VL 81
IS 4
BP 462
EP 471
DI 10.1006/expr.1995.1139
PG 10
WC Parasitology
SC Parasitology
GA TN324
UT WOS:A1995TN32400006
PM 8542987
DA 2020-12-17
ER

PT J
AU BRITTO, C
   CARDOSO, MA
   VANNI, CMM
   HASSLOCHERMORENO, A
   XAVIER, SS
   OELEMANN, W
   SANTORO, A
   PIRMEZ, C
   MOREL, CM
   WINCKER, P
AF BRITTO, C
   CARDOSO, MA
   VANNI, CMM
   HASSLOCHERMORENO, A
   XAVIER, SS
   OELEMANN, W
   SANTORO, A
   PIRMEZ, C
   MOREL, CM
   WINCKER, P
TI POLYMERASE CHAIN-REACTION DETECTION OF TRYPANOSOMA-CRUZI IN HUMAN
   BLOOD-SAMPLES AS A TOOL FOR DIAGNOSIS AND TREATMENT EVALUATION
SO PARASITOLOGY
LA English
DT Article
DE TRYPANOSOMA CRUZI; KINETOPLAST DNA; CHAGAS DISEASE; PCR
ID KINETOPLAST MINICIRCLE DNA; CHRONIC CHAGAS-DISEASE; REACTION
   AMPLIFICATION; STRAIN CLASSIFICATION; SENSITIVE DETECTION; SEQUENCES;
   ANTIGENS; CURE
AB Trypanosoma cruzi specific sequences were amplified by the polymerase chain reaction from total blood of human chagasic patients and normal individuals. A 330 bp fragment originating from kinetoplast DNA was specifically detected in most chagasic individuals. We tested the sensitivity and specificity of this method in normal and affected individuals attending the Evandro Chagas Hospital, Rio de Janeiro. The results of these tests were compared with serological diagnosis performed using standard techniques, and in some cases with xenodiagnosis. We found that none of the serologically negative individuals gave any specific amplification product, whereas 55 out of 61 patients previously serodiagnosed as chagasic were positive using the PCR method (sensitivity: 90 %). Xenodiagnosis, which is currently considered to be the most sensitive parasitological technique for Chagas' disease diagnosis, detected only 12 out of 28 serologically positive patients (sensitivity: 43 %). The usefulness of the PCR method was further investigated with chagasic patients who had received anti-parasite treatment with benznidazole. It has always been difficult to evaluate the incidence of cure in such cases by serology, since a humoral response against T. cruzi antigens may remain for years even in the absence of the parasite. We observed a positive amplification result in only 9 out of 32 treated patients who remained reactive when tested using classical serology. These observations suggest that PCR is the most sensitive technique available for direct detection of T. cruzi in chagasic patients and that it can be a very useful instrument for the follow-up of patients after specific treatment.
C1 OSWCRU,INST OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,MOLEC BIOL ENDEM DIS LAB,BR-21045900 RIO JANEIRO,BRAZIL.
   FDN OSWALDO CRUZ,INST OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,IMMUNOPATHOL LAB,RIO JANEIRO,BRAZIL.
   FDN OSWALDO CRUZ,INST OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,IMMUNOPATHOL LAB,RIO JANEIRO,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Pirmez, Claude/AAF-9977-2019; Pirmez,
   Claude/K-8579-2012; Morel, Carlos/Q-9657-2019; Hasslocher-Moreno,
   Alejandro Marcel/F-3414-2011; Britto, Constanca/L-7658-2016
OI Morel, Carlos M/0000-0003-2752-0009; Pirmez, Claude/0000-0002-7443-0455;
   Pirmez, Claude/0000-0002-7443-0455; Morel, Carlos/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030
CR AVILA H, 1990, MOL BIOCHEM PARASIT, V42, P175, DOI 10.1016/0166-6851(90)90160-N
   AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   AVILA HA, 1993, J CLIN MICROBIOL, V31, P2421, DOI 10.1128/JCM.31.9.2421-2426.1993
   Brener Z., 1990, Modern parasite biology: cellular, immunological, and molecular aspects., P247
   BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335
   BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   Coura J. R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P107, DOI 10.1590/S0074-02761984000500020
   DECASTRO SL, 1993, ACTA TROP, V53, P83, DOI 10.1016/0001-706X(93)90021-3
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   GALVAO LMC, 1993, T ROY SOC TROP MED H, V87, P220, DOI 10.1016/0035-9203(93)90501-G
   GAZZINELLI RT, 1993, AM J TROP MED HYG, V49, P625, DOI 10.4269/ajtmh.1993.49.625
   LEVIN MJ, 1991, FEMS MICROBIOL IMMUN, V89, P11, DOI 10.1111/j.1574-6968.1991.tb04965.x
   Moncayo A., 1993, 11 PROGRAMME REPORT, P67
   MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989
   REQUENA JM, 1992, MOL BIOCHEM PARASIT, V51, P271, DOI 10.1016/0166-6851(92)90077-W
   RUSSOMANDO G, 1992, J CLIN MICROBIOL, V30, P2864, DOI 10.1128/JCM.30.11.2864-2868.1992
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x
   SEGURA EL, 1987, CHAGAS DISEASE VECTO, V2, P41
   SOUTO RP, 1993, MOL BIOCHEM PARASIT, V62, P45, DOI 10.1016/0166-6851(93)90176-X
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   WINCKER P, 1994, IN PRESS AM J TROPIC
NR 23
TC 120
Z9 128
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211
SN 0031-1820
J9 PARASITOLOGY
JI Parasitology
PD APR
PY 1995
VL 110
BP 241
EP 247
DI 10.1017/S0031182000080823
PN 3
PG 7
WC Parasitology
SC Parasitology
GA QR322
UT WOS:A1995QR32200001
PM 7724232
DA 2020-12-17
ER

PT J
AU WINCKER, P
   BOSSENO, MF
   BRITTO, C
   YAKSIC, N
   CARDOSO, MA
   MOREL, CM
   BRENIERE, SF
AF WINCKER, P
   BOSSENO, MF
   BRITTO, C
   YAKSIC, N
   CARDOSO, MA
   MOREL, CM
   BRENIERE, SF
TI HIGH CORRELATION BETWEEN CHAGAS-DISEASE SEROLOGY AND PCR-BASED DETECTION
   OF TRYPANOSOMA-CRUZI KINETOPLAST DNA IN BOLIVIAN CHILDREN LIVING IN AN
   ENDEMIC AREA
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Article
DE TRYPANOSOMA CRUZI; CHAGAS DISEASE; KINETOPLAST DNA; PCR DIAGNOSIS
ID POLYMERASE CHAIN-REACTION; REACTION AMPLIFICATION; MINICIRCLE DNA;
   DIAGNOSIS
AB The detection of Trypanosoma cruzi kinetoplast DNA by polymerase chain reaction (PCR) amplification is a potentially powerful tool for the parasitological diagnosis of Chagas' disease. We have applied this technique in a field situation in Bolivia, where 45 children from a primary school were subjected to serological testing, buffy coat analysis and PCR diagnosis. 26 of the 28 serology-positive individuals were also positive by PCR. In addition, two serology-negative children gave a positive result by PCR, including one who was positive in the buffy coat test. These results suggest that PCR detection of T. cruzi DNA in blood can be a very useful complement to serology in Chagas' disease diagnosis in Bolivia.
C1 ORSTOM,CNRS,UMR,LA PAZ,BOLIVIA.
   UNIV MAYOR SAN ANDRES,INST BOLIVIANO BIOL ALTURA,LA PAZ,BOLIVIA.
RP WINCKER, P (corresponding author), FUNDACAO OSWALDO CRUZ,INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,BR-21045900 RIO JANEIRO,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Britto,
   Constanca/L-7658-2016; Breniere, Simone Frederique/J-9214-2016
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030; Breniere, Simone
   Frederique/0000-0003-4385-3989
CR AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   AVILA HA, 1993, J CLIN MICROBIOL, V31, P2421, DOI 10.1128/JCM.31.9.2421-2426.1993
   Brener Z., 1980, Advances in Parasitology, V18, P247, DOI 10.1016/S0065-308X(08)60401-7
   BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335
   BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030
   Camargo M E, 1974, Rev Inst Med Trop Sao Paulo, V16, P200
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   GALVAO LMC, 1993, T ROY SOC TROP MED H, V87, P220, DOI 10.1016/0035-9203(93)90501-G
   MONCAYO A, 1993, TROPICAL DIS RES PRO, P67
   MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989
   RUSSOMANDO G, 1992, J CLIN MICROBIOL, V30, P271
   SEGURA EL, 1987, CHAGAS DISEASE VECTO, V2, P41
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   Valencia Telleria A., 1990, INVESTIGACION EPIDEM
NR 15
TC 67
Z9 72
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1097
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD DEC 15
PY 1994
VL 124
IS 3
BP 419
EP 423
PG 5
WC Microbiology
SC Microbiology
GA PW836
UT WOS:A1994PW83600025
PM 7851750
DA 2020-12-17
ER

PT J
AU WINCKER, P
   BRITTO, C
   PEREIRA, JB
   CARDOSO, MA
   OELEMANN, W
   MOREL, CM
AF WINCKER, P
   BRITTO, C
   PEREIRA, JB
   CARDOSO, MA
   OELEMANN, W
   MOREL, CM
TI USE OF A SIMPLIFIED POLYMERASE CHAIN-REACTION PROCEDURE TO DETECT
   TRYPANOSOMA-CRUZI IN BLOOD-SAMPLES FROM CHRONIC CHAGASIC PATIENTS IN A
   RURAL ENDEMIC AREA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID KINETOPLAST MINICIRCLE DNA; REACTION AMPLIFICATION; DISEASE; DIAGNOSIS;
   CARDIOMYOPATHY; PARASITISM; SEQUENCES
AB The feasibility of using DNA amplification by the polymerase chain reaction (PCR) for specific detection of Trypanosoma cruzi in human blood specimens was investigated. One hundred blood samples were collected in an endemic area of Minas Gerais, Brazil. They were submitted to DNA extraction and PCR amplification with kinetoplast DNA-specific primers using a simplified boiling procedure that linearized most minicircle molecules without the aid of chemical reagents. Samples that gave negative results were checked for possible inhibition of amplification using primers derived from a human-specific sequence, and those showing some level of inhibition were retested after a new DNA extraction. Of 86 patients previously diagnosed as chagasic by serologic techniques, 83 were positive in our PCR test (sensitivity = 96.5%), including all the xenodiagnosis-positive patients and 21 (87.5%) of 24 xenodiagnosis-negative individuals. In addition, four of six patients with doubtful serologic results were confirmed as positive by PCR. Our results suggest that the PCR may be a useful complement to serology in the diagnosis of Chagas' disease, and that it is the most powerful technique available for parasite detection in patients with chronic disease.
C1 INST OSWALDO CRUZ,FIOCRUZ MS,DEPT MED TROP,BIOL MOLEC & DOENCAS ENDEM LAB,BR-21045900 RIO JANEIRO,BRAZIL.
RP WINCKER, P (corresponding author), INST OSWALDO CRUZ,FIOCRUZ MS,DEPT BIOQUIM & BIOL MOLEC,BIOL MOLEC & DOENCAS ENDEM LAB,BR-21045900 RIO JANEIRO,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Britto,
   Constanca/L-7658-2016
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030
CR AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   AVILA HA, 1993, J CLIN MICROBIOL, V31, P2421, DOI 10.1128/JCM.31.9.2421-2426.1993
   BARBOSA AJA, 1986, REV I MED TROP, V28, P91, DOI 10.1590/S0036-46651986000200005
   Brener Z., 1990, Modern parasite biology: cellular, immunological, and molecular aspects., P247
   BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335
   BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   Coura J. R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P107, DOI 10.1590/S0074-02761984000500020
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   GALVAO LMC, 1993, T ROY SOC TROP MED H, V87, P220, DOI 10.1016/0035-9203(93)90501-G
   HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S
   JONES EM, 1993, AM J TROP MED HYG, V48, P348, DOI 10.4269/ajtmh.1993.48.348
   MONCAYO A, 1993, WHO SPECIAL PROGRAM, P67
   MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989
   Pereira J B, 1985, Mem Inst Oswaldo Cruz, V80, P63, DOI 10.1590/S0074-02761985000100010
   Pereira J B, 1992, Rev Soc Bras Med Trop, V25, P101, DOI 10.1590/S0037-86821992000200003
   RUSSOMANDO G, 1992, J CLIN MICROBIOL, V30, P2864, DOI 10.1128/JCM.30.11.2864-2868.1992
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x
   SEGURA EL, 1987, CHAGAS DISEASE VECTO, V2, P41
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
NR 21
TC 201
Z9 210
U1 0
U2 7
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DRIVE SUITE 130, MCLEAN, VA 22101
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 1994
VL 51
IS 6
BP 771
EP 777
DI 10.4269/ajtmh.1994.51.771
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA QB813
UT WOS:A1994QB81300008
PM 7810810
DA 2020-12-17
ER

PT J
AU DEGRAVE, W
   FERNANDES, O
   THIEMANN, O
   WINCKER, P
   BRITTO, C
   CARDOSO, A
   PEREIRA, JB
   BOZZA, M
   LOPES, U
   MOREL, C
AF DEGRAVE, W
   FERNANDES, O
   THIEMANN, O
   WINCKER, P
   BRITTO, C
   CARDOSO, A
   PEREIRA, JB
   BOZZA, M
   LOPES, U
   MOREL, C
TI DETECTION OF TRYPANOSOMA-CRUZI AND LEISHMANIA USING THE POLYMERASE
   CHAIN-REACTION
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Note
DE CHAGAS DISEASE; LEISHMANIASIS; PCR
C1 INST OSWALDO CRUZ,DEPT MED TROP,BR-21045900 RIO JANEIRO,BRAZIL.
   UERJ,DEPT PATOL,RIO JANEIRO,BRAZIL.
   UNIV FED RIO DE JANEIRO,CCS,INST BIOFIS CARLOS CHAGAS FILHO,MOLEC PARASITOL LAB,BR-21949900 RIO JANEIRO,BRAZIL.
RP DEGRAVE, W (corresponding author), INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,AV BRASIL 4365,BR-21045900 RIO JANEIRO,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Lopes, Ulisses Gazos/T-6634-2019; Thiemann,
   Otavio H/D-9767-2012; Morel, Carlos M/B-4079-2009; Lopes,
   Ulisses/N-4416-2013; Degrave, Wim/B-4162-2009; Britto,
   Constanca/L-7658-2016
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030
NR 0
TC 16
Z9 18
U1 0
U2 1
PU MEM INST OSWALDO CRUZ
PI RIO DE JANEIRO
PA SECRETARY CAIXA POSTAL 926, 20001 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL-SEP
PY 1994
VL 89
IS 3
BP 367
EP 368
DI 10.1590/S0074-02761994000300013
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA QD873
UT WOS:A1994QD87300012
PM 7476218
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU AVILA, HA
   PEREIRA, JB
   THIEMANN, O
   DEPAIVA, E
   DEGRAVE, W
   MOREL, CM
   SIMPSON, L
AF AVILA, HA
   PEREIRA, JB
   THIEMANN, O
   DEPAIVA, E
   DEGRAVE, W
   MOREL, CM
   SIMPSON, L
TI DETECTION OF TRYPANOSOMA-CRUZI IN BLOOD SPECIMENS OF CHRONIC CHAGASIC
   PATIENTS BY POLYMERASE CHAIN-REACTION AMPLIFICATION OF KINETOPLAST
   MINICIRCLE DNA - COMPARISON WITH SEROLOGY AND XENODIAGNOSIS
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID DISEASE; DIAGNOSIS; AGENT; PCR; SEQUENCES; CLONES
AB A panel of 114 blood samples from chronic chagasic patients and nonchagasic patients was screened for Trypanosoma cruzi by xenodiagnostic, serologic, and polymerase chain reaction (PCR) amplification tests. Blood samples were preserved in a guanidine-EDTA buffer, and total blood DNA was isolated after chemical nuclease cleavage with 1,10-phenanthroline-copper ion and used as a template for PCR amplification of the conserved and variable regions of T. cruzi minicircle molecules. The PCR products were screened by Southern blot hybridization with a digoxigenin-labeled oligonucleotide probe specific for the conserved region of the minicircle. The method showed a sensitivity of 100% compared witb the serologic test. In addition, all of the serology-positive, xenodiagnosis-negative samples were positive by PCR. This demonstrates that PCR amplification of T. cruzi kinetoplast minicircle DNA could replace xenodiagnosis for evaluation of parasitemia in chronic chagasic patients and could serve as a complement for serologic testing in the screening of blood bank donors.
C1 UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024.
   UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024.
   UNIV CALIF LOS ANGELES,HOWARD HUGHES MED INST,LOS ANGELES,CA 90024.
   FDN OSWALDO CRUZ,DEPT TROP MED,BR-21045 RIO JANEIRO,BRAZIL.
   FDN OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,BR-21045 RIO JANEIRO,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Thiemann, Otavio H/D-9767-2012; Degrave,
   Wim/B-4162-2009; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM 14839] Funding Source: Medline; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [F31GM014839] Funding
   Source: NIH RePORTER
CR APPLEMAN MD, 1993, TRANSFUSION, V33, P61, DOI 10.1046/j.1537-2995.1993.33193142312.x
   ARAUJO FG, 1992, CHAGAS DISEASE AM TR, P219
   ASHALL F, 1988, J CLIN MICROBIOL, V26, P576, DOI 10.1128/JCM.26.3.576-578.1988
   AVILA H, 1990, MOL BIOCHEM PARASIT, V42, P175, DOI 10.1016/0166-6851(90)90160-N
   AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335
   Camargo ME, 1992, CHAGAS DIS AM TRYPAN, P165
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   GIBSON KM, 1991, J VIROL METHODS, V32, P277, DOI 10.1016/0166-0934(91)90058-8
   KATAOKA A, 1991, J MED VIROL, V33, P159, DOI 10.1002/jmv.1890330304
   KERNDT PR, 1991, TRANSFUSION, V31, P814, DOI 10.1046/j.1537-2995.1991.31992094668.x
   MANSONBAHR PEC, 1987, MANSONS TROPICAL DIS, P74
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   PUCHHAMMERSTOCKL E, 1990, J MED VIROL, V32, P77, DOI 10.1002/jmv.1890320202
   Rassi A., 1992, CHAGAS DIS AM TRYPAN, P81
   RUSSOMANDO G, 1992, J CLIN MICROBIOL, V30, P2864, DOI 10.1128/JCM.30.11.2864-2868.1992
   SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x
   SEGURA EL, 1987, CHAGAS DISEASE VECTO, V2, P41
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x
   VANMEIRVENNE N, 1985, BRIT MED BULL, V41, P156
NR 23
TC 127
Z9 134
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 1993
VL 31
IS 9
BP 2421
EP 2426
DI 10.1128/JCM.31.9.2421-2426.1993
PG 6
WC Microbiology
SC Microbiology
GA LT813
UT WOS:A1993LT81300030
PM 8408566
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU BRITTO, C
   CARDOSO, MA
   WINCKER, P
   MOREL, CM
AF BRITTO, C
   CARDOSO, MA
   WINCKER, P
   MOREL, CM
TI A SIMPLE PROTOCOL FOR THE PHYSICAL CLEAVAGE OF TRYPANOSOMA-CRUZI
   KINETOPLAST DNA PRESENT IN BLOOD-SAMPLES AND ITS USE IN POLYMERASE
   CHAIN-REACTION (PCR)-BASED DIAGNOSIS OF CHRONIC CHAGAS-DISEASE
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Note
C1 INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,AV BRASIL 4365,BR-21045 RIO JANEIRO,RJ,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Britto,
   Constanca/L-7658-2016
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Britto, Constanca/0000-0003-0788-7030
NR 0
TC 108
Z9 110
U1 0
U2 1
PU MEM INST OSWALDO CRUZ
PI RIO DE JANEIRO
PA SECRETARY CAIXA POSTAL 926, 20001 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JAN-MAR
PY 1993
VL 88
IS 1
BP 171
EP 172
DI 10.1590/S0074-02761993000100030
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LB710
UT WOS:A1993LB71000030
PM 8246754
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU GONCALVES, AM
   NEHME, NS
   SARAVIA, N
   SEGURA, I
   MOREL, CM
AF GONCALVES, AM
   NEHME, NS
   SARAVIA, N
   SEGURA, I
   MOREL, CM
TI SCHIZODEME ANALYSIS WITH THE RESTRICTION ENDONUCLEASE RSA-I
   DIFFERENTIATES BETWEEN TRYPANOSOMA-RANGELI AND TRYPANOSOMA-CRUZI
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Note
ID KINETOPLAST DNA MINICIRCLES
C1 CTR INT ENTRENAMIENTO & INVEST MED,CALI,COLOMBIA.
RP GONCALVES, AM (corresponding author), INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,CAIXA POSTAL 926,BR-20001 RIO DE JANEIRO,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR DALESSANDRO A, 1976, BIOL KINETOPLASTIDA, P328
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   HUDSON L, 1987, ACTA TROP, V44, P387
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   STEINDEL M, 1991, MEM I OSWALDO CRUZ, V86, P73, DOI 10.1590/S0074-02761991000100012
NR 5
TC 6
Z9 6
U1 0
U2 0
PU MEM INST OSWALDO CRUZ
PI RIO DE JANEIRO
PA SECRETARY CAIXA POSTAL 926, 20001 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT-DEC
PY 1991
VL 86
IS 4
BP 477
EP 478
DI 10.1590/S0074-02761991000400021
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HB720
UT WOS:A1991HB72000021
PM 1842443
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU AVILA, H
   GONCALVES, AM
   NEHME, NS
   MOREL, CM
   SIMPSON, L
AF AVILA, H
   GONCALVES, AM
   NEHME, NS
   MOREL, CM
   SIMPSON, L
TI SCHIZODEME ANALYSIS OF TRYPANOSOMA-CRUZI STOCKS FROM SOUTH AND
   CENTRAL-AMERICA BY ANALYSIS OF PCR-AMPLIFIED MINICIRCLE VARIABLE REGION
   SEQUENCES
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024.
   UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024.
   INST OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,RIO DE JANEIRO,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 07323] Funding Source: Medline
CR BRUNK CF, 1977, ANAL BIOCHEM, V82, P455, DOI 10.1016/0003-2697(77)90183-X
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   FRASCH ACC, 1981, MOL BIOCHEM PARASIT, V4, P163, DOI 10.1016/0166-6851(81)90015-3
   GOMEZEICHELMANN MC, 1988, MOL BIOCHEM PARASIT, V27, P143, DOI 10.1016/0166-6851(88)90034-5
   GONCALVES A, 1984, APPLICATION BIOCH MO, P253
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   GONCALVES AM, 1990, MEM I OSWALDO CRUZ, V85, P101, DOI 10.1590/S0074-02761990000100017
   KEMP DJ, 1989, P NATL ACAD SCI USA, V86, P2423, DOI 10.1073/pnas.86.7.2423
   LOPES UG, 1986, MOL BIOCHEM PARASIT, V20, P77, DOI 10.1016/0166-6851(86)90144-1
   MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   NTAMBI JM, 1985, J BIOL CHEM, V260, P5574
   SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230
   SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051
   SPITHILL TW, 1984, MOL BIOCHEM PARASIT, V12, P217, DOI 10.1016/0166-6851(84)90137-3
   STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x
   WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585
NR 20
TC 72
Z9 75
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD SEP-OCT
PY 1990
VL 42
IS 2
BP 175
EP 187
DI 10.1016/0166-6851(90)90160-N
PG 13
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA EB775
UT WOS:A1990EB77500003
PM 2270100
OA Green Published
DA 2020-12-17
ER

PT J
AU HAGUENOER, JM
   CORDIER, S
   MOREL, C
   LEFEBVRE, JL
   HEMON, D
AF HAGUENOER, JM
   CORDIER, S
   MOREL, C
   LEFEBVRE, JL
   HEMON, D
TI OCCUPATIONAL RISK-FACTORS FOR UPPER RESPIRATORY-TRACT AND UPPER
   DIGESTIVE-TRACT CANCERS
SO BRITISH JOURNAL OF INDUSTRIAL MEDICINE
LA English
DT Article
C1 CTR LUTTE CONTRE CANC NORD,F-59020 LILLE,FRANCE.
   INSERM,U170,F-94807 VILLEJUIF,FRANCE.
RP HAGUENOER, JM (corresponding author), FAC MED LILLE,IMT,REG NORD,F-59045 LILLE,FRANCE.
RI Morel, Carlos/Q-9657-2019; Hemon, Denis/P-8695-2017; Cordier,
   Sylvaine/X-7440-2019; Cordier, Sylvaine/F-7919-2013
OI Morel, Carlos/0000-0003-2752-0009; Cordier, Sylvaine/0000-0002-2349-2277
CR BRESLOW NE, 1980, IARC SCI PUBL, V32
   BROWNSON RC, 1987, ARCH ENVIRON HEALTH, V42, P192
   DECOUFLE P, 1979, ARCH ENVIRON HEALTH, V34, P33, DOI 10.1080/00039896.1979.10667364
   ELWOOD JM, 1984, INT J CANCER, V34, P603, DOI 10.1002/ijc.2910340504
   FLANDERS WD, 1984, AM J EPIDEMIOL, V119, P23, DOI 10.1093/oxfordjournals.aje.a113722
   LINDQVIST C, 1979, AM J EPIDEMIOL, V109, P521, DOI 10.1093/oxfordjournals.aje.a112710
   MOSS E, 1974, BRIT J IND MED, V31, P224
   MOULIN JJ, 1985, B CANCER, V72, P155
   MOULIN JJ, 1986, SCAND J WORK ENV HEA, V12, P27, DOI 10.5271/sjweh.2177
   OLSEN J, 1984, EUR J CANCER CLIN ON, V20, P639, DOI 10.1016/0277-5379(84)90010-5
   OLSEN J, 1984, J EPIDEMIOL COMMUN H, V38, P117, DOI 10.1136/jech.38.2.117
   PUNTONI R, 1987, SCAND J WORK ENV HEA, V2, P162
   REZVANI A, 1986, ATLAS MORTALITE CANC
   Rothman K J, 1980, Epidemiol Rev, V2, P195
   SIMONATA L, 1983, ENCY OCCUPATIONAL HL, V1, P369
   TUYNS AJ, 1977, B CANCER, V64, P45
   WALDRON HA, 1975, BRIT J CANCER, V32, P256, DOI 10.1038/bjc.1975.203
   WATERHOUSE JA, 1982, IARC SCI PUBL, V42
   WHITAKER CJ, 1979, BRIT J IND MED, V36, P292
   ZAGRANISKI RT, 1986, AM J EPIDEMIOL, V124, P67, DOI 10.1093/oxfordjournals.aje.a114371
   1985, MONOGRAPHS EVALUATIO, V37
   1981, MONOGRAPHS EVALUATIO, V25
NR 22
TC 35
Z9 35
U1 0
U2 3
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR
SN 0007-1072
J9 BRIT J IND MED
PD JUN
PY 1990
VL 47
IS 6
BP 380
EP 383
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DG535
UT WOS:A1990DG53500004
PM 2378815
DA 2020-12-17
ER

PT J
AU PACHECO, RS
   GRIMALDI, G
   MOMEN, H
   MOREL, CM
AF PACHECO, RS
   GRIMALDI, G
   MOMEN, H
   MOREL, CM
TI POPULATION HETEROGENEITY AMONG CLONES OF NEW-WORLD LEISHMANIA SPECIES
SO PARASITOLOGY
LA English
DT Article
RP PACHECO, RS (corresponding author), INST OSWALDO CRUZ FIOCRUZ,AV BRASIL 4365,MANGUINHOS 21040,CAIXA POSTAL 926,RIO DE JANEIRO,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Momen, Hooman/A-1850-2008; Morel, Carlos
   M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Momen, Hooman/0000-0002-2324-1515;
   Morel, Carlos M/0000-0003-2752-0009
CR AVISE JC, 1979, GENETICS, V92, P279
   BONGERTZ V, 1983, AM J TROP MED HYG, V32, P716, DOI 10.4269/ajtmh.1983.32.716
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   ENGEL JC, 1982, J PROTOZOOL, V29, P555, DOI 10.1111/j.1550-7408.1982.tb01334.x
   GOLDBERG SS, 1983, J PARASITOL, V69, P91, DOI 10.2307/3281282
   GONCALVES A, 1984, APPLICATION BIOCH MO, P253
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   GRIMALDI G, 1987, AM J TROP MED HYG, V36, P270, DOI 10.4269/ajtmh.1987.36.270
   HANDMAN E, 1983, MOL BIOCHEM PARASIT, V7, P111, DOI 10.1016/0166-6851(83)90039-7
   Jaffe C. L., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P47
   KEPPEL AD, 1980, J PARASITOL, V66, P349
   MOREL CM, 1980, P NATIONAL ACADEMY S, V7, P6810
   PACHECO R S, 1987, Memorias do Instituto Oswaldo Cruz, V82, P537, DOI 10.1590/S0074-02761987000400011
   PACHECO RS, 1984, LEISHMANIA TAXONOMIE, P57
   SAFJANOVA VM, 1980, PARAZITOLOGIYA+, V14, P229
   Shurkhal AV, 1986, LEISHMANIA TAXONOMIE, P91
   SPITHILL TW, 1984, MOL BIOCHEM PARASIT, V12, P217, DOI 10.1016/0166-6851(84)90137-3
   TANURI A, 1981, J PROTOZOOL, V28, P360, DOI 10.1111/j.1550-7408.1981.tb02867.x
   Yoshida E L, 1979, Rev Inst Med Trop Sao Paulo, V21, P110
   YOSHIDA ELA, 1985, REV I MED TROP, V27, P172, DOI 10.1590/S0036-46651985000400002
NR 21
TC 19
Z9 19
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211
SN 0031-1820
J9 PARASITOLOGY
JI Parasitology
PD JUN
PY 1990
VL 100
BP 393
EP 398
DI 10.1017/S0031182000078677
PN 3
PG 6
WC Parasitology
SC Parasitology
GA DJ530
UT WOS:A1990DJ53000007
PM 2163502
DA 2020-12-17
ER

PT J
AU CARNEIRO, M
   CHIARI, E
   GONCALVES, AM
   PEREIRA, AAD
   MOREL, CM
   ROMANHA, AJ
AF CARNEIRO, M
   CHIARI, E
   GONCALVES, AM
   PEREIRA, AAD
   MOREL, CM
   ROMANHA, AJ
TI CHANGES IN THE ISOENZYME AND KINETOPLAST DNA PATTERNS OF
   TRYPANOSOMA-CRUZI STRAINS INDUCED BY MAINTENANCE IN MICE
SO ACTA TROPICA
LA English
DT Article
C1 FDN INST OSWALDO CRUZ, 10C, DEPT BIOQUIM & BIOL MOLEC, RIO DE JANEIRO, BRAZIL.
   FDN INST OSWALDO CRUZ, CTR PESQUISAS RENE RACHOU, BELO HORIZONTE, BRAZIL.
RP CARNEIRO, M (corresponding author), UNIV FED MINAS GERAIS, ICB, DEPT PARASITOL, AV ANTONIO CARLOS 6627, CP 2486, BR-30161 BELO HORIZONTE, MATO GROSSO, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR BRENER Z, 1977, Pan American Health Organization Scientific Publication, V347, P11
   Brener Z., 1985, REV SOC BRASILEIRA S, V18, P1
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CARNEIRO M, 1989, UNPUB MEM I O CRUZ
   CHIARI E, 1979, C INT DOENCA CHAGAS
   CHIARI E, 1980, 7 REUN AN PESQ BAS D
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   GONCALVES AM, 1984, NEW APPROACHES IDENT, P253
   Harris H, 1976, HDB ENZYME ELECTROPH
   LANA M, 1981, 8 REUN AN PESQ BAS D
   LUQUETTI AO, 1986, T ROY SOC TROP MED H, V80, P462, DOI 10.1016/0035-9203(86)90347-0
   MILES MA, 1980, T ROY SOC TROP MED H, V74, P221, DOI 10.1016/0035-9203(80)90251-5
   MILES MA, 1981, LANCET, V1, P1338
   MIRELMAN D, 1987, PARASITOL TODAY, V3, P37, DOI 10.1016/0169-4758(87)90210-9
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   ROMANHA AJ, 1979, COMP BIOCHEM PHYS B, V62, P139, DOI 10.1016/0305-0491(79)90299-2
   ROMANHA AJ, 1979, C INT DOENCA CHAGAS
   ROMANHA AJ, 1982, THESIS UFMG
   SANCHEZ DO, 1984, MOL BIOCHEM PARASIT, V11, P169, DOI 10.1016/0166-6851(84)90063-X
   SCHLEMPER BR, 1982, THESIS UFRJ
   TIBAYRENC M, 1983, T ROY SOC TROP MED H, V77, P73, DOI 10.1016/0035-9203(83)90019-6
   TIBAYRENC M, 1986, T ROY SOC TROP MED H, V80, P442, DOI 10.1016/0035-9203(86)90338-X
   TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x
NR 24
TC 49
Z9 50
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JAN
PY 1990
VL 47
IS 1
BP 35
EP 45
DI 10.1016/0001-706X(90)90005-K
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CG850
UT WOS:A1990CG85000004
PM 1967507
OA Green Published
DA 2020-12-17
ER

PT J
AU GONCALVES, AM
   NEHME, NS
   MOREL, CM
AF GONCALVES, AM
   NEHME, NS
   MOREL, CM
TI AN IMPROVED SILVER STAINING PROCEDURE FOR SCHIZODEME ANALYSIS IN
   POLYACRYLAMIDE GRADIENT GELS
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
RP GONCALVES, AM (corresponding author), INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,CAIXA POSTAL 926,BR-20001 RIO DE JANEIRO,RJ,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR BEIDLER JL, 1982, ANAL BIOCHEM, V126, P374, DOI 10.1016/0003-2697(82)90530-9
   BOULIKAS T, 1981, J BIOCHEM BIOPH METH, V5, P219, DOI 10.1016/0165-022X(81)90046-4
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   GUILLEMETTE JG, 1983, ELECTROPHORESIS, V4, P92, DOI 10.1002/elps.1150040112
   HERRING AJ, 1982, J CLIN MICROBIOL, V16, P473, DOI 10.1128/JCM.16.3.473-477.1982
   MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4
   SCHLEICHER M, 1983, ANAL BIOCHEM, V131, P312, DOI 10.1016/0003-2697(83)90175-6
NR 9
TC 21
Z9 21
U1 0
U2 0
PU MEM INST OSWALDO CRUZ
PI RIO DE JANEIRO
PA SECRETARY CAIXA POSTAL 926, 20001 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JAN-MAR
PY 1990
VL 85
IS 1
BP 101
EP 106
DI 10.1590/S0074-02761990000100017
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DC771
UT WOS:A1990DC77100017
PM 1699112
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU ESQUENAZI, D
   MOREL, CM
   TRAUBCSEKO, YM
AF ESQUENAZI, D
   MOREL, CM
   TRAUBCSEKO, YM
TI CHARACTERIZATION OF TUBULIN GENES IN TRYPANOSOMA-RANGELI
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 FDN OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,AV BRASIL 4365,BR-21045 RIO DE JANEIRO,RJ,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR AFCHAIN D, 1979, J PARASITOL, V65, P507, DOI 10.2307/3280312
   Anez N., 1982, Memorias do Instituto Oswaldo Cruz, V77, P405, DOI 10.1590/S0074-02761982000400007
   ANTHONY RL, 1981, ANN TROP MED HYG, V30, P192
   BRONZINA AA, 1980, MEDICINA-BUENOS AIRE, V40, P45
   CASTRO C, 1981, MOL BIOCHEM PARASIT, V4, P273, DOI 10.1016/0166-6851(81)90060-8
   CLEVELAND DW, 1985, ANNU REV BIOCHEM, V54, P331, DOI 10.1146/annurev.bi.54.070185.001555
   DALESSANDRO A, 1977, AM J TROP MED HYG, V26, P623, DOI 10.4269/ajtmh.1977.26.623
   DALESSANDRO A, 1969, J PARASITOL, V55, P846, DOI 10.2307/3277229
   DEANE L. M., 1958, REV BRAS MALARIOL E DOENCAS TROP, V10, P451
   FRASCH ACC, 1981, MOL BIOCHEM PARASIT, V4, P163, DOI 10.1016/0166-6851(81)90015-3
   HOARE CA, 1964, J PROTOZOOL, V11, P200, DOI 10.1111/j.1550-7408.1964.tb01741.x
   HOARE CA, 1976, ZOOLOGICAL MONOGRAPH
   HUANG PL, 1984, MOL CELL BIOL, V4, P1372, DOI 10.1128/MCB.4.7.1372
   Jaffe C. L., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P47
   KIMMEL BE, 1985, GENE, V35, P237, DOI 10.1016/0378-1119(85)90002-2
   LANDFEAR SM, 1985, MOL BIOCHEM PARASIT, V15, P61, DOI 10.1016/0166-6851(85)90029-5
   LANDFEAR SM, 1983, MOL CELL BIOL, V3, P1070, DOI 10.1128/MCB.3.6.1070
   LEON W, 1978, NUCLEIC ACIDS RES, V5, P491, DOI 10.1093/nar/5.2.491
   MAINGON R, 1988, EUR J BIOCHEM, V171, P285, DOI 10.1111/j.1432-1033.1988.tb13788.x
   MANIATIS T, 1982, MOL CLONING
   MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2
   MILES MA, 1983, AM J TROP MED HYG, V32, P1251, DOI 10.4269/ajtmh.1983.32.1251
   Ozaki LS, 1984, GENES ANTIGENS PARAS, P165
   PAINDAVOINE P, 1986, PARASITOLOGY, V92, P31, DOI 10.1017/S0031182000063435
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   RUSSELL DG, 1984, MOL CELL BIOL, V4, P779, DOI 10.1128/MCB.4.4.779
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SEEBECK T, 1983, P NATL ACAD SCI-BIOL, V80, P4634, DOI 10.1073/pnas.80.15.4634
   SMITH GE, 1980, ANAL BIOCHEM, V109, P123, DOI 10.1016/0003-2697(80)90019-6
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Tejera E., 1920, Bulletin de la Societe de Pathologie Exotique Paris, V13
   THOMASHOW LS, 1983, CELL, V32, P35, DOI 10.1016/0092-8674(83)90494-4
   TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115
   1986, OMS SERIE RAPPORTS T, V739, P16
NR 34
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD MAY 15
PY 1989
VL 34
IS 3
BP 253
EP 260
DI 10.1016/0166-6851(89)90054-6
PG 8
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA U5315
UT WOS:A1989U531500007
PM 2733730
OA Green Published
DA 2020-12-17
ER

PT J
AU STURM, NR
   DEGRAVE, W
   MOREL, C
   SIMPSON, L
AF STURM, NR
   DEGRAVE, W
   MOREL, C
   SIMPSON, L
TI SENSITIVE DETECTION AND SCHIZODEME CLASSIFICATION OF TRYPANOSOMA-CRUZI
   CELLS BY AMPLIFICATION OF KINETOPLAST MINICIRCLE DNA-SEQUENCES - USE IN
   DIAGNOSIS OF CHAGAS-DISEASE
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024.
   UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024.
   FIOCRUZ,OSWALDO CRUZ INST,DEPT BIOCHEM & MOLEC BIOL,RIO DE JANEIRO,BRAZIL.
RI Degrave, Wim/B-4162-2009; Morel, Carlos M/B-4079-2009; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR d'Alessandro A., 1976, P327
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4
   FRASCH ACC, 1980, BIOCHIM BIOPHYS ACTA, V607, P397, DOI 10.1016/0005-2787(80)90150-1
   GONCALVES A, 1984, APPLICATION BIOCH MO, P253
   MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SAUCIER JM, 1981, BIOCHEM BIOPH RES CO, V101, P988, DOI 10.1016/0006-291X(81)91846-5
   Schenone H, 1977, Bol Chil Parasitol, V32, P63
   SIMPSON L, 1974, J PROTOZOOL, V21, P382, DOI 10.1111/j.1550-7408.1974.tb03675.x
   SIMPSON L, 1971, J MOL BIOL, V56, P443, DOI 10.1016/0022-2836(71)90394-9
   SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051
   SIMPSON L, 1979, P NATL ACAD SCI USA, V76, P1585, DOI 10.1073/pnas.76.4.1585
   TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x
   WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585
   ZOLG JW, 1988, AM J TROP MED HYG, V39, P33, DOI 10.4269/ajtmh.1988.39.33
NR 18
TC 226
Z9 234
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD MAR 15
PY 1989
VL 33
IS 3
BP 205
EP 214
DI 10.1016/0166-6851(89)90082-0
PG 10
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA T4344
UT WOS:A1989T434400001
PM 2565018
OA Green Published
DA 2020-12-17
ER

PT J
AU CRUZ, AK
   PIRES, MQ
   LIMA, VG
   MOREL, CM
AF CRUZ, AK
   PIRES, MQ
   LIMA, VG
   MOREL, CM
TI RESTRICTION ENDONUCLEASES FROM MICROORGANISMS ISOLATED IN BRAZIL - AN
   ISOSCHIZOMER OF HAE-III FROM A THERMOPHILIC BACILLUS SP
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
C1 FIOCRUZ MS, INST OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, BR-21045 RIO DE JANEIRO, BRAZIL.
   UNIV BRASILIA, DEPT BIOL CELULAR, BR-70910 BRASILIA, DF, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Cruz, Angela
   Kaysel/N-8445-2014
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Cruz, Angela Kaysel/0000-0002-4260-4713
CR ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8
   COLLINS J, 1980, ARZNEIMITTELFORSCH, V30-1, P541
   CRUZ AK, 1984, FEBS LETT, V173, P99, DOI 10.1016/0014-5793(84)81025-X
   DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X
   GAROFF H, 1981, ANAL BIOCHEM, V115, P450, DOI 10.1016/0003-2697(81)90031-2
   KATZ L, 1973, J BACTERIOL, V114, P577, DOI 10.1128/JB.114.2.577-591.1973
   KELLY TJ, 1970, J MOL BIOL, V51, P393, DOI 10.1016/0022-2836(70)90150-6
   KESSLER C, 1985, GENE, V33, P1, DOI 10.1016/0378-1119(85)90119-2
   MAIA JCC, 1984, GENES ANTIGENS PARAS, P139
   MANIATIS T, 1982, MOL CLONING LABORATO, P159
   Maxam A M, 1980, Methods Enzymol, V65, P499
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6
   Roberts R J, 1984, Nucleic Acids Res, V12 Suppl, pr167
   ROBERTS RJ, 1976, CRC CR REV BIOCH MOL, V4, P123, DOI 10.3109/10409237609105456
   SANGER F, 1978, FEBS LETT, V87, P107, DOI 10.1016/0014-5793(78)80145-8
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X
   SUSSMAN R, 1962, CR HEBD ACAD SCI, V254, P1517
   VANHEUVERSWYN H, 1977, NUCLEIC ACIDS RES, V4, P1015, DOI 10.1093/nar/4.4.1015
   VOLCKAERT G, 1977, ANAL BIOCHEM, V83, P222, DOI 10.1016/0003-2697(77)90530-9
NR 21
TC 2
Z9 2
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1989
VL 22
IS 11
BP 1321
EP 1328
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA CB840
UT WOS:A1989CB84000001
PM 2638923
DA 2020-12-17
ER

PT J
AU MOREL, CM
AF MOREL, CM
TI 1ST NATIONAL SYMPOSIUM ON THE BIOLOGICAL-CONTROL OF PESTS AND VECTORS -
   RIO-DE-JANEIRO, BRAZIL, NOVEMBER 15-18, 1988 - OPENING ADDRESS
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA Portuguese
DT Editorial Material
RP MOREL, CM (corresponding author), OSWALDO CRUZ INST,RIO DE JANEIRO,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MEM INST OSWALDO CRUZ
PI RIO DE JANEIRO
PA SECRETARY CAIXA POSTAL 926, 20001 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 1989
VL 84
SU 3
BP 4
EP 4
PG 1
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CE243
UT WOS:A1989CE24300001
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU LAKE, JA
   DELACRUZ, VF
   FERREIRA, PCG
   MOREL, C
   SIMPSON, L
AF LAKE, JA
   DELACRUZ, VF
   FERREIRA, PCG
   MOREL, C
   SIMPSON, L
TI EVOLUTION OF PARASITISM - KINETOPLASTID PROTOZOAN HISTORY RECONSTRUCTED
   FROM MITOCHONDRIAL RIBOSOMAL-RNA GENE-SEQUENCES
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024.
   FDN OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,RIO DE JANEIRO,BRAZIL.
RP LAKE, JA (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024, USA.
RI Ferreira, Paulo C G/I-2836-2015; Morel, Carlos M/B-4079-2009; Morel,
   Carlos/Q-9657-2019
OI Ferreira, Paulo C G/0000-0002-5510-999X; Morel, Carlos
   M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR BEVERLEY SM, 1987, P NATL ACAD SCI USA, V84, P484, DOI 10.1073/pnas.84.2.484
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   CARPENTER FM, 1977, 15 P INT C ENT WASH, P63
   DELACRUZ VF, 1985, NUCLEIC ACIDS RES, V13, P2337, DOI 10.1093/nar/13.7.2337
   DELACRUZ VF, 1985, P NATL ACAD SCI USA, V82, P1401, DOI 10.1073/pnas.82.5.1401
   DESALLE R, 1987, J MOL EVOL, V26, P157, DOI 10.1007/BF02111289
   EPERON IC, 1983, NUCLEIC ACIDS RES, V11, P105, DOI 10.1093/nar/11.1.105
   FITCH WM, 1977, AM NAT, V111, P223, DOI 10.1086/283157
   GALINARI S, 1978, EXP PARASITOL, V46, P277, DOI 10.1016/0014-4894(78)90141-8
   GLEN W, 1975, CONTINENTAL DRIFT PL
   GOMEZEICHELMANN MC, 1988, MOL BIOCHEM PARASIT, V27, P143, DOI 10.1016/0166-6851(88)90034-5
   HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7
   Hoare C.A., 1972, TRYPANOSOMES MAMMALS
   HUTNER S, 1979, BIOL KINETOPLASTIDA, V2, P654
   KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031
   LAKE JA, 1987, J MOL EVOL, V26, P59, DOI 10.1007/BF02111282
   LAKE JA, 1987, MOL BIOL EVOL, V4, P167
   LAMBRECHT FL, 1980, P AM PHILOS SOC, V124, P367
   MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980
   Ochman H., 1987, ESCHERICHIA COLI SAL, P1649
   PLATNICK N I, 1987, Cladistics, V3, P121, DOI 10.1111/j.1096-0031.1987.tb00502.x
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sibley C.G., 1981, P301
   SIMPSON L, 1986, INT REV CYTOL, V99, P119
   SIMPSON L, 1987, J BIOL CHEM, V262, P6182
   SIMPSON L, 1978, CELL, V14, P169, DOI 10.1016/0092-8674(78)90311-2
   SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051
   SLOOF P, 1985, NUCLEIC ACIDS RES, V13, P4171, DOI 10.1093/nar/13.11.4171
   WALLBANKS KR, 1985, PARASITOLOGY, V90, P67, DOI 10.1017/S0031182000049027
   WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041
   WILSON AC, 1987, TRENDS GENET, V3, P241, DOI 10.1016/0168-9525(87)90257-5
   WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x
NR 32
TC 106
Z9 108
U1 0
U2 4
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL
PY 1988
VL 85
IS 13
BP 4779
EP 4783
DI 10.1073/pnas.85.13.4779
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA P2277
UT WOS:A1988P227700043
PM 3133662
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU DEGRAVE, W
   FRAGOSO, SP
   BRITTO, C
   VANHEUVERSWYN, H
   KIDANE, GZ
   CARDOSO, MAB
   MUELLER, RU
   SIMPSON, L
   MOREL, CM
AF DEGRAVE, W
   FRAGOSO, SP
   BRITTO, C
   VANHEUVERSWYN, H
   KIDANE, GZ
   CARDOSO, MAB
   MUELLER, RU
   SIMPSON, L
   MOREL, CM
TI PECULIAR SEQUENCE ORGANIZATION OF KINETOPLAST DNA MINICIRCLES FROM
   TRYPANOSOMA-CRUZI
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 INST OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,AVENIDA BRASIL 4365,BR-21045 RIO DE JANEIRO,RJ,BRAZIL.
   UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024.
   UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024.
RI P, CM/B-1358-2013; Degrave, Wim/B-4162-2009; Morel, Carlos/Q-9657-2019;
   Fragoso, Stenio/AAB-4703-2019; Morel, Carlos M/B-4079-2009; Britto,
   Constanca/L-7658-2016
OI Morel, Carlos/0000-0003-2752-0009; Fragoso, Stenio/0000-0002-0909-7940;
   Morel, Carlos M/0000-0003-2752-0009; Britto,
   Constanca/0000-0003-0788-7030; van heuverswyn, hugo/0000-0002-4086-3615
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI009102, R37AI009102, R01AI009102, R01AI009102, R01AI009102,
   R01AI009102, R37AI009102, R01AI009102, R37AI009102, R01AI009102,
   R37AI009102, R01AI009102, R01AI009102, R01AI009102, R37AI009102,
   R01AI009102, R37AI009102, R01AI009102, R01AI009102, R01AI009102,
   R37AI009102, R01AI009102, R01AI009102, R37AI009102, R37AI009102,
   R01AI009102, R01AI009102, R37AI009102, R01AI009102, R37AI009102] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI09102] Funding
   Source: Medline
CR BRENER Z, 1977, Pan American Health Organization Scientific Publication, V347, P11
   CAMARGO E, 1964, REV I MED TROP S PAU, V63, P93
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   GONCALVES A, 1984, APPLICATION BIOCH MO, P253
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
   GONCALVES AM, 1985, REV SOC BRAS MED TRO, V18, P67
   GONZALEZ A, 1986, NUCLEIC ACIDS RES, V14, P9217, DOI 10.1093/nar/14.22.9217
   JASMER DP, 1986, MOL BIOCHEM PARASIT, V18, P321, DOI 10.1016/0166-6851(86)90089-7
   KIDANE GZ, 1984, GENE, V27, P265, DOI 10.1016/0378-1119(84)90071-4
   LOPES UG, 1984, J PARASITOL, V70, P89, DOI 10.2307/3281930
   MACINA RA, 1986, MOL BIOCHEM PARASIT, V21, P25, DOI 10.1016/0166-6851(86)90075-7
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   Maxam A M, 1980, Methods Enzymol, V65, P499
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   MOREL C M, 1986, Parasitology Today, V2, P97, DOI 10.1016/0169-4758(86)90038-4
   Morel C.M., 1984, Memorias do Instituto Oswaldo Cruz, V79, P51, DOI 10.1590/S0074-02761984000500011
   NTAMBI JM, 1986, J BIOL CHEM, V261, P1890
   PONZI M, 1984, MOL BIOCHEM PARASIT, V13, P111, DOI 10.1016/0166-6851(84)90105-1
   RIOU GF, 1977, BIOCHEMISTRY-US, V16, P2390, DOI 10.1021/bi00630a013
   ROGERS D, 1986, P NATL ACAD SCI US, V84, P565
   SAIKI RK, 1985, BIO-TECHNOL, V3, P1008, DOI 10.1038/nbt1185-1008
   SANCHEZ DO, 1984, FEBS LETT, V168, P139, DOI 10.1016/0014-5793(84)80223-9
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SIMPSON L, 1974, J PROTOZOOL, V21, P382, DOI 10.1111/j.1550-7408.1974.tb03675.x
NR 24
TC 110
Z9 112
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD JAN 1
PY 1988
VL 27
IS 1
BP 63
EP 70
DI 10.1016/0166-6851(88)90025-4
PG 8
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA L3405
UT WOS:A1988L340500007
PM 2830509
OA Green Published
DA 2020-12-17
ER

PT J
AU HAGUENOER, JM
   CORDIER, S
   MOREL, C
   HEMON, D
AF HAGUENOER, JM
   CORDIER, S
   MOREL, C
   HEMON, D
TI OCCUPATIONAL RISK-FACTORS FOR UPPER RESPIRATORY AND DIGESTIVE-TRACT
   CANCERS
SO SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH
LA English
DT Meeting Abstract
C1 FAC MED LILLE,INST MED TRAVAIL,F-59045 LILLE,FRANCE.
   INSERM,U170,F-94800 VILLEJUIF,FRANCE.
RI Cordier, Sylvaine/X-7440-2019; Cordier, Sylvaine/F-7919-2013; Hemon,
   Denis/P-8695-2017; Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SCAND J WORK ENV HEALTH
PI HELSINKI
PA TOPELIUKSENKATU 41A, SF-00250 HELSINKI, FINLAND
SN 0355-3140
J9 SCAND J WORK ENV HEA
JI Scand. J. Work Environ. Health
PD APR
PY 1987
VL 13
IS 2
BP 170
EP 170
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA H3122
UT WOS:A1987H312200055
DA 2020-12-17
ER

PT J
AU GARCIA, ES
   VIEIRA, E
   GONCALVES, AM
   MOREL, CM
   ALVES, MM
   COLLI, W
AF GARCIA, ES
   VIEIRA, E
   GONCALVES, AM
   MOREL, CM
   ALVES, MM
   COLLI, W
TI A STRAIN OF TRYPANOSOMA-CRUZI, AND ITS BIOCHEMICAL-CHARACTERIZATION
   AFTER PASSAGE THROUGH DIFFERENT INVERTEBRATE HOSTS
SO ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
LA English
DT Note
C1 UNIV SAO PAULO,DEPT BIOCHEM,SAO PAULO,SP,BRAZIL.
RP GARCIA, ES (corresponding author), FUNDACAO OSWALDO CRUZ,DEPT BIOCHEM & MOLEC BIOL,AV BRASIL 4365,C POSTAL 926,BR-21040 RIO DE JANEIRO,BRAZIL.
RI Colli, Walter/G-1188-2012; Morel, Carlos M/B-4079-2009; Neto, Eduardo
   Vieira/C-5193-2014; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Neto, Eduardo
   Vieira/0000-0002-0247-837X; Morel, Carlos/0000-0003-2752-0009; Colli,
   Walter/0000-0001-7305-4673
CR ALVES MJM, 1983, INFECT IMMUN, V39, P377, DOI 10.1128/IAI.39.1.377-382.1983
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   GARCIA ES, 1980, J PARASITOL, V66, P1052, DOI 10.2307/3280417
   GARCIA ES, 1984, GENES ANTIGENS PARAS, P43
   GARCIA ES, 1982, AM J TROP MED HYG, V31, P359
   GARCIA ES, 1985, MEMORIAS I O CRUZ, V79, P33
   Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95
NR 7
TC 7
Z9 7
U1 0
U2 2
PU CARFAX PUBL CO
PI ABINGDON
PA PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE
SN 0003-4983
J9 ANN TROP MED PARASIT
JI Ann. Trop. Med. Parasitol.
PD JUN
PY 1986
VL 80
IS 3
BP 361
EP 363
DI 10.1080/00034983.1986.11812030
PG 3
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA D0076
UT WOS:A1986D007600014
PM 2432842
DA 2020-12-17
ER

PT J
AU GOLDENBERG, S
   CONTRERAS, VT
   SALLES, JM
   BONALDO, MC
   FRANCO, MPAL
   LINSS, J
   LAFAILLE, J
   MOREL, CM
AF GOLDENBERG, S
   CONTRERAS, VT
   SALLES, JM
   BONALDO, MC
   FRANCO, MPAL
   LINSS, J
   LAFAILLE, J
   MOREL, CM
TI STATE SPECIFIC GENE-EXPRESSION DURING TRYPANOSOMA-CRUZI DEVELOPMENT
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 FIOCRUZ,DEPT BIOCHEM & MOLEC BIOL,RIO DE JANEIRO,BRAZIL.
RI P, CM/B-1358-2013; Morel, Carlos/Q-9657-2019; Bonaldo, Myrna
   C/D-9494-2013; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PY 1986
SU 10A
BP 174
EP 174
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AYE10
UT WOS:A1986AYE1000463
DA 2020-12-17
ER

PT J
AU CONTRERAS, VT
   MOREL, CM
   GOLDENBERG, S
AF CONTRERAS, VT
   MOREL, CM
   GOLDENBERG, S
TI EFFECT OF GUINEA-PIG FRESH SERUM ON TRYPANOSOMA-CRUZI PROTEIN-SYNTHESIS
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 INST OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,RIO DE JANEIRO,RJ,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1985
VL 57
IS 1
BP 136
EP 136
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ARG33
UT WOS:A1985ARG3300064
DA 2020-12-17
ER

PT J
AU GOLDENBERG, S
   SALLES, JM
   CONTRERAS, VT
   FRANCO, MPL
   KATZIN, AM
   COLLI, W
   MOREL, CM
AF GOLDENBERG, S
   SALLES, JM
   CONTRERAS, VT
   FRANCO, MPL
   KATZIN, AM
   COLLI, W
   MOREL, CM
TI CHARACTERIZATION OF MESSENGER-RNA FROM EPIMASTIGOTES AND METACYCLIC
   TRYPOMASTIGOTES OF TRYPANOSOMA-CRUZI
SO FEBS LETTERS
LA English
DT Article
RP GOLDENBERG, S (corresponding author), INST OSWALDO CRUZ, DEPT BIOCHEM & MOLEC BIOL, AVE BRASIL 4365, BR-21040 RIO DE JANEIRO, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Colli, Walter/G-1188-2012; Katzin,
   Alejandro/E-9862-2013; GOLDENBERG, SAMUEL/B-4116-2009; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Katzin,
   Alejandro/0000-0002-4782-2162; GOLDENBERG, SAMUEL/0000-0002-4892-163X;
   Morel, Carlos/0000-0003-2752-0009; Colli, Walter/0000-0001-7305-4673
CR ANDREWS NW, 1984, EUR J BIOCHEM, V140, P599, DOI 10.1111/j.1432-1033.1984.tb08144.x
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CONTRERAS VT, 1984, MOL BIOCH PARASITOL
   CRANE MSJ, 1980, J PROTOZOOL, V27, P336, DOI 10.1111/j.1550-7408.1980.tb04273.x
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   FILHO SA, 1984, ACTA TROP, V41, P109
   GOLDENBERG S, 1984, GENES ANTIGENS PARAS, P187
   Goldenberg S., 1984, NEW APPROACHES VACCI
   IMAIZUMISCHERRER MT, 1982, DEV BIOL, V93, P126, DOI 10.1016/0012-1606(82)90246-9
   KATZIN AM, 1983, BIOCHIM BIOPHYS ACTA, V727, P403, DOI 10.1016/0005-2736(83)90425-X
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7
   LASKEY RA, 1977, FEBS LETT, V82, P314, DOI 10.1016/0014-5793(77)80609-1
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PARODI AJ, 1983, J BIOL CHEM, V258, P5589
   PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x
   Scherrer K., 1980, EUKARYOTIC GENE REGU, V1, P57
   SCHERRER K, 1969, FUNDAMENTAL TECHNIQU
   THOMASHOW LS, 1983, CELL, V32, P35, DOI 10.1016/0092-8674(83)90494-4
   VINCENT A, 1981, MOL BIOL REP, V7, P71, DOI 10.1007/BF00778736
   WALLACH M, 1982, NATURE, V299, P650, DOI 10.1038/299650a0
   ZINGALES B, 1982, MOL BIOCHEM PARASIT, V6, P111, DOI 10.1016/0166-6851(82)90069-X
NR 23
TC 29
Z9 29
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PY 1985
VL 180
IS 2
BP 265
EP 270
DI 10.1016/0014-5793(85)81083-8
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AAZ18
UT WOS:A1985AAZ1800024
PM 2857136
OA Bronze
DA 2020-12-17
ER

PT J
AU CONTRERAS, VT
   SALLES, JM
   THOMAS, N
   MOREL, CM
   GOLDENBERG, S
AF CONTRERAS, VT
   SALLES, JM
   THOMAS, N
   MOREL, CM
   GOLDENBERG, S
TI INVITRO DIFFERENTIATION OF TRYPANOSOMA-CRUZI UNDER CHEMICALLY DEFINED
   CONDITIONS
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 INST OSWALDO CRUZ, DEPT BIOCHEM & MOLEC BIOL, AVENIDA BRASIL 4365, BR-21040 RIO DE JANEIRO, RJ, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; P,
   CM/B-1358-2013; GOLDENBERG, SAMUEL/B-4116-2009
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   GOLDENBERG, SAMUEL/0000-0002-4892-163X
CR BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227
   CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x
   CHIARI E, 1975, PAHO SCI PUBL, V318, P144
   CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2
   CONTRERAS VT, 1985, ANN ACAD BRAS CIENC
   Cosgrove W. B., 1971, P1
   Deane M. P., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P11
   DEANE MP, 1984, J PROTOZOOL, V31, P276, DOI 10.1111/j.1550-7408.1984.tb02960.x
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   Goldenberg S., 1984, Memorias do Instituto Oswaldo Cruz, V79, P39
   GOLDENBERG S, 1984, NEW APPROACHES VACCI, P442
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANAR DE, 1979, J PROTOZOOL, V26, P457, DOI 10.1111/j.1550-7408.1979.tb04653.x
   NEWTON BA, 1973, S SOC GEN MICROBIOL, V23, P339
   ODALY JA, 1976, J PROTOZOOL, V23, P577, DOI 10.1111/j.1550-7408.1976.tb03845.x
   PAN CT, 1971, J PROTOZOOL, V18, P556, DOI 10.1111/j.1550-7408.1971.tb03375.x
   SHER A, 1983, J PROTOZOOL, V30, P278, DOI 10.1111/j.1550-7408.1983.tb02916.x
   SULLIVAN JJ, 1982, T ROY SOC TROP MED H, V76, P300, DOI 10.1016/0035-9203(82)90173-0
   UCROS H, 1983, ACTA TROP, V40, P105
   WOOD, 1976, REV INST MED TROP, V18, P93
   WOOD DE, 1969, EXP PARASITOL, V24, P176, DOI 10.1016/0014-4894(69)90155-6
NR 23
TC 305
Z9 309
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
EI 1872-9428
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PY 1985
VL 16
IS 3
BP 315
EP 327
DI 10.1016/0166-6851(85)90073-8
PG 13
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA ASF40
UT WOS:A1985ASF4000009
PM 3903496
OA Green Published
DA 2020-12-17
ER

PT J
AU CONTRERAS, VT
   MOREL, CM
   GOLDENBERG, S
AF CONTRERAS, VT
   MOREL, CM
   GOLDENBERG, S
TI STAGE SPECIFIC GENE-EXPRESSION PRECEDES MORPHOLOGICAL-CHANGES DURING
   TRYPANOSOMA-CRUZI METACYCLOGENESIS
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 INST OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, BR-21040 RIO DE JANEIRO, BRAZIL.
RI Morel, Carlos/Q-9657-2019; GOLDENBERG, SAMUEL/B-4116-2009; P,
   CM/B-1358-2013; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; GOLDENBERG,
   SAMUEL/0000-0002-4892-163X; Morel, Carlos M/0000-0003-2752-0009
CR ANDREWS NW, 1984, EUR J BIOCHEM, V140, P599, DOI 10.1111/j.1432-1033.1984.tb08144.x
   ARAUJO FG, 1981, J IMMUNOL, V127, P855
   BRACK C, 1968, Acta Tropica, V25, P289
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   BRENER Z, 1975, PAN AM HLTH ORG SCI, V318, P83
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227
   CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x
   CHIARI E, 1975, SCI PUBL PAHO WHO, V318, P144
   Deane M. P., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P11
   DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1
   DUSANIC DG, 1980, J PARASITOL, V66, P1046, DOI 10.2307/3280415
   DVORAK J A, 1977, Pan American Health Organization Scientific Publication, V347, P1
   FONG D, 1981, P NATL ACAD SCI-BIOL, V78, P7624, DOI 10.1073/pnas.78.12.7624
   GARCIA ES, 1984, GENES ANTIGENS PARAS, P43
   Goldenberg S., 1984, NEW APPROACHES VACCI
   HARINGTON JS, 1961, PARASITOLOGY, V51, P319, DOI 10.1017/S0031182000070566
   KATZIN AM, 1983, BIOCHIM BIOPHYS ACTA, V727, P403, DOI 10.1016/0005-2736(83)90425-X
   KESSLER SW, 1975, J IMMUNOL, V115, P1617
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7
   MORALES SU, 1977, REV INST MED TROP SP, V19, P213
   NOGUEIRA N, 1975, J EXP MED, V142, P224, DOI 10.1084/jem.142.1.224
   NOGUEIRA N, 1982, P NATL ACAD SCI-BIOL, V79, P1259, DOI 10.1073/pnas.79.4.1259
   ODALY JA, 1976, J PROTOZOOL, V23, P577, DOI 10.1111/j.1550-7408.1976.tb03845.x
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   SHER A, 1983, J PROTOZOOL, V30, P278, DOI 10.1111/j.1550-7408.1983.tb02916.x
   SNARY D, 1979, FEBS LETT, V100, P166, DOI 10.1016/0014-5793(79)81156-4
   SOUSA MA, 1983, MEM I OSWALDO CRUZ, V78, P317
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   Wigglesworth VB, 1931, J EXP BIOL, V8, P411
   WOOD DE, 1969, EXP PARASITOL, V24, P176, DOI 10.1016/0014-4894(69)90155-6
   ZELEDON R, 1975, PAN AM HLTH ORG SCI, V318, P9
   ZINGALES B, 1982, MOL BIOCHEM PARASIT, V6, P111, DOI 10.1016/0166-6851(82)90069-X
NR 34
TC 95
Z9 97
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
EI 1872-9428
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PY 1985
VL 14
IS 1
BP 83
EP 96
DI 10.1016/0166-6851(85)90108-2
PG 14
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA ACR79
UT WOS:A1985ACR7900009
PM 3885031
OA Green Published
DA 2020-12-17
ER

PT J
AU CRUZ, AK
   KIDANE, G
   PIRES, MQ
   RABINOVITCH, L
   GUAYCURUS, TV
   MOREL, CM
AF CRUZ, AK
   KIDANE, G
   PIRES, MQ
   RABINOVITCH, L
   GUAYCURUS, TV
   MOREL, CM
TI AN SAU3AI RESTRICTION ENDONUCLEASE ISOSCHIZOMER FROM BACILLUS-CEREUS
SO FEBS LETTERS
LA English
DT Article
C1 INST OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, AV BRASIL 4365, BR-21040 RIO DE JANEIRO, BRAZIL.
   INST OSWALDO CRUZ, DEPT BACTERIOL, BR-21040 RIO DE JANEIRO, BRAZIL.
RI Rabinovitch, Leon/F-1053-2013; Morel, Carlos M/B-4079-2009; Cruz, Angela
   Kaysel/N-8445-2014; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Cruz, Angela
   Kaysel/0000-0002-4260-4713; Morel, Carlos/0000-0003-2752-0009
CR GREENE PJ, 1978, NUCLEIC ACIDS RES, V5, P2373, DOI 10.1093/nar/5.7.2373
   KATZ L, 1973, J BACTERIOL, V114, P577, DOI 10.1128/JB.114.2.577-591.1973
   MCCLELLAND M, 1983, NUCLEIC ACIDS RES, V11, pR169
   Pirrotta V, 1980, Methods Enzymol, V65, P89
   ROBERTS RJ, 1983, NUCLEIC ACIDS RES, V11, pR135
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X
   SUSSMAN R, 1962, CR HEBD ACAD SCI, V254, P1517
   VANHEUVERSWYN H, 1977, NUCLEIC ACIDS RES, V4, P1015, DOI 10.1093/nar/4.4.1015
   VOLCKAERT G, 1977, ANAL BIOCHEM, V83, P222, DOI 10.1016/0003-2697(77)90530-9
NR 10
TC 7
Z9 7
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PY 1984
VL 173
IS 1
BP 99
EP 102
DI 10.1016/0014-5793(84)81025-X
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA TC725
UT WOS:A1984TC72500022
PM 6086403
OA Bronze
DA 2020-12-17
ER

PT J
AU LOPES, UG
   MOMEN, H
   GRIMALDI, G
   MARZOCHI, MCA
   PACHECO, RS
   MOREL, CM
AF LOPES, UG
   MOMEN, H
   GRIMALDI, G
   MARZOCHI, MCA
   PACHECO, RS
   MOREL, CM
TI SCHIZODEME AND ZYMODEME CHARACTERIZATION OF LEISHMANIA IN THE
   INVESTIGATION OF FOCI OF VISCERAL AND CUTANEOUS LEISHMANIASIS
SO JOURNAL OF PARASITOLOGY
LA English
DT Article
C1 FDN OSWALDO CRUZ, DEPT BIOQUIM & BIOL MOLEC, AVE BRASIL, 4365 MANGUINHOS, BR-21040 RIO DE JANEIRO, RJ, BRAZIL.
RI Momen, Hooman/A-1850-2008; Lopes, Ulisses/N-4416-2013; Lopes, Ulisses
   Gazos/T-6634-2019; Morel, Carlos M/B-4079-2009; Morel,
   Carlos/Q-9657-2019
OI Momen, Hooman/0000-0002-2324-1515; Morel, Carlos M/0000-0003-2752-0009;
   Morel, Carlos/0000-0003-2752-0009
CR ARNOT DE, 1981, MOL BIOCHEM PARASIT, V3, P47, DOI 10.1016/0166-6851(81)90076-1
   BARBOSA W, 1976, ANN TROP MED PARASIT, V70, P389, DOI 10.1080/00034983.1976.11687138
   Barker D. C., 1982, Biochemical characterization of Leishmania. Proceedings of a Workshop held at Pan American Health Organization, Washington, DC, 9-11 December 1980. [Editors: Chance, M.L.;Walton, B.C.], P139
   BARKER DC, 1983, T ROY SOC TROP MED H, V77, P285, DOI 10.1016/0035-9203(83)90146-3
   BARRETT TV, 1980, T ROY SOC TROP MED H, V74, P84, DOI 10.1016/0035-9203(80)90016-4
   CAMARGO EP, 1982, J PROTOZOOL, V29, P251, DOI 10.1111/j.1550-7408.1982.tb04022.x
   CHANCE ML, 1974, ANN TROP MED PARASIT, V68, P307, DOI 10.1080/00034983.1974.11686953
   CHANCE ML, 1982, 1980 P WORKSH PAN AM
   CHANCE ML, 1979, PROBLEMS IDENTIFICAT
   FRASCH ACC, 1981, MOL BIOCHEM PARASIT, V4, P163, DOI 10.1016/0166-6851(81)90015-3
   Gardener P J, 1977, Trop Dis Bull, V74, P1069
   GARDENER PJ, 1974, ANN TROP MED PARASIT, V68, P317, DOI 10.1080/00034983.1974.11686954
   GARNHAM PCC, 1971, B WORLD HEALTH ORGAN, V44, P477
   GONCALVES AM, 1984, APPLICATION BIOCH MO
   GREENE PJ, 1978, NUCLEIC ACIDS RES, V5, P2373, DOI 10.1093/nar/5.7.2373
   GUTTERIDGE WE, 1969, J PROTOZOOL, V16, P521, DOI 10.1111/j.1550-7408.1969.tb02311.x
   Harris H, 1976, HDB ENZYME ELECTROPH
   Lainson R., 1979, P1
   LAINSON R, 1972, BRIT MED BULL, V28, P44, DOI 10.1093/oxfordjournals.bmb.a070892
   LOPES UG, 1982, THESIS U FEDERAL MIN
   LUMSDEN WHR, 1977, ANN SOC BELG MED TR, V57, P361
   MARZOCHI M.C.A., 1980, REV INST MED TROP SP, V22, P97
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239
   MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980
   MIYAKE J, 1977, LKB310 APPL NOT
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   MOREL C, 1980, AM J TROP MED HYG, V29, P1070, DOI 10.4269/ajtmh.1980.29.1070
   NEWTON BA, 1976, BIOL KINETOPLASTIDA, V1
   PESSOA SAMUEL B., 1961, ARQ HIG E SAUDE PUBL, V26, P41
   SALAZAR HC, 1979, RES MED, V8, P19
   Simpson L., 1981, Modern genetic concepts and techniques in the study of parasites. Proceedings of a Symposium held in Geneva, Switzerland, 27-29 May 1980, by UNDP/WORLD BANK/WHO Special Programme for Research and Training in Tropical Diseases., P65
   SMITH HO, 1973, J MOL BIOL, V81, P419, DOI 10.1016/0022-2836(73)90152-6
NR 33
TC 58
Z9 61
U1 0
U2 1
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0022-3395
EI 1937-2345
J9 J PARASITOL
JI J. Parasitol.
PY 1984
VL 70
IS 1
BP 89
EP 98
DI 10.2307/3281930
PG 10
WC Parasitology
SC Parasitology
GA TC371
UT WOS:A1984TC37100011
PM 6204035
DA 2020-12-17
ER

PT J
AU DEANE, MP
   SOUSA, MA
   PEREIRA, NM
   GONCALVES, AM
   MOMEN, H
   MOREL, CM
AF DEANE, MP
   SOUSA, MA
   PEREIRA, NM
   GONCALVES, AM
   MOMEN, H
   MOREL, CM
TI TRYPANOSOMA-CRUZI - INOCULATION SCHEDULES AND RE-ISOLATION METHODS
   SELECT INDIVIDUAL STRAINS FROM DOUBLY INFECTED MICE, AS DEMONSTRATED BY
   SCHIZODEME AND ZYMODEME ANALYSES
SO JOURNAL OF PROTOZOOLOGY
LA English
DT Article
C1 OSWALDO CRUZ INST,DEPT BIOCHEM & MOLEC BIOL,BR-21040 RIO DE JANEIRO,RJ,BRAZIL.
RP DEANE, MP (corresponding author), OSWALDO CRUZ INST,DEPT PROTOZOOL,AV BRASIL 4365,BR-21040 RIO DE JANEIRO,RJ,BRAZIL.
RI Morel, Carlos M/B-4079-2009; Momen, Hooman/A-1850-2008; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Momen, Hooman/0000-0002-2324-1515;
   Morel, Carlos/0000-0003-2752-0009
CR ANDRADE S. G., 1974, Revista de Patologia Tropical, V3, P65
   ANDRADE S G, 1970, Revista do Instituto de Medicina Tropical de Sao Paulo, V12, P395
   Andrade S.G., 1981, Revista do Instituto de Medicina Tropical de Sao Paulo, V23, P245
   Andrade S. G., 1979, Revista Medica da Bahia, V25, P256
   BARRETT TV, 1980, T ROY SOC TROP MED H, V74, P84, DOI 10.1016/0035-9203(80)90016-4
   Brener Z., 1980, Advances in Parasitology, V18, P247, DOI 10.1016/S0065-308X(08)60401-7
   BRENER Z, 1979, TRYPANOSOMA CRUZI DO, P1
   Cancado J.R., 1979, TRYPANOSOMA CRUZI DO, P362
   COVER B, 1981, T ROY SOC TROP MED H, V75, P274, DOI 10.1016/0035-9203(81)90334-5
   DEANE MP, 1974, EXP PARASITOL, V35, P406, DOI 10.1016/0014-4894(74)90046-0
   DEANE MP, 1963, J PROTOZOOL, V10, P391, DOI 10.1111/j.1550-7408.1963.tb01694.x
   EBERT F, 1982, TROPENMED PARASITOL, V33, P137
   GONCALVES AM, 1983, APPLICATION BIOCH MO
   GRIMALDI G, 1982, INT J PARASITOL, V12, P185, DOI 10.1016/0020-7519(82)90015-7
   HOFF R, 1974, J PARASITOL, V60, P527, DOI 10.2307/3278377
   KAGAN IG, 1961, J INFECT DIS, V108, P213, DOI 10.1093/infdis/108.2.213
   KRETTLI AU, 1979, CLIN EXP IMMUNOL, V37, P416
   KRETTLI AU, 1980, C INSERM CANCER IMMU, V97, P553
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   MILES MA, 1980, T ROY SOC TROP MED H, V74, P221, DOI 10.1016/0035-9203(80)90251-5
   MILES MA, 1977, T ROY SOC TROP MED H, V71, P217, DOI 10.1016/0035-9203(77)90012-8
   MILES MA, 1981, LANCET, V1, P1338
   MIYAKE J, 1977, LKB310 APPL NOT
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   MOREL C, 1980, AM J TROP MED HYG, V29, P1070, DOI 10.4269/ajtmh.1980.29.1070
   NUSSENZWEIG V, 1966, EXP PARASITOL, V18, P224, DOI 10.1016/0014-4894(66)90020-8
   NUSSENZWEIG V, 1963, EXP PARASITOL, V14, P221, DOI 10.1016/0014-4894(63)90027-4
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Silva L. H. P., 1953, FOLIA CLIN BIOL, V20, P191
   SILVA LHP, 1959, REV INST MED TROP SP, V1, P99
NR 30
TC 62
Z9 63
U1 0
U2 2
PU SOC PROTOZOOLOGISTS
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044
SN 0022-3921
J9 J PROTOZOOL
PY 1984
VL 31
IS 2
BP 276
EP 280
DI 10.1111/j.1550-7408.1984.tb02960.x
PG 5
WC Zoology
SC Zoology
GA SY945
UT WOS:A1984SY94500013
PM 6433005
DA 2020-12-17
ER

PT J
AU CAMARGO, EP
   MATTEI, DM
   BARBIERI, CL
   MOREL, CM
AF CAMARGO, EP
   MATTEI, DM
   BARBIERI, CL
   MOREL, CM
TI ELECTROPHORETIC ANALYSIS OF ENDONUCLEASE-GENERATED FRAGMENTS OF K-DNA,
   OF ESTERASE ISOENZYMES, AND OF SURFACE-PROTEINS AS AIDS FOR SPECIES
   IDENTIFICATION OF INSECT TRYPANOSOMATIDS
SO JOURNAL OF PROTOZOOLOGY
LA English
DT Article
C1 FUNDACAO OSWALDO CRUZ, BR-21040 RIO DE JANEIRO, BRAZIL.
RP CAMARGO, EP (corresponding author), ESCOLA PAULISTA MED, DEPT MICRO IMMUNO & PARASITOL, BR-04023 SAO PAULO, SP, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Mattei, Denise M/B-1088-2014; Camargo,
   Erney P/A-6765-2009; Barbieri, Clara L./E-1505-2012; Morel,
   Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Camargo, Erney
   P/0000-0003-0011-5871; Barbieri, Clara L./0000-0001-9426-2308; Morel,
   Carlos/0000-0003-2752-0009
CR BAGSTER IA, 1973, NATURE, V244, P364, DOI 10.1038/244364a0
   BECKER Y, 1959, B RES COUNC ISRAEL E, V8, P147
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   CAMARGO EP, 1978, EXP PARASITOL, V46, P141, DOI 10.1016/0014-4894(78)90125-X
   CARVALHO A. L. M., 1973, Revista de Patologia Tropical, V2, P223
   Chance M. L., 1979, Problems in the identification of parasites and their vectors. (Symp. Brit. Soc. Parasit., Vol.17, London, 27 Oct. 1978). [Edited : Taylor, A.E.R.; Muller, R.]., P55
   CHANG KP, 1975, J PROTOZOOL, V22, P271, DOI 10.1111/j.1550-7408.1975.tb05866.x
   Cleveland LR, 1930, AM J HYG, V12, P614, DOI 10.1093/oxfordjournals.aje.a115287
   COSGROVE WB, 1963, EXP PARASITOL, V13, P173, DOI 10.1016/0014-4894(63)90067-5
   DAGGETT PM, 1972, J PARASITOL, V58, P946, DOI 10.2307/3286591
   DOORIS PM, 1976, J PROTOZOOL, V23, P433, DOI 10.1111/j.1550-7408.1976.tb03805.x
   FIGUEIREDO EN, 1978, J PROTOZOOL, V25, P546, DOI 10.1111/j.1550-7408.1978.tb04184.x
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   GALINARI S, 1978, EXP PARASITOL, V46, P277, DOI 10.1016/0014-4894(78)90141-8
   GREENE PJ, 1978, NUCLEIC ACIDS RES, V5, P2373, DOI 10.1093/nar/5.7.2373
   GUTTMAN HN, 1967, J PROTOZOOL, V14, P267, DOI 10.1111/j.1550-7408.1967.tb01996.x
   GUTTMAN HN, 1963, EXP PARASITOL, V14, P129, DOI 10.1016/0014-4894(63)90017-1
   GUTTMAN HN, 1964, BIOCHEMISTRY PHYSIOL, V3, P459
   HALEVY S, 1962, B RES COUNC ISRAEL, VE 10, P65
   HILL GC, 1971, BIOCHIM BIOPHYS ACTA, V243, P225, DOI 10.1016/0005-2795(71)90079-1
   HOARE CA, 1966, NATURE, V212, P1385, DOI 10.1038/2121385a0
   JANOVY J, 1974, J PROTOZOOL, V21, P53, DOI 10.1111/j.1550-7408.1974.tb03616.x
   KILGOUR V, 1973, NATURE-NEW BIOL, V244, P69
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEON W, 1980, BIOCHIM BIOPHYS ACTA, V607, P221, DOI 10.1016/0005-2787(80)90075-1
   LIMA WMQ, 1979, J PROTOZOOL, V26, P648
   Lwoff M, 1940, RECHERCHES POUVOIR S
   MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980
   MCGHEE RB, 1969, J PROTOZOOL, V16, P514, DOI 10.1111/j.1550-7408.1969.tb02310.x
   MEYER H, 1966, J BIOL CHEM, V241, P5000
   MILES MA, 1980, T ROY SOC TROP MED H, V74, P221, DOI 10.1016/0035-9203(80)90251-5
   MILES MA, 1979, BIOL KINETOPLASTIDA, V2, P117
   MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810
   MUNDIM MH, 1977, J PROTOZOOL, V24, P329, DOI 10.1111/j.1550-7408.1977.tb00988.x
   Newton B. A., 1972, Comparative biochemistry of parasites,, P127
   NEWTON BA, 1973, T ROY SOC TROP MED H, V67, P259, DOI 10.1016/0035-9203(73)90161-2
   NEWTON BA, 1976, BIOL KINETOPLASTIDA, V1, P406
   Noguchi H, 1926, J EXP MED, V44, P327, DOI 10.1084/jem.44.3.327
   Noguchi H, 1926, J EXP MED, V44, P307, DOI 10.1084/jem.44.3.307
   PLESSMANNCAMARGO E, 1978, J PARASITOL, V64, P1120, DOI 10.2307/3279739
   READY PD, 1980, T ROY SOC TROP MED H, V74, P238, DOI 10.1016/0035-9203(80)90252-7
   ROGERS WE, 1971, J PROTOZOOL, V18, P645, DOI 10.1111/j.1550-7408.1971.tb03390.x
   ROITMAN C, 1972, J PROTOZOOL, V19, P346, DOI 10.1111/j.1550-7408.1972.tb03473.x
   ROITMAN I, 1977, J PROTOZOOL, V24, P553, DOI 10.1111/j.1550-7408.1977.tb01013.x
   ROITMAN I, 1976, J PROTOZOOL, V23, P291, DOI 10.1111/j.1550-7408.1976.tb03773.x
   SCHMITTNER SM, 1970, J PARASITOL, V56, P684, DOI 10.2307/3277713
   Vickerman K., 1976, P1
   VICKERMAN K, 1976, BIOLOGY KINETOPLASTI, V1, P35
   VITETTA ES, 1968, J GEN MICROBIOL, V50, P67, DOI 10.1099/00221287-50-1-67
   VITETTA ES, 1967, J GEN MICROBIOL, V48, P45, DOI 10.1099/00221287-48-1-45
   VONBRAND T, 1951, BIOCH PHYSL PROTOZOA, V1, P177
   Wallace F. G., 1977, Protozoology, V3, P51
   WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4
   WALLACE FG, 1979, BIOL KINETOPLASTIDA, V2, P213
   WERTLIEB DM, 1963, J PROTOZOOL, V10, P109, DOI 10.1111/j.1550-7408.1963.tb01644.x
   YOSHIDA N, 1975, J PROTOZOOL, V22, P128, DOI 10.1111/j.1550-7408.1975.tb00957.x
   YOSHIDA N, 1978, J PROTOZOOL, V25, P550, DOI 10.1111/j.1550-7408.1978.tb04185.x
   YOSHIDA N, 1978, J BACTERIOL, V136, P1184, DOI 10.1128/JB.136.3.1184-1186.1978
NR 60
TC 35
Z9 36
U1 0
U2 1
PU SOC PROTOZOOLOGISTS
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0022-3921
J9 J PROTOZOOL
PY 1982
VL 29
IS 2
BP 251
EP 258
DI 10.1111/j.1550-7408.1982.tb04022.x
PG 8
WC Zoology
SC Zoology
GA PA178
UT WOS:A1982PA17800019
PM 6284925
DA 2020-12-17
ER

PT J
AU MOREL, C
   LANGEARD, M
   VERGNAUD, M
   MONROCQ, N
AF MOREL, C
   LANGEARD, M
   VERGNAUD, M
   MONROCQ, N
TI LUNG-TISSUE DIFFUSION OF INTRAVENOUS TRIMETHOPRIM-SULFAMETHOXAZOLE
   COMBINATION
SO PATHOLOGIE BIOLOGIE
LA French
DT Article
RP MOREL, C (corresponding author), CHU CAEN,MICROBIOL LAB,F-1400 CAEN,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x
   BUSHBY SRM, 1969, POSTGRAD MED J     S, V45, P10
   Craig WA, 1973, J INFECT DIS S, V128
   HAMILTONMILLER JMT, 1979, J ANTIMICROB CHEMOTH, V5, P61, DOI 10.1093/jac/5.Supplement_B.61
   HANSEN I, 1973, CHEMOTHERAPY, V19, P221, DOI 10.1159/000221459
   HUGHES DTD, 1973, J INFECTIOUS DISEA S, V128, P701
   MOREL C, 1979, MED MALADIES INFECT, V9, P217, DOI 10.1016/S0399-077X(79)80051-7
   REEVES DS, 1979, INFECTION S4, V7, P330
NR 8
TC 2
Z9 2
U1 0
U2 0
PU EXPANSION SCI FRANCAISE
PI PARIS
PA 31 BLVD LATOUR MAUBOURG, 75007 PARIS, FRANCE
SN 0369-8114
J9 PATHOL BIOL
JI Pathol. Biol.
PY 1982
VL 30
IS 6
BP 380
EP 384
PG 5
WC Pathology
SC Pathology
GA NV077
UT WOS:A1982NV07700011
PM 7050846
DA 2020-12-17
ER

PT J
AU MOREL, C
   SIMPSON, L
AF MOREL, C
   SIMPSON, L
TI CHARACTERIZATION OF PATHOGENIC TRYPANOSOMATIDAE BY RESTRICTION
   ENDONUCLEASE FINGERPRINTING OF KINETOPLAST DNA MINICIRCLES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
C1 UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024.
RP MOREL, C (corresponding author), FDN OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,AV BRASIL 4365,RIO DE JANEIRO 21040,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR AFCHAIN D, 1973, Protistologica, V9, P213
   AFCHAIN D, 1976, THESIS LILLE
   BAKER JR, 1978, AM J TROP MED HYG, V27, P483, DOI 10.4269/ajtmh.1978.27.483
   Brack C., 1976, P211
   BRENER Z, 1977, Pan American Health Organization Scientific Publication, V347, P11
   CAMARGO EP, 1978, EXP PARASITOL, V46, P141, DOI 10.1016/0014-4894(78)90125-X
   CAMARGO EP, 1979, JUL C INT DOENC CHAG, pM14
   Chance M. L., 1979, Problems in the identification of parasites and their vectors. (Symp. Brit. Soc. Parasit., Vol.17, London, 27 Oct. 1978). [Edited : Taylor, A.E.R.; Muller, R.]., P55
   EBERT F, 1978, PARASITOL, V29, P115
   GODFREY DG, 1976, T ROY SOC TROP MED H, V70, P219, DOI 10.1016/0035-9203(76)90043-2
   HUTNER SH, 1979, BIOL KINETOPLASTIDA, V2, P653
   LAINSON R, 1979, BIOL KINETOPLASTIDA, V2, P1
   LEON W, 1980, BIOCHIM BIOPHYS ACTA, V607, P221, DOI 10.1016/0005-2787(80)90075-1
   LUMSDEN WHR, 1974, T ROY SOC TROP MED H, V68, P74, DOI 10.1016/0035-9203(74)90261-2
   LUMSDEN WHR, 1977, ANN SOC BELG MED TR, V57, P361
   LUMSDEN WHR, 1979, BIOL KINETOPLASTIDA, V2, P693
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   MILES MA, 1979, BIOL KINETOPLASTIDA, V2, P117
   MUHLPFORDT H, 1977, TROPENMED PARASITOL, V28, P1
   MUHLPFORDT H, 1975, TROPENMED PARASITOL, V26, P239
   NEWTON BA, 1976, BIOLOGY KINETOPLASTI, V1, P405
   ROMANHA AJ, 1979, COMP BIOCHEM PHYS B, V62, P139, DOI 10.1016/0305-0491(79)90299-2
   ROMANHA AJ, 1979, JUL C INT DOENC CHAG, P70
   SCHLEMPER BR, 1979, JUL C INT SOBR DOENC, P35
   VICKERMAN K, 1976, BIOL KINETOPLASTIDA, V1, P1
NR 25
TC 38
Z9 38
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DRIVE SUITE 130, MCLEAN, VA 22101
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 1980
VL 29
IS 5
BP 1070
EP 1074
DI 10.4269/ajtmh.1980.29.1070
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KW127
UT WOS:A1980KW12700008
PM 6254386
OA Green Published
DA 2020-12-17
ER

PT J
AU GALLER, R
   VANHEUVERSWYN, H
   MULLER, RU
   TEDESCHI, V
   CALCAGNOTTO, AM
   CARDOSO, MAB
   MAGALHAES, MMR
   MOREL, C
AF GALLER, R
   VANHEUVERSWYN, H
   MULLER, RU
   TEDESCHI, V
   CALCAGNOTTO, AM
   CARDOSO, MAB
   MAGALHAES, MMR
   MOREL, C
TI MOLECULAR-CLONING OF KINETOPLAST DNA MINICIRCLE SEQUENCES FROM
   TRYPANOSOMA-CRUZI
SO ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES
LA English
DT Meeting Abstract
C1 FDN OSWALDO CRUZ,DEPT BIOQUIM & BIOL MOLEC,RIO DE JANEIRO,RJ,BRAZIL.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC BIOL CHILE
PI SANTIAGO
PA CASILLA 14164 CORREO, SANTIAGO 9, CHILE
SN 0004-0533
J9 ARCH BIOL MED EXP
PY 1980
VL 13
IS 4
BP 456
EP 456
PG 1
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA MH542
UT WOS:A1980MH54200021
DA 2020-12-17
ER

PT J
AU MOREL, C
   CHIARI, E
   CAMARGO, EP
   MATTEI, DM
   ROMANHA, AJ
   SIMPSON, L
AF MOREL, C
   CHIARI, E
   CAMARGO, EP
   MATTEI, DM
   ROMANHA, AJ
   SIMPSON, L
TI STRAINS AND CLONES OF TRYPANOSOMA-CRUZI CAN BE CHARACTERIZED BY PATTERN
   OF RESTRICTION ENDONUCLEASE PRODUCTS OF KINETOPLAST DNA MINICIRCLES
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA-BIOLOGICAL SCIENCES
LA English
DT Article
C1 UNIV FED MINAS GERAIS, ICB, BELO HORIZONTE 30000, MG, BRAZIL.
   ESCOLA PAULISTA MED, SAO PAULO 04023, SP, BRAZIL.
   UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA.
   FIOCRUZ, CTR PESOULSAS RENE RACHOU, BELO HORIZONTE 30000, MG, BRAZIL.
   UNIV CALIF LOS ANGELES, DEPT BIOL, LOS ANGELES, CA 90024 USA.
RP MOREL, C (corresponding author), FDN OSWALDO CRUZ, AVE BRASIL 4365, RIO DE JANEIRO 21040, RJ, BRAZIL.
RI Camargo, Erney P/A-6765-2009; Morel, Carlos/Q-9657-2019; Morel, Carlos
   M/B-4079-2009; Mattei, Denise M/B-1088-2014
OI Camargo, Erney P/0000-0003-0011-5871; Morel, Carlos/0000-0003-2752-0009;
   Morel, Carlos M/0000-0003-2752-0009; 
CR ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350
   BAKER JR, 1978, AM J TROP MED HYG, V27, P483, DOI 10.4269/ajtmh.1978.27.483
   Brack C., 1976, P211
   BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220
   BRENER Z, 1977, Pan American Health Organization Scientific Publication, V347, P11
   BRENER Z, 1979, TRYPANOSOMA CRUZI DO
   BRUNK CF, 1977, ANAL BIOCHEM, V82, P455, DOI 10.1016/0003-2697(77)90183-X
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   Chance M. L., 1979, Problems in the identification of parasites and their vectors. (Symp. Brit. Soc. Parasit., Vol.17, London, 27 Oct. 1978). [Edited : Taylor, A.E.R.; Muller, R.]., P55
   GILMOUR J S, 1954, Genetica, V27, P147, DOI 10.1007/BF01664158
   GOLDBERG SS, 1980, J PARASITOL, V66, P677, DOI 10.2307/3280531
   GREENE PJ, 1978, NUCLEIC ACIDS RES, V5, P2373, DOI 10.1093/nar/5.7.2373
   LEON W, 1980, BIOCHIM BIOPHYS ACTA, V607, P221, DOI 10.1016/0005-2787(80)90075-1
   LUMSDEN WHR, 1977, ANN SOC BELG MED TR, V57, P361
   MASUDA H, 1979, GENE, V6, P51, DOI 10.1016/0378-1119(79)90085-4
   MATTEI DM, 1977, FEBS LETT, V74, P264, DOI 10.1016/0014-5793(77)80860-0
   MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0
   MILES MA, 1977, T ROY SOC TROP MED H, V71, P217, DOI 10.1016/0035-9203(77)90012-8
   MILES MA, 1979, BIOL KINETOPLASTIDA, V2, P117
   RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3
   RIOU GF, 1977, BIOCHEMISTRY-US, V16, P2390, DOI 10.1021/bi00630a013
   RIOU GF, 1978, BIOCHIMIE, V60, P365, DOI 10.1016/S0300-9084(78)80670-1
   ROMANHA AJ, 1979, COMP BIOCHEM PHYS B, V62, P139, DOI 10.1016/0305-0491(79)90299-2
   ROMANHA AJ, 1979, 1979 C INT DOENC CHA
   Silva L. H. P., 1953, FOLIA CLIN BIOL, V20, P191
   SIMPSON L, 1974, J PROTOZOOL, V21, P382, DOI 10.1111/j.1550-7408.1974.tb03675.x
   SIMPSON L, 1979, P NATL ACAD SCI USA, V76, P1585, DOI 10.1073/pnas.76.4.1585
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
NR 28
TC 297
Z9 300
U1 1
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI-BIOL
PY 1980
VL 77
IS 11
BP 6810
EP 6814
DI 10.1073/pnas.77.11.6810
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KT322
UT WOS:A1980KT32200107
PM 6256762
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU BERGOGNEBEREZIN, E
   BERTHELOT, G
   KAFE, H
   MOREL, C
AF BERGOGNEBEREZIN, E
   BERTHELOT, G
   KAFE, H
   MOREL, C
TI PENETRATION OF AMPICILLIN INTO HUMAN BRONCHIAL-SECRETIONS
SO INFECTION
LA English
DT Article
C1 CTR HOSP REG CAEN,DEPT MICROBIOL,F-14033 CAEN,FRANCE.
RP BERGOGNEBEREZIN, E (corresponding author), HOP BICHAT,DEPT MICROBIOL,F-75877 PARIS 18,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR BARZA M, 1974, J INFECT DIS, P59
   BERGOGNEBEREZIN E, 1976, MED MAL INFECT, V6, P134
   BODIN NO, 1975, ANTIMICROB AGENTS CH, V8, P518, DOI 10.1128/AAC.8.5.518
   GROVE DC, 1955, MEDICAL ENCYCLOPEDIA
   MAY J R, 1963, Tubercle, V44, P162, DOI 10.1016/S0041-3879(63)80070-7
   MAY JR, 1965, LANCET, V1, P929
   PENNINGTON JE, 1976, IMMUNOLOGIC INFECTIO
NR 7
TC 7
Z9 7
U1 0
U2 0
PU MMW MEDIZIN VERLAG GMBH
PI MUNICH 80
PA NEUMARKTER STRASSE 18, W-8000 MUNICH 80, GERMANY
SN 0300-8126
J9 INFECTION
JI Infection
PY 1979
VL 7
SU 5
BP S463
EP S464
DI 10.1007/BF01659772
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA HK381
UT WOS:A1979HK38100009
PM 511358
DA 2020-12-17
ER

PT J
AU MOREL, C
   BERGOGNEBEREZIN, E
   BENARD, Y
AF MOREL, C
   BERGOGNEBEREZIN, E
   BENARD, Y
TI BRONCHIAL DIFFUSION OF TRIMETHOPRIM-SULFAMETHOXAZOLE
SO MEDECINE ET MALADIES INFECTIEUSES
LA French
DT Article
RP MOREL, C (corresponding author), CTR HOSP UNIV CAEN, MICROBIOL LAB, F-14033 CAEN, FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
NR 0
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0399-077X
J9 MED MALADIES INFECT
JI Med. Mal. Infect.
PY 1979
VL 9
IS 4
BP 217
EP 222
DI 10.1016/S0399-077X(79)80051-7
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA HA298
UT WOS:A1979HA29800005
DA 2020-12-17
ER

PT J
AU BERGOGNEBEREZIN, E
   BERTHELOT, G
   KAFE, H
   LAMBERTZECHOVSKY, N
   MOREL, C
   BENARD, Y
AF BERGOGNEBEREZIN, E
   BERTHELOT, G
   KAFE, H
   LAMBERTZECHOVSKY, N
   MOREL, C
   BENARD, Y
TI STUDY ON THE PENETRATION OF TETRACYCLINES INTO BRONCHIAL-SECRETIONS
SO MEDECINE ET MALADIES INFECTIEUSES
LA French
DT Article
RP BERGOGNEBEREZIN, E (corresponding author), HOP BICHAT,SERV CENT MICROBIOL,F-75877 PARIS 18,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SOC FRANCAISE EDITION MED
PI PARIS
PA 22-24 RUE DU CHATEAU RENTIERS, 75013 PARIS, FRANCE
SN 0399-077X
J9 MED MALADIES INFECT
JI Med. Mal. Infect.
PY 1979
VL 9
IS 12
BP 688
EP 692
DI 10.1016/S0399-077X(79)80070-0
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA JA870
UT WOS:A1979JA87000003
DA 2020-12-17
ER

PT J
AU BERGOGNEBEREZIN, E
   MOREL, C
   BENARD, Y
   BERTHELOT, G
   KAFE, H
AF BERGOGNEBEREZIN, E
   MOREL, C
   BENARD, Y
   BERTHELOT, G
   KAFE, H
TI PHARMACOKINETIC STUDY OF BETA-LACTAM ANTIBIOTICS IN BRONCHIAL-SECRETIONS
SO SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
C1 CTR HOSP REG CAEN,MICROBIOL LAB,CAEN,FRANCE.
   PITIE SALPETRIERE HOSP,PARIS,FRANCE.
RP BERGOGNEBEREZIN, E (corresponding author), BICHAT HOSP,MICROBIOL LAB,PARIS,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR BODIN NO, 1975, ANTIMICROB AGENTS CH, V8, P518, DOI 10.1128/AAC.8.5.518
   CROFTON J, 1969, BMJ-BRIT MED J, V2, P209, DOI 10.1136/bmj.2.5651.209
   FISHMAN RA, 1966, ARCH NEUROL-CHICAGO, V15, P113, DOI 10.1001/archneur.1966.00470140003001
   GROVE DC, 1955, ASSAY METHOD ANTIBIO
   HAFEZ FF, 1965, THORAX, V20, P219, DOI 10.1136/thx.20.3.219
   HALPRIN GM, 1973, ANTIMICROB AGENTS CH, V3, P703, DOI 10.1128/AAC.3.6.703
   Hogben C. A. M., 1971, HDB EXPT PHARMACOL 1, V28, P1
   INGOLD A, 1975, BRIT J DIS CHEST, V69, P211, DOI 10.1016/0007-0971(75)90082-0
   MAY JR, 1965, LANCET, V1, P929
   MAY JR, 1964, POSTGRAD MED J, VS 40, P193, DOI 10.1136/pgmj.40.Suppl.193
   PENNINGTON JE, 1973, J INFECT DIS, V128, P63, DOI 10.1093/infdis/128.1.63
   PENNINGTON JE, 1976, IMMUNOLOGIC INFECTIO, P355
   SAGGERS BA, 1968, ARCH DIS CHILD, V43, P404, DOI 10.1136/adc.43.230.404
   STEWART SM, 1970, THORAX, V25, P304, DOI 10.1136/thx.25.3.304
   WONG GS, 1973, JAMA, V59, P219
NR 15
TC 12
Z9 12
U1 0
U2 1
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0036-5548
J9 SCAND J INFECT DIS
JI Scand. J. Infect. Dis.
PY 1978
SU 14
BP 267
EP 272
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FS332
UT WOS:A1978FS33200032
PM 279981
DA 2020-12-17
ER

PT J
AU MATTEI, DM
   GOLDENBERG, S
   MOREL, C
   AZEVEDO, HP
   ROITMAN, I
AF MATTEI, DM
   GOLDENBERG, S
   MOREL, C
   AZEVEDO, HP
   ROITMAN, I
TI BIOCHEMICAL STRAIN CHARACTERIZATION OF TRYPANOSOMA-CRUZI BY RESTRICTION
   ENDONUCLEASE CLEAVAGE OF KINETOPLAST-DNA
SO FEBS LETTERS
LA English
DT Article
C1 UNIV BRASILIA, DEPT BIOL CELULAR, BIOQUIM LAB, BRASILIA 70000, BRAZIL.
   UNIV BRASILIA, DEPT BIOL CELULAR, MICROBIOL & IMMUNOL LAB, BRASILIA 70000, BRAZIL.
RI P, CM/B-1358-2013; GOLDENBERG, SAMUEL/B-4116-2009; Morel,
   Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009; Mattei, Denise
   M/B-1088-2014
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; Morel,
   Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009; 
CR BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220
   Brener Z., 1974, Revista Inst Med trop Sao Paulo, V16, P39
   BRENER Z, 1976, J PROTOZOOL, V23, P147, DOI 10.1111/j.1550-7408.1976.tb05258.x
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   DANNA KJ, 1973, J MOL BIOL, V78, P363, DOI 10.1016/0022-2836(73)90122-8
   GODFREY DG, 1975, 318 AM TRYP RES PUBL, P91
   HAUSCHKA TS, 1949, J PARASITOL, V35, P593, DOI 10.2307/3273639
   KLEISEN CM, 1976, EUR J BIOCHEM, V64, P141, DOI 10.1111/j.1432-1033.1976.tb10282.x
   MURRAY K, 1975, J MOL BIOL, V98, P551, DOI 10.1016/S0022-2836(75)80086-6
   NATHANS D, 1975, ANNU REV BIOCHEM, V44, P273, DOI 10.1146/annurev.bi.44.070175.001421
   NEWTON BA, 1976, BIOLOGY KINETOPLASTI, V1, P405
   NUSSENZWEIG V, 1963, EXP PARASITOL, V14, P221, DOI 10.1016/0014-4894(63)90027-4
   POTTER SS, 1975, P NATL ACAD SCI USA, V72, P4496, DOI 10.1073/pnas.72.11.4496
   RIOU G, 1975, CR ACAD SCI D NAT, V280, P2701
   ROITMAN C, 1972, J PROTOZOOL, V19, P346, DOI 10.1111/j.1550-7408.1972.tb03473.x
   ROITMAN I, 1976, J PROTOZOOL, V23, P291, DOI 10.1111/j.1550-7408.1976.tb03773.x
   Silva L. H. P., 1953, FOLIA CLIN BIOL, V20, P191
   SIMPSON L, 1974, J PROTOZOOL, V21, P382, DOI 10.1111/j.1550-7408.1974.tb03675.x
   SIMPSON L, 1971, J MOL BIOL, V56, P443, DOI 10.1016/0022-2836(71)90394-9
   SMITH HO, 1973, J MOL BIOL, V81, P419, DOI 10.1016/0022-2836(73)90152-6
   WOLSTENHOLME DR, 1974, J PROTOZOOL, V21, P622, DOI 10.1111/j.1550-7408.1974.tb03716.x
NR 22
TC 48
Z9 48
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PY 1977
VL 74
IS 2
BP 264
EP 268
DI 10.1016/0014-5793(77)80860-0
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA CY980
UT WOS:A1977CY98000021
PM 321246
OA Bronze
DA 2020-12-17
ER

PT J
AU FAVRE, A
   MOREL, C
   SCHERRER, K
AF FAVRE, A
   MOREL, C
   SCHERRER, K
TI SECONDARY STRUCTURE AND POLY(A) CONTENT OF GLOBIN MESSENGER-RNA AS A
   PURE RNA AND IN POLYRIBOSOME-DERIVED RIBONUCLEOPROTEIN COMPLEXES
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 UNIV PARIS, CNRS, INST BIOL MOLEC, LAB BIOCHIM DEV, PARIS, FRANCE.
   INST SUISSE RECH EXPTL CANC, LAUSANNE, FRANCE.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR ADAMS JM, 1970, NATURE, V227, P570, DOI 10.1038/227570a0
   ADESNIK M, 1972, J MOL BIOL, V67, P397, DOI 10.1016/0022-2836(72)90458-5
   BLAKE RD, 1966, J MOL BIOL, V19, P145, DOI 10.1016/S0022-2836(66)80057-8
   BOBST AM, 1974, BIOCHEMISTRY-US, V13, P2129, DOI 10.1021/bi00707a021
   BOEDTKER H, 1967, BIOCHEMISTRY-US, V6, P2718, DOI 10.1021/bi00861a011
   BOLLEN A, 1970, FEBS LETT, V11, P49, DOI 10.1016/0014-5793(70)80489-6
   BRAHMS J, 1964, J MOL BIOL, V10, P73, DOI 10.1016/S0022-2836(64)80029-2
   BRODY E, 1970, COLD SPRING HARB SYM, V35, P203, DOI 10.1101/SQB.1970.035.01.028
   COTTER RI, 1967, NATURE, V216, P864, DOI 10.1038/216864a0
   DIRHEIMER G, 1972, BIOCHIMIE, V54, P127, DOI 10.1016/S0300-9084(72)80097-X
   DUBOCHET J, 1973, EUR J BIOCHEM, V36, P465, DOI 10.1111/j.1432-1033.1973.tb02931.x
   ENGLANDER JJ, 1972, J MOL BIOL, V63, P153, DOI 10.1016/0022-2836(72)90527-X
   FAVRE A, 1971, J MOL BIOL, V58, P367, DOI 10.1016/0022-2836(71)90252-X
   FAVRE A, 1972, FEBS LETT, V26, P15, DOI 10.1016/0014-5793(72)80531-3
   FAVRE A, 1974, BIOCHEM BIOPH RES CO, V56, P273, DOI 10.1016/S0006-291X(74)80344-X
   FELLNER P, 1972, NATURE-NEW BIOL, V239, P1
   GRALLA J, 1974, NATURE, V248, P330, DOI 10.1038/248330a0
   HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462
   HOUDEBINE LM, 1974, NUCLEIC ACIDS RES, V1, P413, DOI 10.1093/nar/1.3.413
   ILAN J, 1973, P NATL ACAD SCI USA, V70, P1355, DOI 10.1073/pnas.70.5.1355
   IMAIZUMI T, 1973, P NATL ACAD SCI USA, V70, P1122, DOI 10.1073/pnas.70.4.1122
   KREISHMAN GP, 1971, J MOL BIOL, V61, P45, DOI 10.1016/0022-2836(71)90205-1
   Le Pecq J B, 1971, Methods Biochem Anal, V20, P41, DOI 10.1002/9780470110393.ch2
   LINN L, 1970, NATURE, V227, P710
   Min Jou W, 1972, Nature, V237, P82
   MOLLOY GR, 1972, BIOCHEMISTRY-US, V11, P3256, DOI 10.1021/bi00767a020
   MOREL C, 1973, EUR J BIOCHEM, V36, P455, DOI 10.1111/j.1432-1033.1973.tb02930.x
   MORGAN AR, 1972, CAN J BIOCHEM CELL B, V50, P210, DOI 10.1139/o72-028
   PEMBERTON RE, 1972, J MOL BIOL, V65, P531, DOI 10.1016/0022-2836(72)90207-0
   POHL F, 1972, P NATL ACAD SCI USA, V69, P3805, DOI 10.1073/pnas.69.12.3805
   PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5
   ROSS PD, 1960, P NATL ACAD SCI USA, V46, P1360, DOI 10.1073/pnas.46.10.1360
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SCHERRER K, 1973, PROTEIN SYNTHESIS RE, P95
   SHULMAN RG, 1973, P NATL ACAD SCI USA, V70, P2042, DOI 10.1073/pnas.70.7.2042
   STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0
   STEWART AG, 1973, EUR J BIOCHEM, V34, P205, DOI 10.1111/j.1432-1033.1973.tb21105.x
   THOMAS G, 1972, FEBS LETT, V26, P169, DOI 10.1016/0014-5793(72)80566-0
   UHLENBECK OC, 1972, J MOL BIOL, V65, P25, DOI 10.1016/0022-2836(72)90489-5
   URBANKE C, 1973, EUR J BIOCHEM, V33, P511, DOI 10.1111/j.1432-1033.1973.tb02710.x
   WILLIAMSON R, 1971, BIOCHEMISTRY-US, V10, P3014, DOI 10.1021/bi00792a005
NR 41
TC 48
Z9 48
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1975
VL 57
IS 1
BP 147
EP 157
DI 10.1111/j.1432-1033.1975.tb02285.x
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AP932
UT WOS:A1975AP93200016
PM 1175639
DA 2020-12-17
ER

PT J
AU VISCARDI, RC
   OZAKI, LS
   MOREL, C
AF VISCARDI, RC
   OZAKI, LS
   MOREL, C
TI DIFFERENT SENSITIVITIES OF AVIAN-HEMOGLOBIN AND MAMMALIAN-HEMOGLOBIN
   SYNTHESIS TO ELEVATED-TEMPERATURES
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
C1 UNIV BRASILIA, DEPT BIOL CELULAR, BR-70000 BRASILIA, BRAZIL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR DUBOCHET J, 1973, EUR J BIOCHEM, V36, P465, DOI 10.1111/j.1432-1033.1973.tb02931.x
   FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4
   GANDER ES, 1973, EUR J BIOCHEM, V38, P443, DOI 10.1111/j.1432-1033.1973.tb03078.x
   GOLDSTEIN ES, 1973, J MOL BIOL, V80, P243, DOI 10.1016/0022-2836(73)90170-8
   GORDON MS, 1972, ANIMAL PHYSIOLOGY PR, P353
   HART JS, 1971, COMPARATIVE PHYSIOLO, P29
   HEYWOOD SM, 1974, P NATL ACAD SCI USA, V71, P2428, DOI 10.1073/pnas.71.6.2428
   KING JR, 1961, BIOLOGY COMPARATIVE, P277
   LEIBOWITZ R, 1971, J VIROL, V8, P661, DOI 10.1128/JVI.8.5.661-668.1971
   LINGREL JB, 1972, METHODS MOLECULAR BI, V2, P231
   LODISH HF, 1971, J BIOL CHEM, V246, P7131
   MCCORMICK W, 1969, J MOL BIOL, V39, P315, DOI 10.1016/0022-2836(69)90320-9
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   MOREL C, 1973, EUR J BIOCHEM, V36, P455, DOI 10.1111/j.1432-1033.1973.tb02930.x
   PERLMAN S, 1972, NATURE-NEW BIOL, V238, P143
   RUDLAND PS, 1974, P NATL ACAD SCI USA, V71, P750, DOI 10.1073/pnas.71.3.750
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1966, B SOC CHIM BIOL, V48, P1037
   SCHERRER K, PROTEIN SYNTHESIS RE, P95
   SCHOCHETMAN G, 1972, J MOL BIOL, V63, P577, DOI 10.1016/0022-2836(72)90449-4
   SCHREIER MH, 1973, EUR J BIOCHEM, V34, P213, DOI 10.1111/j.1432-1033.1973.tb02748.x
   Simpson S, 1905, J PHYSIOL-LONDON, V33, P225
   Spirin AS, 1966, CURRENT TOPICS DEVEL, P1
   SPRECHMAN LM, 1972, J BIOL CHEM, V247, P5004
   STEWART AG, 1973, EUR J BIOCHEM, V34, P205, DOI 10.1111/j.1432-1033.1973.tb21105.x
   TERMAN SA, 1970, P NATL ACAD SCI USA, V65, P985, DOI 10.1073/pnas.65.4.985
   TERROINE E. F., 1927, ANN PHYSIOL & PHYSICOCHIMIE BIOL, V3, P422
   TOMKINS GM, 1969, SCIENCE, V166, P1474, DOI 10.1126/science.166.3912.1474
NR 28
TC 3
Z9 3
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PY 1975
VL 2
IS 1
BP 41
EP 47
DI 10.1007/BF00357296
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA W0860
UT WOS:A1975W086000006
PM 1128516
DA 2020-12-17
ER

PT J
AU GANDER, ES
   MUELLER, RU
   GOLDENBERG, S
   MOREL, C
AF GANDER, ES
   MUELLER, RU
   GOLDENBERG, S
   MOREL, C
TI EDTA-DERIVED AND PUROMYCIN-DERIVED DUCK-GLOBIN-MESSENGER AND RABBIT
   GLOBIN-MESSENGER RIBONUCLEOPROTEIN COMPLEXES ISOLATED BY
   OLIGO(DT)-CELLULOSE CHROMATOGRAPHY
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
C1 UNIV BRASILIA,DEPT BIOL CELULAR,70000 BRASILIA,BRAZIL.
RI GOLDENBERG, SAMUEL/B-4116-2009; P, CM/B-1358-2013; Morel,
   Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI GOLDENBERG, SAMUEL/0000-0002-4892-163X; Morel,
   Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR BLOBEL G, 1972, BIOCHEM BIOPH RES CO, V47, P88, DOI 10.1016/S0006-291X(72)80014-7
   BLOBEL G, 1973, P NATL ACAD SCI USA, V70, P924, DOI 10.1073/pnas.70.3.924
   ERNST V, 1975, BIOCHIM BIOPHYS ACTA, V378, P251, DOI 10.1016/0005-2787(75)90113-6
   GANDER ES, 1973, EUR J BIOCHEM, V38, P443, DOI 10.1111/j.1432-1033.1973.tb03078.x
   GANDER ES, 1972, EUR J BIOCHEM, V29, P369, DOI 10.1111/j.1432-1033.1972.tb01998.x
   GANDER ES, IN PRESS
   HELLERMAN JG, 1975, P NATL ACAD SCI USA, V72, P1021, DOI 10.1073/pnas.72.3.1021
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEBLEU B, 1971, EUR J BIOCHEM, V19, P264, DOI 10.1111/j.1432-1033.1971.tb01313.x
   LINDBERG U, 1974, J MOL BIOL, V86, P451, DOI 10.1016/0022-2836(74)90030-8
   LUKANIDIN EM, 1972, NATURE-NEW BIOL, V238, P193, DOI 10.1038/newbio238193a0
   MATRINGE H, 1972, BIOCHIMIE, V54, P1493, DOI 10.1016/S0300-9084(72)80094-4
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   MOREL C, 1973, EUR J BIOCHEM, V36, P455, DOI 10.1111/j.1432-1033.1973.tb02930.x
   OLSNES S, 1971, EUR J BIOCHEM, V23, P557, DOI 10.1111/j.1432-1033.1971.tb01654.x
   PEDERSON T, 1974, J MOL BIOL, V83, P163, DOI 10.1016/0022-2836(74)90386-6
   WILLIAMSON R, 1973, FEBS LETT, V37, P1, DOI 10.1016/0014-5793(73)80413-2
NR 17
TC 18
Z9 18
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PY 1975
VL 2
IS 4
BP 343
EP 349
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BD345
UT WOS:A1975BD34500010
PM 814407
DA 2020-12-17
ER

PT J
AU AUDURIER, A
   CORMIER, M
   DENIS, F
   LEMELAND, J
   MOREL, C
   PELICOT, J
   PESTREALEXANDRE, M
AF AUDURIER, A
   CORMIER, M
   DENIS, F
   LEMELAND, J
   MOREL, C
   PELICOT, J
   PESTREALEXANDRE, M
TI PHAGE-TYPING OF S-AUREUS ISOLATED IN 7 HOSPITALS
SO REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
LA French
DT Article
C1 UER MED & TECH MED,LAB BACTERIOL & HYG,1 RUE GASTON VEIL,F-44035 NANTES,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR AUDURIER A, 1974, REV EPIDEMIOL SANTE, V22, P325
   AUDURIER A, 1972, ANN CHIR, V26, P1209
   BLAIR JE, 1961, B WORLD HEALTH ORGAN, V24, P771
   BLOUSE LE, 1973, P SOC EXP BIOL MED, V142, P572, DOI 10.3181/00379727-142-37069
   FOUACE J., 1970, Bull. Inst. Pasteur, V68, P799
   NAHMIAS AJ, 1972, STAPHYLOCOCCI, P483
   Parker MT, 1972, METHODS MICROBIOLO B, V7B, P1
   1971, INT J SYST BACTERIOL, V21, P165
NR 8
TC 1
Z9 1
U1 0
U2 0
PU MASSON EDITEUR
PI PARIS 06
PA 120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE
SN 0398-7620
J9 REV EPIDEMIOL SANTE
JI Rev. Epidemiol. Sante Publique
PY 1975
VL 23
IS 2
BP 83
EP 92
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA W0927
UT WOS:A1975W092700001
PM 124523
DA 2020-12-17
ER

PT J
AU FREYMUTH, F
   MOREL, C
AF FREYMUTH, F
   MOREL, C
TI VALUE OF A MICRO-COMPLEMENT FIXATION-TEST IN SEROLOGY OF RESPIRATORY
   VIRUS-INFECTIONS
SO ANNALES DE MICROBIOLOGIE
LA French
DT Article
C1 CTR HOSP UNIV CAEN,LAB VIROL,14033 CAEN,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR LENNETTE EH, 1969, AM PUB HLTH ASS, P52
   ROSENBAUM MJ, 1970, HEALTH LAB SCI, V7, P42
   Thomas M, 1973, Cah Med, V14, P99
NR 3
TC 3
Z9 3
U1 0
U2 0
PU MASSON EDITEUR
PI PARIS 06
PA 120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE
SN 0300-5410
J9 ANN INST PASTEUR MIC
PY 1974
VL A125
IS 3
BP 387
EP 393
PG 7
WC Microbiology
SC Microbiology
GA T4057
UT WOS:A1974T405700011
PM 4417373
DA 2020-12-17
ER

PT J
AU BERGOGNE.E
   ZECHOVSK.N
   MOREL, C
AF BERGOGNE.E
   ZECHOVSK.N
   MOREL, C
TI EXPERIMENTAL IN-VITRO STUDY OF NEW SEMI-SYNTHETIC PENICILLIN - EPICILLIN
SO MEDECINE ET MALADIES INFECTIEUSES
LA French
DT Article
C1 HOP BICHAT,SERV CENT MICROBIOL,PARIS,FRANCE.
   CTR HOP UNIV CAEN,SERV CENT MICROBIOL,14033 CAEN,FRANCE.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC FRANCAISE EDITION MED
PI PARIS
PA 22-24 RUE DU CHATEAU RENTIERS, 75013 PARIS, FRANCE
SN 0399-077X
J9 MED MALADIES INFECT
JI Med. Mal. Infect.
PY 1974
VL 4
IS 10
BP 551
EP &
DI 10.1016/S0399-077X(74)80006-5
PG 0
WC Infectious Diseases
SC Infectious Diseases
GA U8674
UT WOS:A1974U867400006
DA 2020-12-17
ER

PT J
AU GANDER, ES
   STEWART, AG
   MOREL, CM
   SCHERRER, K
AF GANDER, ES
   STEWART, AG
   MOREL, CM
   SCHERRER, K
TI ISOLATION AND CHARACTERIZATION OF RIBOSOME-FREE CYTOPLASMIC
   MESSENGER-RIBONUCLEOPROTEIN COMPLEXES FROM AVIAN ERYTHROBLASTS
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 SWISS INST EXPTL CANC RES, MOLEC BIOL DEPT, RUE DE BUGNON 21, LAUSANNE, SWITZERLAND.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P1881, DOI 10.1073/pnas.68.8.1881
   BRENNER M, 1962, DUNNSCHICHT CHROMATO
   BURNY A, 1969, BIOCHIM BIOPHYS ACTA, V190, P228, DOI 10.1016/0005-2787(69)90176-2
   CARTOUZOU G, 1968, EUR J BIOCHEM, V4, P41, DOI 10.1111/j.1432-1033.1968.tb00171.x
   EGLY JM, 1972, FEBS LETT, V22, P181, DOI 10.1016/0014-5793(72)80039-5
   GANDER ES, 1972, EUR J BIOCHEM, V29, P369, DOI 10.1111/j.1432-1033.1972.tb01998.x
   HENSHAW EC, 1968, J MOL BIOL, V36, P401, DOI 10.1016/0022-2836(68)90164-2
   ILAN J, 1973, NATURE-NEW BIOL, V241, P176, DOI 10.1038/newbio241176a0
   IMAIZUMI T, 1973, P NATL ACAD SCI USA, V70, P1122, DOI 10.1073/pnas.70.4.1122
   JACOBSLO.M, 1972, P NATL ACAD SCI USA, V69, P1425, DOI 10.1073/pnas.69.6.1425
   KRUH J, 1972, BIOCHEMISTRY CELL DI
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOENING UE, 1967, BIOCHEM J, V102, P251, DOI 10.1042/bj1020251
   LUKANIDIN EM, 1971, FEBS LETT, V19, P152, DOI 10.1016/0014-5793(71)80501-X
   MANGOLD HK, 1962, DUNNSCHICHT CHROMATO
   MATRINGE H, 1972, BIOCHIMIE, V54, P1493, DOI 10.1016/S0300-9084(72)80094-4
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   MOREL C, 1973, EUR J BIOCHEM, V36, P455, DOI 10.1111/j.1432-1033.1973.tb02930.x
   PERRY RP, 1968, J MOL BIOL, V35, P37, DOI 10.1016/S0022-2836(68)80035-X
   SAMARINA OP, 1968, J MOL BIOL, V33, P251, DOI 10.1016/0022-2836(68)90292-1
   SCHAPIRA G, 1966, J MOL BIOL, V20, P427, DOI 10.1016/0022-2836(66)90001-5
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1973, ACTA ENDOCRINOL-COP, P95
   SCHERRER K, 1973, 18 OHOLO BIOL C
   SCHREIER MH, 1973, J MOL BIOL, V73, P329, DOI 10.1016/0022-2836(73)90346-X
   SEIFERT W, 1971, FEBS LETT, V16, P175, DOI 10.1016/0014-5793(71)80125-4
   SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20
   SPOHR G, 1972, EUR J BIOCHEM, V31, P194, DOI 10.1111/j.1432-1033.1972.tb02519.x
   SPOHR G, 1970, EUR J BIOCHEM, V17, P296, DOI 10.1111/j.1432-1033.1970.tb01168.x
   SPOHR G, 1972, FEBS LETT, V28, P165, DOI 10.1016/0014-5793(72)80702-6
   STEWART AG, 1973, EUR J BIOCHEM, V34, P205, DOI 10.1111/j.1432-1033.1973.tb21105.x
   VENOYAMA K, 1973, J MOL BIOL, V74, P453
   WEBER K, 1969, J BIOL CHEM, V244, P4406
NR 33
TC 105
Z9 105
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1973
VL 38
IS 3
BP 443
EP 452
DI 10.1111/j.1432-1033.1973.tb03078.x
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA R0864
UT WOS:A1973R086400006
PM 4772669
DA 2020-12-17
ER

PT J
AU MOREL, C
   GANDER, ES
   HERZBERG, M
   DUBOCHET, J
   SCHERRER, K
AF MOREL, C
   GANDER, ES
   HERZBERG, M
   DUBOCHET, J
   SCHERRER, K
TI DUCK-GLOBIN MESSENGER-RIBONUCLEOPROTEIN COMPLEX - RESISTANCE TO HIGH
   IONIC-STRENGTH, PARTICLE GEL-ELECTROPHORESIS, COMPOSITION AND
   VISUALIZATION BY DARK-FIELD ELECTRON-MICROSCOPY
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 SWISS INST EXPTL CANC RES, MOLEC BIOL DEPT, CH-1011 LAUSANNE, SWITZERLAND.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR BALTIMORE D, 1970, Journal of Molecular Biology, V47, P263, DOI 10.1016/0022-2836(70)90301-3
   BARBER EJ, 1966, 21 NAT CANC I MON, P219
   BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P1881, DOI 10.1073/pnas.68.8.1881
   BOEDTKER H, 1968, J MOL BIOL, V35, P61, DOI 10.1016/S0022-2836(68)80036-1
   BRIMACOMBE R, 1971, NATURE-NEW BIOL, V231, P209, DOI 10.1038/newbio231209a0
   DAHLBERG AE, 1969, J MOL BIOL, V41, P139, DOI 10.1016/0022-2836(69)90131-4
   DUBOCHET J, 1973, EUR J BIOCHEM, V36, P465, DOI 10.1111/j.1432-1033.1973.tb02931.x
   EGLY JM, 1972, FEBS LETT, V22, P181, DOI 10.1016/0014-5793(72)80039-5
   GEORGIEV GP, 1969, J THEOR BIOL, V25, P473, DOI 10.1016/S0022-5193(69)80034-2
   GEORGIEV GP, 1963, NATURE, V200, P1291, DOI 10.1038/2001291a0
   GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0
   HENSHAW EC, 1968, J MOL BIOL, V36, P401, DOI 10.1016/0022-2836(68)90164-2
   ILAN J, 1973, NATURE-NEW BIOL, V241, P176, DOI 10.1038/newbio241176a0
   IMAIZUMI T, 1973, P NATL ACAD SCI USA, V70, P1122, DOI 10.1073/pnas.70.4.1122
   JONES RF, 1972, FED P, V31
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANE CD, 1971, J MOL BIOL, V61, P73, DOI 10.1016/0022-2836(71)90207-5
   LANE CD, 1973, EUR J BIOCHEM, V34, P219, DOI 10.1111/j.1432-1033.1973.tb02749.x
   LEBLEU B, 1971, EUR J BIOCHEM, V19, P264, DOI 10.1111/j.1432-1033.1971.tb01313.x
   LEE SY, 1971, BIOCHEMISTRY-US, V10, P510, DOI 10.1021/bi00779a025
   LESNAW JA, 1970, VIROLOGY, V42, P724, DOI 10.1016/0042-6822(70)90318-1
   LOENING UE, 1967, BIOCHEM J, V102, P251, DOI 10.1042/bj1020251
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUKANIDIN EM, 1971, FEBS LETT, V19, P152, DOI 10.1016/0014-5793(71)80501-X
   MIRAULT ME, 1971, EUR J BIOCHEM, V23, P372, DOI 10.1111/j.1432-1033.1971.tb01631.x
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   NOLL H, 1967, NATURE, V215, P360, DOI 10.1038/215360a0
   OLSNES S, 1970, BIOCHIM BIOPHYS ACTA, V213, P149, DOI 10.1016/0005-2787(70)90016-X
   OLSNES S, 1971, EUR J BIOCHEM, V23, P248, DOI 10.1111/j.1432-1033.1971.tb01615.x
   PEMBERTON RE, 1972, NATURE-NEW BIOL, V235, P99, DOI 10.1038/newbio235099a0
   SAMARINA OP, 1968, J MOL BIOL, V33, P251, DOI 10.1016/0022-2836(68)90292-1
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1963, P NATL ACAD SCI USA, V49, P240, DOI 10.1073/pnas.49.2.240
   SCHERRER K, 1966, B SOC CHIM BIOL, V48, P1037
   SCHERRER K, 1966, P NATL ACAD SCI USA, V56, P1571, DOI 10.1073/pnas.56.5.1571
   SCHERRER K, 1969, FUNDAMENTAL TECHNIQU
   SCHOCHETMAN G, 1972, J MOL BIOL, V63, P577, DOI 10.1016/0022-2836(72)90449-4
   SCHREIER MH, 1973, EUR J BIOCHEM, V34, P213, DOI 10.1111/j.1432-1033.1973.tb02748.x
   SCHWEIGER H, 1970, BIOCHIM BIOPHYS ACTA, V204, P317
   SEIFERT W, 1971, FEBS LETT, V16, P175, DOI 10.1016/0014-5793(71)80125-4
   SPOHR G, 1972, EUR J BIOCHEM, V31, P194, DOI 10.1111/j.1432-1033.1972.tb02519.x
   SPOHR G, 1972, Cell Differentiation, V1, P53, DOI 10.1016/0045-6039(72)90113-3
   SPOHR G, 1970, EUR J BIOCHEM, V17, P296, DOI 10.1111/j.1432-1033.1970.tb01168.x
   SPOHR G, 1972, FEBS LETT, V28, P165, DOI 10.1016/0014-5793(72)80702-6
   STEWART AG, 1973, EUR J BIOCHEM, V34, P205, DOI 10.1111/j.1432-1033.1973.tb21105.x
   WEBER K, 1969, J BIOL CHEM, V244, P4406
NR 46
TC 86
Z9 87
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1973
VL 36
IS 2
BP 455
EP 464
DI 10.1111/j.1432-1033.1973.tb02930.x
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA Q2837
UT WOS:A1973Q283700017
PM 4738397
OA Bronze
DA 2020-12-17
ER

PT J
AU DUBOCHET, J
   MOREL, C
   LEBLEU, B
   HERZBERG, M
AF DUBOCHET, J
   MOREL, C
   LEBLEU, B
   HERZBERG, M
TI STRUCTURE OF GLOBIN MESSENGER-RNA AND MRNA-PROTEIN PARTICLES - USE OF
   DARK-FIELD ELECTRON-MICROSCOPY
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 UNIV BASEL,BIOZENTRUM,ABT MIKROBIOL,CH-4056 BASIL,SWITZERLAND.
   WEIZMANNN INST SCI,DEPT BIOCHEM,REHOVOTH,ISRAEL.
   BAR ILAN UNIV,DEPT LIFE SCI,RAMAT GAN,ISRAEL.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0
   DAVIS RW, 1968, P NATL ACAD SCI USA, V60, P243, DOI 10.1073/pnas.60.1.243
   DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X
   Dubochet J, 1972, Microsc Acta, V72, P119
   GANDER ES, 1972, EUR J BIOCHEM, V29, P369, DOI 10.1111/j.1432-1033.1972.tb01998.x
   HERZBERG M, 1969, J MOL BIOL, V44, P297, DOI 10.1016/0022-2836(69)90176-4
   INMAN RB, 1967, J MOL BIOL, V25, P209, DOI 10.1016/0022-2836(67)90138-6
   JONES OW, 1966, J MOL BIOL, V22, P199, DOI 10.1016/0022-2836(66)90126-4
   KLEINSCHMIDT A, 1962, BIOCHIM BIOPHYS ACTA, V61, P857, DOI 10.1016/0926-6550(62)90001-4
   LEBLEU B, 1971, EUR J BIOCHEM, V19, P264, DOI 10.1111/j.1432-1033.1971.tb01313.x
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   MOREL C, 1973, EUR J BIOCHEM, V36, P455, DOI 10.1111/j.1432-1033.1973.tb02930.x
   OTTENSMEYER FP, 1969, BIOPHYS J, V9, P1149
   REVEL M, 1969, COLD SPRING HARB SYM, V34, P261, DOI 10.1101/SQB.1969.034.01.032
   REVEL M, 1968, J MOL BIOL, V33, P231, DOI 10.1016/0022-2836(68)90291-X
   SCHERRER K, 1968, J CELL PHYSIOL
   SPOHR G, 1970, EUR J BIOCHEM, V17, P296, DOI 10.1111/j.1432-1033.1970.tb01168.x
NR 17
TC 41
Z9 41
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1973
VL 36
IS 2
BP 465
EP 472
DI 10.1111/j.1432-1033.1973.tb02931.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA Q2837
UT WOS:A1973Q283700018
PM 4738398
OA Bronze
DA 2020-12-17
ER

PT J
AU STEWART, AG
   GANDER, ES
   MOREL, C
   LUPPIS, B
   SCHERRER, K
AF STEWART, AG
   GANDER, ES
   MOREL, C
   LUPPIS, B
   SCHERRER, K
TI DIFFERENTIAL TRANSLATION OF DUCK GLOBULIN AND RABBIT GLOBULIN MESSENGER
   RNAS IN RETICULOCYTE-LYSATE SYSTEMS
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 SWISS INST EXPTL CANC RES,DEPT MOLEC BIOL,LAVSANNE 1005,SWITZERLAND.
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR ADAMSON SD, 1968, ARCH BIOCHEM BIOPHYS, V125, P671, DOI 10.1016/0003-9861(68)90625-5
   Anson ML, 1930, J GEN PHYSIOL, V13, P469, DOI 10.1085/jgp.13.4.469
   BORSOOK H, 1957, J BIOL CHEM, V229, P1057
   EVANS MJ, 1969, BIOCHEMISTRY-US, V8, P3000, DOI 10.1021/bi00835a048
   HEYWOOD SM, 1970, P NATL ACAD SCI USA, V67, P1782, DOI 10.1073/pnas.67.4.1782
   HOUSMAN D, 1971, P NATL ACAD SCI USA, V68, P2716, DOI 10.1073/pnas.68.11.2716
   HUNT T, 1971, P NATL ACAD ACI USA, V68, P1075
   LANE CD, 1973, EUR J BIOCHEM, V34, P219, DOI 10.1111/j.1432-1033.1973.tb02749.x
   LINGREL JB, 1972, METHODS PROTEIN BIOS
   LOCKARD RE, 1971, NATURE-NEW BIOL, V233, P204
   LOCKARD RE, 1969, BIOCHEM BIOPH RES CO, V37, P204, DOI 10.1016/0006-291X(69)90720-7
   LODISH HF, 1970, J MOL BIOL, V50, P689, DOI 10.1016/0022-2836(70)90093-8
   LODISH HF, 1971, BIOCHEMISTRY-US, V10, P2348, DOI 10.1021/bi00788a027
   MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1
   MATHEWS MB, 1970, NATURE, V228, P661, DOI 10.1038/228661a0
   MATHEWS MB, 1971, NATURE-NEW BIOL, V233, P206
   METAFORA S, 1972, P NATL ACAD SCI USA, V69, P1299, DOI 10.1073/pnas.69.5.1299
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   PEMBERTON RE, 1972, NATURE-NEW BIOL, V235, P99, DOI 10.1038/newbio235099a0
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1970, COLD SPRING HARB SYM, V35, P539, DOI 10.1101/SQB.1970.035.01.070
   SCHREIER MH, 1973, EUR J BIOCHEM, V34, P213, DOI 10.1111/j.1432-1033.1973.tb02748.x
   SMITHIES O, 1965, SCIENCE, V150, P1595, DOI 10.1126/science.150.3703.1595
   SPOHR G, 1972, EUR J BIOCHEM, V31, P194, DOI 10.1111/j.1432-1033.1972.tb02519.x
   STAVNEZER J, 1971, NATURE-NEW BIOL, V230, P172
NR 25
TC 50
Z9 50
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1973
VL 34
IS 2
BP 205
EP 212
DI 10.1111/j.1432-1033.1973.tb21105.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA P4625
UT WOS:A1973P462500001
PM 4711204
OA Bronze
DA 2020-12-17
ER

PT J
AU LANE, CD
   GREGORY, CM
   MOREL, C
AF LANE, CD
   GREGORY, CM
   MOREL, C
TI DUCK HEMOGLOBIN SYNTHESIS IN FROG CELLS - TRANSLATION AND ASSAY OF
   RETICULOCYTE 9-S RNA IN OOCYTES OF XENOPUS-LAEVIS
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 UNIV OXFORD,DEPT ZOOL,OXFORD,ENGLAND.
   SWISS INST EXPTL CANC RES,DEPT MOLEC BIOL,LAUSANNE 1005,SWITZERLAND.
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR ATTARDI G, 1970, EXP CELL RES, V62, P11, DOI 10.1016/0014-4827(79)90505-6
   ATTARDI G, 1966, J MOL BIOL, V20, P145, DOI 10.1016/0022-2836(66)90123-9
   BERNS AJM, 1972, P NATL ACAD SCI USA, V69, P1606, DOI 10.1073/pnas.69.6.1606
   GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0
   HUEZ G, 1967, BIOCHIM BIOPHYS ACTA, V145, P629, DOI 10.1016/0005-2787(67)90122-0
   HUNT T, 1969, J MOL BIOL, V43, P123, DOI 10.1016/0022-2836(69)90083-7
   LANE CD, 1971, J MOL BIOL, V61, P73, DOI 10.1016/0022-2836(71)90207-5
   LANE CD, 1972, BIOLOGY RADIOBIOLOGY
   LANE CD, 1971, THESIS BODLEIAN LIBR
   LINGREL JB, 1972, METHODS PROTEIN SYNT, V2
   LOCKARD RE, 1969, BIOCHEM BIOPH RES CO, V37, P204, DOI 10.1016/0006-291X(69)90720-7
   MARBAIX G, 1972, J MOL BIOL, V67, P517, DOI 10.1016/0022-2836(72)90469-X
   MELLI M, 1972, NATURE-NEW BIOL, V236, P172, DOI 10.1038/newbio236172a0
   MOAR VA, 1971, J MOL BIOL, V61, P93, DOI 10.1016/0022-2836(71)90208-7
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
   OFFORD RE, 1969, DATA BIOCHEMICAL RES
   PEMBERTON RE, 1972, NATURE-NEW BIOL, V235, P99, DOI 10.1038/newbio235099a0
   SCHAPIRA G, 1968, METHODS ENZYMOL    B, V12
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1970, COLD SPRING HARB SYM, V35, P539, DOI 10.1101/SQB.1970.035.01.070
   SCHERRER K, 1966, B SOC CHIM BIOL, V48, P1037
   SCHERRER K, 1969, FUNDAMENTAL TECHNIQU
   SCHREIER MH, 1973, EUR J BIOCHEM, V34, P213, DOI 10.1111/j.1432-1033.1973.tb02748.x
   STEWART AG, 1973, EUR J BIOCHEM, V34, P205, DOI 10.1111/j.1432-1033.1973.tb21105.x
NR 24
TC 25
Z9 25
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1973
VL 34
IS 2
BP 219
EP 227
DI 10.1111/j.1432-1033.1973.tb02749.x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA P4625
UT WOS:A1973P462500003
PM 4736390
OA Bronze
DA 2020-12-17
ER

PT J
AU SANKOFF, D
   MOREL, C
   CEDERGREN, RJ
AF SANKOFF, D
   MOREL, C
   CEDERGREN, RJ
TI EVOLUTION OF 5S RNA AND NON-RANDOMNESS OF BASE REPLACEMENT
SO NATURE-NEW BIOLOGY
LA English
DT Article
C1 UNIV MONTREAL, CTR RECH MATH, CASE POSTALE 6128, MONTREAL 101, QUEBEC, CANADA.
   UNIV MONTREAL, DEPT BIOCHIM, CASE POSTALE 6128, MONTREAL 101, QUEBEC, CANADA.
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR BROWNLEE GG, 1972, FEBS LETT, V25, P8, DOI 10.1016/0014-5793(72)80442-3
   BROWNLEE GG, 1968, J MOL BIOL, V34, P379
   CEDERGREN RJ, 1972, J THEOR BIOL, V37, P209, DOI 10.1016/0022-5193(72)90017-3
   DAYHOFF MO, 1969, SCI AM, V221, P86
   DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5
   DUBUY B, 1971, J BIOL CHEM, V246, P747
   FORGET BG, 1967, SCIENCE, V158, P1695, DOI 10.1126/science.158.3809.1695
   HINDLEY J, 1972, FEBS LETT, V26, P157, DOI 10.1016/0014-5793(72)80563-5
   SANKOFF D, 1973, 262 PUBL CENT RECH M
   VOGEL F, 1972, J MOL EVOL, V1, P334, DOI 10.1007/BF01653962
   WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020
NR 11
TC 71
Z9 72
U1 1
U2 1
PU STOCKTON PRESS LTD
PI BASINGSTOKE,HAMPSHIRE
PA BRUNEL RD HOUNDMILLS, BASINGSTOKE,HAMPSHIRE RG21 2XS, ENGLAND
J9 NATURE-NEW BIOL
PY 1973
VL 245
IS 147
BP 232
EP 234
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA R1139
UT WOS:A1973R113900005
PM 4201431
DA 2020-12-17
ER

PT J
AU MOREL, C
   SCHERRER, K
   GANDER, E
AF MOREL, C
   SCHERRER, K
   GANDER, E
TI FURTHER STUDIES ON DUCK GLOBIN MESSENGER RIBONUCLEOPROTEIN COMPLEX
   (MRNP)
SO EXPERIENTIA
LA English
DT Meeting Abstract
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR BALTIMORE D, 1970, Journal of Molecular Biology, V47, P263, DOI 10.1016/0022-2836(70)90301-3
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
NR 2
TC 0
Z9 0
U1 0
U2 0
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 0014-4754
J9 EXPERIENTIA
JI Experientia
PY 1972
VL 28
IS 6
BP 749
EP &
PG 0
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA M7681
UT WOS:A1972M768100174
DA 2020-12-17
ER

PT J
AU STEWART, A
   SCHERRER, K
   MOREL, C
AF STEWART, A
   SCHERRER, K
   MOREL, C
TI PREPARATION OF A 9S RNA FROM DUCK IMMATURE RED BLOOD-CELLS AND ITS
   TRANSLATION IN A RABBIT RETICULOCYTE CELL-FREE SYSTEM
SO EXPERIENTIA
LA English
DT Meeting Abstract
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
CR ADAMSON SD, 1968, ARCH BIOCHEM BIOPHYS, V125, P671, DOI 10.1016/0003-9861(68)90625-5
   MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1
NR 2
TC 0
Z9 0
U1 0
U2 0
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 0014-4754
J9 EXPERIENTIA
JI Experientia
PY 1972
VL 28
IS 6
BP 751
EP &
PG 0
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA M7681
UT WOS:A1972M768100185
DA 2020-12-17
ER

PT J
AU QUEIROZ, O
   MOREL, C
   CELATI, C
AF QUEIROZ, O
   MOREL, C
   CELATI, C
TI PHOTOPERIODISM AND ENZYME ACTIVITY - LONG-TERM ADAPTATION OF COMPLEX
   METABOLIC NETWORK TO CHANGES IN PHOTOPERIOD
SO COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES
   SERIE D
LA French
DT Article
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR BRULFERT J, IN PRESS
   KORNBERG H. L., 1966, ESSAYS BIOCHEM, V2, P1
   MAEBA P, 1965, BIOCHEM BIOPH RES CO, V21, P503, DOI 10.1016/0006-291X(65)90412-2
   MOREL C, IN PRESS
   QUEIROZ O, 1968, PHYSIOL VEG, V6, P117
   QUEIROZ O, 1966, PHYSIOL VEG, V4, P323
   Waddington C.H., 1957, STRATEGY GENES
   WEBER G, 1962, ADV ENZYME REGUL, V1, P1
NR 8
TC 5
Z9 5
U1 0
U2 0
PU GAUTHIER-VILLARS/EDITIONS ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75015 PARIS, FRANCE
J9 CR ACAD SCI D NAT
PY 1971
VL 272
IS 24
BP 3045
EP &
PG 0
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA J6703
UT WOS:A1971J670300013
DA 2020-12-17
ER

PT J
AU MOREL, C
   KAYIBANDA, B
   SCHERRER, K
AF MOREL, C
   KAYIBANDA, B
   SCHERRER, K
TI ISOLATION OF A MESSENGER RIBONUCLEOPROTEIN COMPLEX FROM DUCK
   ERYTHROBLASTS
SO EXPERIENTIA
LA English
DT Meeting Abstract
RI Morel, Carlos/Q-9657-2019; Morel, Carlos M/B-4079-2009
OI Morel, Carlos/0000-0003-2752-0009; Morel, Carlos M/0000-0003-2752-0009
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 0014-4754
J9 EXPERIENTIA
JI Experientia
PY 1971
VL 27
IS 6
BP 739
EP +
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA J5836
UT WOS:A1971J583600154
DA 2020-12-17
ER

PT J
AU MOREL, C
   KAYIBANDA, B
   SCHERRER, K
AF MOREL, C
   KAYIBANDA, B
   SCHERRER, K
TI PROTEINS ASSOCIATED WITH GLOBIN MESSENGER RNA IN AVIAN ERYTHROBLASTS
   ISOLATION AND COMPARISON WITH PROTEINS BOUND TO NUCLEAR MESSENGER-LLIKE
   RNA
SO FEBS LETTERS
LA English
DT Article
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR ACHESON N, PERSONAL COMMUNICATI
   BALTIMORE D, 1970, Journal of Molecular Biology, V47, P263, DOI 10.1016/0022-2836(70)90301-3
   BURNY A, 1969, BIOCHIM BIOPHYS ACTA, V190, P228, DOI 10.1016/0005-2787(69)90176-2
   CARTOUZOU G, 1968, EUR J BIOCHEM, V4, P41, DOI 10.1111/j.1432-1033.1968.tb00171.x
   GEORGIEV GP, PERSONAL COMMUNICATI
   GIRARD M, 1966, P NATL ACAD SCI USA, V56, P999, DOI 10.1073/pnas.56.3.999
   HENSHAW EC, 1968, J MOL BIOL, V36, P401, DOI 10.1016/0022-2836(68)90164-2
   HENSHAW EC, 1970, BIOCHIM BIOPHYS ACTA, V199, P405, DOI 10.1016/0005-2787(70)90083-3
   HUEZ G, 1967, BIOCHIM BIOPHYS ACTA, V145, P629, DOI 10.1016/0005-2787(67)90122-0
   KAYIBANDA B, IN PRESS
   KRICHEVSKAYA AA, 1969, BIOCHIM BIOPHYS ACTA, V194, P619, DOI 10.1016/0005-2795(69)90129-9
   LEBLEU B, 1971, EUR J BIOCHEM, V19, P264, DOI 10.1111/j.1432-1033.1971.tb01313.x
   LESNAW JA, 1970, VIROLOGY, V42, P724, DOI 10.1016/0042-6822(70)90318-1
   LINGREL JB, PERSONAL COMMUNICATI
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUKANIDIN EM, PERSONAL COMMUNICATI
   MIRAULT ME, TO BE PUBLISHED
   MOREL C, 1971, EXPERIENTIA, V27, P739
   MOREL C, UNPUBLISHED
   NOLL H, 1967, NATURE, V215, P360, DOI 10.1038/215360a0
   OLSNES S, 1970, EUR J BIOCHEM, V15, P464, DOI 10.1111/j.1432-1033.1970.tb01029.x
   PEMBERTON RE, 1971, PERSONAL COMMUNICATI
   PERRY RP, 1968, J MOL BIOL, V35, P37, DOI 10.1016/S0022-2836(68)80035-X
   SAMARINA OP, 1968, J MOL BIOL, V33, P251, DOI 10.1016/0022-2836(68)90292-1
   SARASIN A, 1969, FEBS LETT, V4, P327, DOI 10.1016/0014-5793(69)80267-X
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1970, COLD SPRING HARB SYM, V35, P539, DOI 10.1101/SQB.1970.035.01.070
   SCHERRER K, 1966, B SOC CHIM BIOL, V48, P1037
   SCHWEIGER A, 1970, BIOCHIM BIOPHYS ACTA, V204, P317, DOI 10.1016/0005-2787(70)90149-8
   SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20
   SPOHR G, 1970, EUR J BIOCHEM, V17, P296, DOI 10.1111/j.1432-1033.1970.tb01168.x
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WILLIAMSON R, 1971, PERSONAL COMMUNICATI
NR 33
TC 107
Z9 108
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PY 1971
VL 18
IS 1
BP 84
EP +
DI 10.1016/0014-5793(71)80413-1
PG 1
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA K6612
UT WOS:A1971K661200022
PM 11946089
DA 2020-12-17
ER

PT J
AU SCHERRER, K
   SPOHR, G
   GRANBOUL.N
   MOREL, C
   GROSCLAU.J
   CHEZZI, C
AF SCHERRER, K
   SPOHR, G
   GRANBOUL.N
   MOREL, C
   GROSCLAU.J
   CHEZZI, C
TI NUCLEAR AND CYTOPLASMIC MESSENGER-LIKE RNA AND THEIR RELATION TO ACTIVE
   MESSENGER RNA IN POLYRIBOSOMES OF HELA CELLS
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR ATTARDI G, 1966, J MOL BIOL, V20, P145, DOI 10.1016/0022-2836(66)90123-9
   BALTIMOR.D, 1970, P NATL ACAD SCI USA, V66, P572, DOI 10.1073/pnas.66.2.572
   BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0
   BEERMAN W, 1965, CELL DIFFERENTIATION, P24
   BIRNBOIM HC, 1967, P NATL ACAD SCI USA, V58, P320, DOI 10.1073/pnas.58.1.320
   BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529
   BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349
   BURNY A, 1969, BIOCHIM BIOPHYS ACTA, V190, P228, DOI 10.1016/0005-2787(69)90176-2
   CARTOUZOU G, 1969, EUR J BIOCHEM, V8, P357, DOI 10.1111/j.1432-1033.1969.tb00536.x
   DANEHOLT B, 1969, CHROMOSOMA, V28, P418
   DARNELL JE, 1968, BACTERIOL REV, V32, P262, DOI 10.1128/MMBR.32.3.262-290.1968
   EDSTROM JE, 1967, J MOL BIOL, V28, P331, DOI 10.1016/S0022-2836(67)80013-5
   Georgiev G P, 1967, Prog Nucleic Acid Res Mol Biol, V6, P259
   GEORGIEV GP, 1969, J THEOR BIOL, V25, P473, DOI 10.1016/S0022-5193(69)80034-2
   GEORGIEV GP, 1963, NATURE, V200, P1291, DOI 10.1038/2001291a0
   GILLESPIE D, 1965, J MOL BIOL, V12, P829, DOI 10.1016/S0022-2836(65)80331-X
   GRANBOUL.N, 1969, EUR J BIOCHEM, V9, P1, DOI 10.1111/j.1432-1033.1969.tb00569.x
   HARRIS H, 1963, PROG NUCLEIC ACID RE, V2, P19, DOI 10.1016/S0079-6603(08)60308-6
   HENSHAW EC, 1968, J MOL BIOL, V36, P401, DOI 10.1016/0022-2836(68)90164-2
   KASAI T, 1968, ORGANIZATIONAL BIOSY
   KOHLER K, 1968, EUR J BIOCHEM, V5, P500, DOI 10.1111/j.1432-1033.1968.tb00398.x
   KOURILSKY P, IN PRESS
   LARA F. J. S., 1967, NAT CANCER INST MONGR, V27, P235
   LINDBERG U, 1970, P NATL ACAD SCI USA, V65, P1089, DOI 10.1073/pnas.65.4.1089
   MONTAGNI.L, 1968, CR ACAD SCI D NAT, V267, P1417
   NEULAT MM, 1966, BIOCHIM BIOPHYS ACTA, V114, P95, DOI 10.1016/0005-2787(66)90256-5
   PARSONS JT, 1968, J BIOL CHEM, V243, P5377
   PENMAN S, 1968, J MOL BIOL, V34, P49, DOI 10.1016/0022-2836(68)90234-9
   PENMAN S, 1963, P NATL ACAD SCI USA, V49, P654, DOI 10.1073/pnas.49.5.654
   PENMAN S, 1966, J MOL BIOL, V17, P117, DOI 10.1016/S0022-2836(66)80098-0
   PERRY RP, 1963, EXP CELL RES, V29, P400, DOI 10.1016/S0014-4827(63)80003-8
   PERRY RP, 1962, P NATL ACAD SCI USA, V48, P2179, DOI 10.1073/pnas.48.12.2179
   PERRY RP, 1968, J MOL BIOL, V35, P37, DOI 10.1016/S0022-2836(68)80035-X
   SAMARINA OP, 1966, NATURE, V210, P1319, DOI 10.1038/2101319a0
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1963, P NATL ACAD SCI USA, V49, P240, DOI 10.1073/pnas.49.2.240
   SCHERRER K, 1966, B SOC CHIM BIOL, V48, P1037
   SCHERRER K, 1966, P NATL ACAD SCI USA, V56, P1571, DOI 10.1073/pnas.56.5.1571
   SCHERRER K, 1965, B SOC CHIM BIOL, V47, P1967
   SCHERRER K, 1967, EXPERIMENTAL BIOLOGY, P244
   SHEARER RW, 1967, BIOCHEMISTRY-US, V6, P283, DOI 10.1021/bi00853a044
   SOEIRO R, 1969, J MOL BIOL, V44, P551, DOI 10.1016/0022-2836(69)90379-9
   SOEIRO R, 1966, J MOL BIOL, V19, P362
   SOEIRO R, 1970, Journal of Cell Biology, V44, P467, DOI 10.1083/jcb.44.3.467
   SOEIRO R, 1968, J CELL BIOL, V39, P112, DOI 10.1083/jcb.39.1.112
   SPIRIN A. S., 1964, ZH OBSHCH BIOL, V25, P321
   SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20
   SPIRIN AS, 1964, FED PROC, V24, pT907
   SPOHR G, IN PRESS
   STEVENIN J, 1968, J MOL BIOL, V33, P777, DOI 10.1016/0022-2836(68)90319-7
   TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0
   WAGNER EK, 1969, P NATL ACAD SCI USA, V64, P626, DOI 10.1073/pnas.64.2.626
NR 52
TC 118
Z9 118
U1 0
U2 2
PU COLD SPRING HARBOR LAB PRESS
PI PLAINVIEW
PA 1 BUNGTOWN RD, PLAINVIEW, NY 11724
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 1970
VL 35
BP 539
EP &
DI 10.1101/SQB.1970.035.01.070
PG 0
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA I5536
UT WOS:A1970I553600066
DA 2020-12-17
ER

PT J
AU SPOHR, G
   GRANBOUL.N
   MOREL, C
   SCHERRER, K
AF SPOHR, G
   GRANBOUL.N
   MOREL, C
   SCHERRER, K
TI MESSENGER RNA IN HELA CELLS - INVESTIGATION OF FREE AND
   POLYRIBOSOME-BOUND CYTOPLASMIC MESSENGER RIBONUCLEOPROTEIN PARTICLES BY
   KINETIC LABELLING AND ELECTRON MICROSCOPY
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009
CR BALTIMORE D, 1970, Journal of Molecular Biology, V47, P263, DOI 10.1016/0022-2836(70)90301-3
   BELITSINA N V, 1968, Molekulyarnaya Biologiya (Moscow), V2, P727
   BENEDETTI EL, 1968, BIOCHEM J, V108, P765, DOI 10.1042/bj1080765
   BURNY A, 1969, BIOCHIM BIOPHYS ACTA, V190, P228, DOI 10.1016/0005-2787(69)90176-2
   CARTOUZOU G, 1969, EUR J BIOCHEM, V8, P357, DOI 10.1111/j.1432-1033.1969.tb00536.x
   CHEZZI C, UNPUBLISHED RESULTS
   COLVILL AJE, 1966, J MOL BIOL, V17, P302, DOI 10.1016/S0022-2836(66)80113-4
   FLORENDO NT, 1970, J ULTRA MOL STRUCT R, V30, P1, DOI 10.1016/S0022-5320(70)90061-4
   FUCHS E, 1964, J MOL BIOL, V10, P546, DOI 10.1016/S0022-2836(64)80076-0
   FUHR JE, 1969, P NATL ACAD SCI USA, V63, P129, DOI 10.1073/pnas.63.1.129
   GEORGIEV GP, 1963, NATURE, V200, P1291, DOI 10.1038/2001291a0
   GILBERT WALTER, 1963, JOUR MOLECULAR BIOL, V6, P389, DOI 10.1016/S0022-2836(63)80051-0
   GIRARD M, 1966, P NATL ACAD SCI USA, V56, P999, DOI 10.1073/pnas.56.3.999
   GRANBOULAN N, UNPUBLISHED RESULTS
   HENSHAW EC, 1965, J MOL BIOL, V14, P241, DOI 10.1016/S0022-2836(65)80244-3
   HENSHAW EC, 1968, J MOL BIOL, V36, P401, DOI 10.1016/0022-2836(68)90164-2
   HENSHAW EC, 1970, BIOCHIM BIOPHYS ACTA, V199, P405, DOI 10.1016/0005-2787(70)90083-3
   JOKLIK W. K., 1965, J MOL BIOL, V13, P511
   KAFATOS FC, 1968, P NATL ACAD SCI USA, V59, P1251, DOI 10.1073/pnas.59.4.1251
   KELLENBERGER E, PERSONAL COMMUNICATI
   KOHLER K, 1968, EUR J BIOCHEM, V5, P500, DOI 10.1111/j.1432-1033.1968.tb00398.x
   LISSITZKY S, 1970, EUR J BIOCHEM, V12, P104, DOI 10.1111/j.1432-1033.1970.tb00826.x
   LUBIN M, 1969, J MOL BIOL, V39, P219, DOI 10.1016/0022-2836(69)90343-X
   MCCONKEY EH, 1965, J MOL BIOL, V14, P257, DOI 10.1016/S0022-2836(65)80245-5
   MIRAULT ME, 1968, J CELL PHYSIOL, V72, P235
   MOREL C, UNPUBLISHED OBSERVAT
   Ovchinnikov L. P., 1969, Molekulyarnaya Biologiya, V3, P465
   PARSONS JT, 1968, J BIOL CHEM, V243, P5377
   PENMAN S, 1968, J MOL BIOL, V34, P49, DOI 10.1016/0022-2836(68)90234-9
   PENMAN S, 1963, P NATL ACAD SCI USA, V49, P654, DOI 10.1073/pnas.49.5.654
   PERRY RP, 1963, EXP CELL RES, V29, P400, DOI 10.1016/S0014-4827(63)80003-8
   PERRY RP, 1962, P NATL ACAD SCI USA, V48, P2179, DOI 10.1073/pnas.48.12.2179
   PERRY RP, 1968, J MOL BIOL, V35, P37, DOI 10.1016/S0022-2836(68)80035-X
   REICH E, 1961, SCIENCE, V134, P556, DOI 10.1126/science.134.3478.556
   RINGBORG U, PERSONAL COMMUNICATI
   SAMARINA OP, 1966, NATURE, V210, P1319, DOI 10.1038/2101319a0
   SAMARINA OP, 1968, J MOL BIOL, V33, P251, DOI 10.1016/0022-2836(68)90292-1
   SCHERRER K, 1968, J CELL PHYSIOL, V72, P181, DOI 10.1002/jcp.1040720413
   SCHERRER K, 1963, P NATL ACAD SCI USA, V49, P240, DOI 10.1073/pnas.49.2.240
   SCHERRER K, 1965, B SOC CHIM BIOL, V47, P1697
   SCHERRER K, 1966, B SOC CHIM BIOL, V48, P1037
   SCHERRER K, 1966, P NATL ACAD SCI USA, V56, P1571, DOI 10.1073/pnas.56.5.1571
   SCHERRER K, IN PRESS
   SCHERRER K, UNPUBLISHED RESULTS
   Scherrer K., 1969, FUNDAMENTAL TECHNIQU, P413
   SCHERRER K, 1967, EXPERIMENTAL BIOLOGY, V1, P244
   SHEARER RW, 1967, BIOCHEMISTRY-US, V6, P283, DOI 10.1021/bi00853a044
   SHELTON E, 1966, J MOL BIOL, V22, P23, DOI 10.1016/0022-2836(66)90177-X
   SIDEBOTTOM E, 1969, J CELL SCI, V5, P351
   SLAYTER HS, 1963, J MOL BIOL, V7, P652, DOI 10.1016/S0022-2836(63)80112-6
   SOEIRO R, 1968, J CELL BIOL, V39, P112, DOI 10.1083/jcb.39.1.112
   Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1
   SPIRIN A. S., 1964, ZH OBSHCH BIOL, V25, P321
   SPIRIN AS, 1965, SCIENCE, V150, P214, DOI 10.1126/science.150.3693.214
   SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20
   SPIRIN AS, 1965, J MOL BIOL, V14, P611, DOI 10.1016/S0022-2836(65)80213-3
   SPIRIN AS, 1965, FED PROC, V24, pT907
   TOMKINS GM, 1969, SCIENCE, V166, P1474, DOI 10.1126/science.166.3912.1474
NR 58
TC 175
Z9 175
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PY 1970
VL 17
IS 2
BP 296
EP +
DI 10.1111/j.1432-1033.1970.tb01168.x
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA I0980
UT WOS:A1970I098000016
PM 5500399
OA Bronze
DA 2020-12-17
ER

PT J
AU DOLLFUS, A
   FORT, B
   MOREL, C
AF DOLLFUS, A
   FORT, B
   MOREL, C
TI JET PHOTOGRAPHY OF SOLAR CORONA WITH STRATOSPHERIC BALLOONS
SO COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES
   SERIE B
LA English
DT Article
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR DOLLFUS A, 1962, CR HEBD ACAD SCI, V255, P148
   DOLLFUS A, 1959, CR HEBD ACAD SCI, V249, P2602
   DOLLFUS A, 1958, CR HEBD ACAD SCI, V247, P42
   DOLLFUS A, 1967 COLL UAI BUD
   NEW KIRK G, 1967 COLL UAI BUD
   NEWKIRK G, 1965, ANN ASTROPHYS, V28, P234
   NEWKIRK G, 1963, APPL OPT, V2, P130
   NEWKIRK G, SOLAR ACTIVITIES  16
   NEWKIRK G, SOLAR ACTIVITIES R 4
   Purcell J., 1962, J OPT SOC AM, V52, P596
   WLERICK G, 1957, ASTROPHYS J, V126, P253, DOI 10.1086/146396
NR 11
TC 5
Z9 5
U1 0
U2 0
PU GAUTHIER-VILLARS/EDITIONS ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75015 PARIS, FRANCE
J9 CR ACAD SCI B PHYS
PY 1968
VL 266
IS 25
BP 1537
EP &
PG 0
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA YZ087
UT WOS:A1968YZ08700020
DA 2020-12-17
ER

PT J
AU NAJER, H
   MOREL, C
   MENIN, J
   GIUDICELLI, R
AF NAJER, H
   MOREL, C
   MENIN, J
   GIUDICELLI, R
TI ISOMERISATION DES N, N-ETHYLENE NARYLUREES
SO COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES
LA English
DT Article
RI Morel, Carlos/Q-9657-2019
OI Morel, Carlos/0000-0003-2752-0009
CR BLOOM BM, 1957, J AM CHEM SOC, V79, P5072, DOI 10.1021/ja01575a065
   FISCHBACK BC, 1957, CHEM ABSTR     9700E, V51
   FISCHBACK BC, 1956, BA 2 775 587
   FROMM E, 1928, LIEBIGS ANN CHEM, V467, P240
   Gabriel S, 1914, BER DTSCH CHEM GES, V47, P1866, DOI 10.1002/cber.19140470280
   GABRIELS S, 1895, BER, V28, P2936
   HEINE HW, 1959, J AM CHEM SOC, V81, P2202, DOI 10.1021/ja01518a048
   MCKAY AF, 1950, J AM CHEM SOC, V72, P3659, DOI 10.1021/ja01164a093
   NAJER H, 1959, B SOC CHIM FR, P352
   NAJER H, 1960, B SOC CHIM FR, P1650
   TISLER M, 1958, Arch Pharm Ber Dtsch Pharm Ges, V291/63, P457, DOI 10.1002/ardp.19582910906
NR 11
TC 8
Z9 8
U1 0
U2 0
PU GAUTHIER-VILLARS/EDITIONS ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75015 PARIS, FRANCE
J9 CR HEBD ACAD SCI
PY 1961
VL 253
IS 21
BP 2369
EP &
PG 0
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 9151A
UT WOS:A19619151A00032
DA 2020-12-17
ER

EF